Several other analysts have also recently commented on the stock. Analysts at Macquarie reiterated a “neutral” rating on shares of M&T Bank Co. in a research note to investors on Thursday. They now have a $110.00 price target on the stock. Separately, analysts at Compass Point raised their price target on shares of M&T Bank Co. from $96.00 to $99.00 in a research note to investors on Thursday. They now have a “neutral” rating on the stock. Finally, analysts at FBR Capital raised their price target on shares of M&T Bank Co. from $100.00 to $115.00 in a research note to investors on Thursday. They now have a “market perform” rating on the stock.

M&T Bank Co. traded up 1.76% on Thursday, hitting $104.88. M&T Bank Co. has a 1-year low of $67.23 and a 1-year high of $103.83. The company has a market cap of $13.287 billion and a price-to-earnings ratio of 18.52.

M&T Bank Co. last released its earnings data on Wednesday, October 17th. The company reported $2.24 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.85 by $0.39. Analysts expect that M&T Bank Co. will post $6.92 EPS for the current fiscal year.

M&T Bank Corporation (M&T) is a bank holding company. As of December 31, 2011, M&T had two wholly owned bank subsidiaries: M&T Bank and Wilmington Trust, National Association (Wilmington Trust, N.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Bank of America reported break-even earnings in the third quarter, compared with a loss according to the Zacks Consensus Estimate. Results were aided by substantial slowdown in provision for credit losses and almost stable operating expenses. Moreover, improved credit quality across most major portfolios as well as strong mortgage banking and investment banking performances were the other highlights of the quarter. On the flip side was the lower top line. Further, the company made significant progress in strengthening its balance sheet during the quarter, reflected by improved capital ratios. After analyzing the results, we maintain a long term Neutral recommendation on the stock.”

Bank of America traded up 0.32% on Thursday, hitting $9.47. Bank of America has a 52-week low of $4.92 and a 52-week high of $10.10. The company has a market cap of $102.1 billion and a price-to-earnings ratio of 10.35.

Bank of America last posted its quarterly earnings results on Wednesday, October 17th. The company reported $0.00 earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.06) by $0.06. The company’s revenue for the quarter was down 28.0% on a year-over-year basis.

BAC has been the subject of a number of other recent research reports. Analysts at Nomura raised their price target on shares of Bank of America to $9.00 in a research note to investors on Thursday. Separately, analysts at RBC Capital reiterated an “outperform” rating on shares of Bank of America in a research note to investors on Thursday. They now have a $12.00 price target on the stock. Finally, analysts at FBR Capital reiterated a “market perform” rating on shares of Bank of America in a research note to investors on Monday, October 8th. They now have a $9.00 price target on the stock.

Bank of America Corporation (Bank of America) is a bank holding company, and a financial holding company.

To view Zacks’ full report, visit www.zacks.com

ProAssurance traded down 0.84% on Thursday, hitting $90.78. ProAssurance has a 1-year low of $72.93 and a 1-year high of $92.84. The company has a market cap of $2.784 billion and a price-to-earnings ratio of 9.47.

ProAssurance last released its earnings data on Monday, August 6th. The company reported $1.92 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.48 by $0.44. ProAssurance’s revenue was down 6.3% compared to the same quarter last year. On average, analysts predict that ProAssurance will post $7.95 earnings per share for the current fiscal year.

ProAssurance Corporation (ProAssurance) is a holding company for property and casualty insurance companies focused on professional liability insurance.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Saks’ second quarter loss of $0.05 per share was in-line with the prior-year quarter. However, it was narrower than the Zacks Consensus Estimate of a loss of $0.09 per share, due to higher revenues. We are encouraged with the strong performance of women’s Wear Now’ and contemporary apparel, shoes as well as men’s contemporary apparel, shoes, and accessories, which drove the comparable store sales in the quarter. However, higher input costs led to contraction in gross margins. Though the company expects gross margin to expand in the second half, we prefer to remain on the sidelines owing to rising costs and economic pressure. “

Saks traded up 0.76% on Thursday, hitting $10.67. Saks has a 52-week low of $8.49 and a 52-week high of $12.14. The company has a market cap of $1.614 billion and a price-to-earnings ratio of 22.77.

Saks last posted its quarterly earnings results on Tuesday, August 14th. The company reported ($0.05) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.09) by $0.04. The company’s quarterly revenue was up 5.1% on a year-over-year basis.

Other equities research analysts have also recently issued reports about the stock. Analysts at UBS AG reiterated a “neutral” rating on shares of Saks in a research note to investors on Friday, September 7th. Separately, analysts at Barclays Capital reiterated an “equalweight” rating on shares of Saks in a research note to investors on Wednesday, August 15th. Finally, analysts at Citigroup raised their price target on shares of Saks from $11.00 to $12.00 in a research note to investors on Wednesday, August 15th. They now have a “neutral” rating on the stock.

Saks Incorporated is a fashion retail organization offering a range of distinctive luxury fashion apparel, shoes, accessories, jewelry, cosmetics, and gifts.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Apollo Group’s adjusted earnings of $0.52 per share comfortably surpassed the Zacks Consensus Estimate of $0.49in the fourth quarter of fiscal 2012. However, lower revenues resulted in a 49% decline from the prior-year quarter. Total revenue declined 11.0% primarily due to lower enrollments at the University of Phoenix. Revenues missed the Zacks expectations by 1.4%. The enrollment decline was due to changing regulatory requirements, an robust competition and a volatile economy. Overall, we like Apollo Group’s dominant market position as well as their continuous efforts to improve services and thereby, student experience and student employability. The company is also undertaking initiatives to improve operating efficiency and rationalize the cost structure. However, the choppy enrollment trend and regulatory changes keeps up on the sidelines. We have a Neutral rating on Apollo with a target price of $22.00.”

A number of other analysts have also recently weighed in on APOL. Analysts at BMO Capital Markets reiterated an “outperform” rating on shares of Apollo Group in a research note to investors on Wednesday. They now have a $34.00 price target on the stock. Separately, analysts at Deutsche Bank cut their price target on shares of Apollo Group from $25.00 to $21.00 in a research note to investors on Wednesday. They now have a “sell” rating on the stock. Finally, analysts at William Blair downgraded shares of Apollo Group from an “outperform” rating to a “market perform” rating in a research note to investors on Wednesday.

Apollo Group traded down 1.07% on Thursday, hitting $21.17. Apollo Group has a 52-week low of $21.34 and a 52-week high of $58.29. The company has a market cap of $2.388 billion and a price-to-earnings ratio of 6.16.

Apollo Group last announced its earnings results on Tuesday, October 16th. The company reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.49 by $0.03. The company’s revenue for the quarter was down 11.0% on a year-over-year basis. On average, analysts predict that Apollo Group will post $3.13 earnings per share for the current fiscal year.

Apollo Group, Inc. (Apollo Group) is a private education provider. The Company offers educational programs and services both online and on-campus at the undergraduate, master’s and doctoral levels through its wholly owned subsidiaries, The University of Phoenix, Inc.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Northern Trust Corporation’s third-quarter 2012 earnings of $0.73 per share lagged the Zacks Consensus Estimate. Overall, results were adversely impacted by lower top line, partially offset by decline in non-interest expenses. Though the shrinkage in expenses reflects prudent expense management by the company, deteriorating credit quality was a negative for the quarter. Moreover, the Dodd-Frank Act will bring in numerous regulatory changes over the next several years, which might act as deterrents to the company’s fundamentals. After reviewing the results, we are maintaining our Neutral recommendation on the shares.”

A number of other analysts have also recently weighed in on NTRS. Analysts at JPMorgan Chase reiterated a “neutral” rating on shares of Northern Trust in a research note to investors on Thursday. They now have a $50.50 price target on the stock. Separately, analysts at Jefferies Group reiterated a “hold” rating on shares of Northern Trust in a research note to investors on Monday, October 8th. They now have a $48.00 price target on the stock, down previously from $49.00.

Shares of Northern Trust traded up 0.23% during mid-day trading on Thursday, hitting $48.32. Northern Trust has a one year low of $34.87 and a one year high of $49.68. The company has a market cap of $11.622 billion and a P/E ratio of 18.40.

Northern Trust last released its earnings data on Wednesday, October 17th. The company reported $0.73 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.74 by $0.01. Northern Trust’s revenue was up .1% compared to the same quarter last year.

Northern Trust Corporation (Northern Trust) is a financial holding company that is a provider of asset servicing, fund administration, asset management, fiduciary and banking solutions for corporations, institutions, families and individuals worldwide.

To view Zacks’ full report, visit www.zacks.com

A number of other analysts have also recently weighed in on ALL. Analysts at Sanford C. Bernstein reiterated an “outperform” rating on shares of Allstate in a research note to investors on Tuesday. They now have a $45.00 price target on the stock. Separately, analysts at RBC Capital reiterated a “sector perform” rating on shares of Allstate in a research note to investors on Friday, October 5th. They now have a $39.00 price target on the stock. Finally, analysts at Goldman Sachs reiterated a “neutral” rating on shares of Allstate in a research note to investors on Tuesday, October 2nd. They now have a $40.00 price target on the stock.

Allstate traded up 1.79% on Thursday, hitting $42.62. Allstate has a 1-year low of $24.50 and a 1-year high of $41.94. The company has a market cap of $20.668 billion and a price-to-earnings ratio of 10.22.

Allstate last announced its earnings results on Tuesday, July 31st. The company reported $0.86 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.57 by $0.29. Allstate’s revenue was up 3.2% compared to the same quarter last year. On average, analysts predict that Allstate will post $4.46 earnings per share for the current fiscal year.

The Allstate Corporation (Allstate) is a holding company for Allstate Insurance Company. The Company’s business is conducted principally through Allstate Insurance Company, Allstate Life Insurance Company and their affiliates.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Based on better-than-expected first-quarter 2013 results, we have upgraded our long-term recommendation on Nike to Neutral. First quarter earnings of $1.27 per share ran past the Zacks Consensus Estimate of $1.12. Moreover, the superior demand for the Nike brand led to a 10% growth in the company’s top line that also surpassed the Zacks Consensus Estimate. However, higher input costs as well as a mix shift towards low-margin businesses continued to weigh on the company’s gross margin, which contracted 80 basis points to 43.5%. Beside the quarter’s implications, we expect the sluggish discretionary spending and intense competition amid rapidly changing customer preferences to undermine Nike’s future prospects. This shadow of darkness, which offsets the solid quarterly performance, keeps us on the sidelines.”

Other equities research analysts have also recently issued reports about the stock. Analysts at DA Davidson reiterated a “neutral” rating on shares of NIKE in a research note to investors on Monday, October 8th. They now have a $104.00 price target on the stock. Separately, analysts at Sterne Agee reiterated a “neutral” rating on shares of NIKE in a research note to investors on Wednesday, October 3rd. They now have a $125.00 price target on the stock. Finally, analysts at Canaccord Genuity raised their price target on shares of NIKE from $92.00 to $94.00 in a research note to investors on Friday, September 28th. They now have a “hold” rating on the stock.

NIKE remained flat at $97.57 during trading on Thursday. NIKE has a 1-year low of $85.10 and a 1-year high of $114.81. The company has a market cap of $43.960 billion and a price-to-earnings ratio of 21.22.

NIKE last released its earnings data on Thursday, September 27th. The company reported $1.23 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.12 by $0.11. The company had revenue of $6.70 billion for the quarter, compared to the consensus estimate of $6.41 billion. The company’s quarterly revenue was up 10.2% on a year-over-year basis.

NIKE, Inc. (NIKE) is engaged in the design, development and worldwide marketing and selling of footwear, apparel, equipment, accessories and services.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Abbott reported third quarter earnings of $1.30 per share, a couple of cents above the Zacks Consensus Estimate and 10.2% above the year-ago earnings. Third quarter revenues, however, declined 0.4% to $9.8 billion, missing the Zacks Consensus Estimate of $9.9 billion. Abbott remains on track to split into two separate publicly traded companies on January 1, 2013. While one company will deal in diversified medical products, the other (AbbVie) will focus on research-based pharmaceuticals. We are positive on the split which should allow the two separate entities to perform in a more focused manner. Humira continues to perform well and this should reduce concerns regarding AbbVie’s growth prospects. “

A number of other firms have also recently commented on ABT. Analysts at Raymond James downgraded shares of Abbott Laboratories from an “outperform” rating to a “market perform” rating in a research note to investors on Thursday. Separately, analysts at RBC Capital reiterated an “outperform” rating on shares of Abbott Laboratories in a research note to investors on Friday, October 12th. They now have a $72.00 price target on the stock. Finally, analysts at JPMorgan Chase reiterated a “neutral” rating on shares of Abbott Laboratories in a research note to investors on Monday, October 8th. They now have a $73.00 price target on the stock.

Abbott Laboratories traded down 3.77% on Thursday, hitting $66.44. Abbott Laboratories has a 1-year low of $52.05 and a 1-year high of $72.47. The company has a market cap of $104.3 billion and a price-to-earnings ratio of 22.45.

Abbott Laboratories last released its earnings data on Wednesday, October 17th. The company reported $1.30 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.28 by $0.02. The company’s quarterly revenue was down .4% on a year-over-year basis. Analysts expect that Abbott Laboratories will post $5.06 EPS for the current fiscal year.

Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a range of health care products.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Bed Bath & Beyond’s second-quarter 2012 earnings of $0.98 per share fell short of the Zacks Consensus Estimate of $1.02 but rose 5.4% year-over-year on the back of a 12.1% top-line growth, healthy comps and new store openings. The quarterly result benefited from the acquisition of World Market and Linen Holdings. Moreover, we remain impressed by the company’s initiatives of expanding and renovating stores as well as its focus on refreshing its merchandise mix to boost productivity. We believe these initiatives along with its focus on boosting online presence and making technological advancements should bode well for future sales. However, erratic consumer behavior and sluggish economic recovery may undermine the company’s performance. Moreover, margins are expected to remain under pressure due shift low-margin categories. Hence, we prefer to be on the sidelines at this juncture.”

Bed Bath & Beyond traded down 0.46% on Thursday, hitting $60.97. Bed Bath & Beyond has a 1-year low of $56.72 and a 1-year high of $75.84. The company has a market cap of $13.721 billion and a price-to-earnings ratio of 14.23.

Bed Bath & Beyond last released its earnings data on Wednesday, September 19th. The company reported $0.98 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.02 by $0.04. The company had revenue of $2.59 billion for the quarter, compared to the consensus estimate of $2.52 billion. The company’s revenue for the quarter was up 12.1% on a year-over-year basis. Analysts expect that Bed Bath & Beyond will post $4.63 EPS for the current fiscal year.

BBBY has been the subject of a number of other recent research reports. Analysts at Nomura reiterated a “neutral” rating on shares of Bed Bath & Beyond in a research note to investors on Tuesday, October 9th. They now have a $66.00 price target on the stock. Separately, analysts at Citigroup raised their price target on shares of Bed Bath & Beyond to $74.00 in a research note to investors on Friday, September 21st. Finally, analysts at Canaccord Genuity cut their price target on shares of Bed Bath & Beyond from $75.00 to $73.00 in a research note to investors on Thursday, September 20th. They now have a “buy” rating on the stock.

Bed Bath & Beyond Inc. is a chain of retail stores, operating under the names Bed Bath & Beyond (BBB), Christmas Tree Shops (CTS), Harmon and Harmon Face Values (Harmon) and buybuy BABY.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Vocus Inc. is a leading provider of software for public relations management. The company reported second quarter loss that was however lower than the Zacks Consensus Estimate. The company provided modest guidance for the third quarter of 2012 but raised full year guidance. Vocus is a successful player in an upcoming market with good growth prospects, utilizing strategic acquisitions to supplement its growth. It deals effectively with competition and continues to see steady increase in the customer base. We believe that the complete integration of iContact will further boost product adoption amongst the SMBs. However, integration risks, gradual increase in IT budgets, risks of operating in international markets are mitigating factors. We therefore maintain our Neutral recommendation on VOCS shares.”

Separately, analysts at FBR Capital raised their price target on shares of Vocus from $20.00 to $25.00 in a research note to investors on Tuesday, July 31st. They now have an “outperform” rating on the stock.

Shares of Vocus traded down 0.33% during mid-day trading on Thursday, hitting $18.18. Vocus has a one year low of $11.95 and a one year high of $24.60. The company’s market cap is $355.7 million.

Vocus last issued its quarterly earnings data on Tuesday, July 24th. The company reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.02. The company’s revenue for the quarter was up 55.5% on a year-over-year basis.

Vocus, Inc. (Vocus) is a provider of cloud marketing software. The Company provides a suite of software for social media marketing, search marketing, e-mail marketing and publicity, creating a solution for its customers.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “School Specialty’s first quarter fiscal 2013 earnings of $1.16 surpassed both the Zacks Consensus Estimate and the prior-year earnings due to a lower tax provision. However, total revenue decreased 8.7% year over year as both the segments witnessed revenue declines mainly due to constrained spending by schools. The company has witnessed significant revenue and margin decline in the last few years due to cautious spending by schools resulting from tight state and local government budgets. Further, School Specialty lowered its revenue expectations for fiscal 2013 due to a challenging market environment. However, we believe that the company’s diversified product and geographic mix strategic and cost-control initiatives combined with its product innovation efforts place it well for long-term growth once the school spending trends return to more normal levels. We therefore remain Neutral on the stock with a target price of $2.25.”

Shares of School Specialty traded down 6.59% during mid-day trading on Thursday, hitting $2.055. School Specialty has a 52 week low of $1.89 and a 52 week high of $8.48. The company’s market cap is $39.4 million.

School Specialty, Inc. (School Specialty) is an education company serving the pre-kindergarten through twelfth grade (preK-12) market with instructional solutions that address a range of educational needs, from basic school supplies to standards-based curriculum solutions.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “PepsiCo’s sluggish top line and currency headwinds dragged the company’s third quarter 2012 earnings per share down by 8% from prior-year quarter to $1.20. However, earnings edged past the Zacks Consensus Estimate of $1.16. Revenues declined 5% in the quarter mainly due to currency headwinds and re-franchising of the beverage business in China and Mexico. Excluding these headwinds, organic revenue was up 5% primarily banking on price increases. Overall, we are encouraged by the company’s strong brand portfolio, its product and geographic diversity and solid cash flow generation. Moreover, PepsiCo’s marketing support investments, brand building innovation and cost saving efforts will boost growth. However, we prefer to remain on the sidelines until we see some meaningful impact of these investments on the operating results. Moreover, a challenging consumer spending environment combined with currency headwinds raises concern. We therefore maintain a Neutral recommendation on PepsiCo with a target price of $74.00.”

PepsiCo traded up 0.84% on Thursday, hitting $70.69. PepsiCo has a 1-year low of $61.50 and a 1-year high of $73.66. The company has a market cap of $110.0 billion and a price-to-earnings ratio of 18.44.

PepsiCo last released its earnings data on Wednesday, October 17th. The company reported $1.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.16 by $0.04. The company’s revenue for the quarter was down 5.3% on a year-over-year basis.

Other equities research analysts have also recently issued reports about the stock. Analysts at JPMorgan Chase reiterated an “overweight” rating on shares of PepsiCo in a research note to investors on Thursday. They now have a $82.00 price target on the stock. Separately, analysts at UBS AG reiterated a “neutral” rating on shares of PepsiCo in a research note to investors on Thursday, September 27th.

PepsiCo, Inc. (PepsiCo) is a global food, snack and beverage company. The Company’s brands include Quaker Oats, Tropicana, Gatorade, Lay’s, Pepsi, Walkers, Gamesa and Sabritas.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We recently downgraded our recommendation on Hot to Neutral based on declining comparable-store sales transactions and rich valuations. We observe that comparable-store sales transactions have been falling year-over-year since the last four quarters. In the second quarter of fiscal 2012, number of transactions dropped 8%, whereas in the first quarter it dipped 6%. During the fourth and third quarters of fiscal 2011, it decreased 7% and 8%, respectively. Moreover, the stock is trading at a premium based on our forward earnings estimates that limits its further upside. However, the company’s improved second-quarter bottom-line performance was a key takeaway. The company posted a loss of $0.02 per share that fared better than the year-ago loss of $0.08. Its sustained focus on improving product offerings, merchandising and promotional activities drove sales up 4.6% year over year. Hot Topic now projects earnings between $0.08 and $0.10 per share in the third quarter and in the range of $0.23 to $0.27 in the fourth quarter. “

Several other analysts have also recently commented on the stock. Analysts at Janney Montgomery Scott reiterated a “buy” rating on shares of Hot Topic in a research note to investors on Thursday, August 16th. Separately, analysts at Piper Jaffray downgraded shares of Hot Topic from an “overweight” rating to a “neutral” rating in a research note to investors on Thursday, August 2nd. Finally, analysts at Susquehanna initiated coverage on shares of Hot Topic in a research note to investors on Tuesday, July 31st. They set a “positive” rating and a $15.00 price target on the stock.

Hot Topic traded down 0.42% on Thursday, hitting $9.45. Hot Topic has a 52-week low of $6.44 and a 52-week high of $10.73. The company has a market cap of $399.6 million and a price-to-earnings ratio of 26.96.

Hot Topic last posted its quarterly earnings results on Wednesday, August 15th. The company reported ($0.02) earnings per share for the quarter, meeting the analysts’ consensus estimate of ($0.02). The company’s revenue for the quarter was up 4.6% on a year-over-year basis. On average, analysts predict that Hot Topic will post $0.42 earnings per share for the current fiscal year.

Hot Topic, Inc. is a mall and Web-based specialty retailer operating the Hot Topic and Torrid concepts, as well as the e-space music concept, ShockHound.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Chevron Corp. is one of the largest integrated energy companies in the world and has an impressive business model. Its current oil and gas development project pipeline is among the best in the industry, boasting large, multiyear projects. Additionally, Chevron possesses one of the healthiest balance sheets among peers, which helps it to capitalize on investment opportunities with the option to make strategic acquisitions. However, due to its integrated nature, Chevron is particularly susceptible to the downside risk from any weakness in the global economy. We are also concerned by the company’s high level of capital spending, which may result in reduced returns going forward. As such, we see the stock performing in line with the broader market and maintain our Neutral recommendation. “

Shares of Chevron traded down 0.67% during mid-day trading on Thursday, hitting $114.41. Chevron has a one year low of $92.29 and a one year high of $118.53. The company has a market cap of $224.5 billion and a P/E ratio of 8.58.

Chevron last issued its quarterly earnings data on Friday, July 27th. The company reported $3.66 EPS for the quarter, beating the Thomson Reuters consensus estimate of $3.24 by $0.42. The company’s quarterly revenue was down 9.2% on a year-over-year basis. On average, analysts predict that Chevron will post $12.88 earnings per share for the current fiscal year.

Several other analysts have also recently commented on the stock. Analysts at Independent Research GmbH reiterated a “hold” rating on shares of Chevron in a research note to investors on Tuesday. They now have a $115.00 price target on the stock. Separately, analysts at Dahlman Rose initiated coverage on shares of Chevron in a research note to investors on Wednesday, October 10th. They set a “hold” rating on the stock. Finally, analysts at UBS AG reiterated a “buy” rating on shares of Chevron in a research note to investors on Wednesday, October 10th. They now have a $125.00 price target on the stock.

Chevron Corporation (Chevron) manages its investments in subsidiaries and affiliates and provides administrative, financial, management and technology support to the United States and international subsidiaries that engage in petroleum operations, chemicals operations, mining operations, power generation and energy services.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Leading network security provider Check Point delivered decent year-over-year growth in the third quarter 2012, but matched the Zacks Consensus Estimate on the bottom lines. However, topline came slightly below the Estimate. Forth quarter guidance lacked luster due to ongoing macro uncertainty and slower billings growth in Europe. However, we think that investor sentiment will be in Check Point’s favor, since it picked up market share from Cisco and Juniper. Check Point continued to benefit from its strength at the high end of the market, and growing demand for its blade solutions. However, scope for margin expansion is limited in the near term given its over-dependence on the indirect sales model), an uncertain economic environment and European exposure. We maintain our Neutral recommendation on Check Point.”

Shares of Check Point Software traded up 0.36% during mid-day trading on Thursday, hitting $41.30. Check Point Software has a 52 week low of $40.92 and a 52 week high of $65.00. The company has a market cap of $8.486 billion and a P/E ratio of 14.85.

Check Point Software last announced its earnings results on Wednesday, October 17th. The company reported $0.79 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.77 by $0.02. The company’s revenue for the quarter was up 7.8% on a year-over-year basis. On average, analysts predict that Check Point Software will post $3.18 earnings per share for the current fiscal year.

CHKP has been the subject of a number of other recent research reports. Analysts at Nomura cut their price target on shares of Check Point Software to $52.00 in a research note to investors on Thursday. Separately, analysts at Macquarie cut their price target on shares of Check Point Software from $60.00 to $55.00 in a research note to investors on Thursday. They now have an “outperform” rating on the stock. Finally, analysts at MKM Partners cut their price target on shares of Check Point Software from $60.00 to $48.00 in a research note to investors on Wednesday. They now have a “buy” rating on the stock.

Check Point Software Technologies Ltd. (Check Point) develops technologies to communications and transactions over the Internet by enterprises and consumers.

To view Zacks’ full report, visit www.zacks.com

A number of other analysts have also recently weighed in on IFNNY. Analysts at Jefferies Group downgraded shares of Infineon Technologies AG from a “hold” rating to an “underperform” rating in a research note to investors on Wednesday, September 26th. Separately, analysts at Natixis Bleichroeder downgraded shares of Infineon Technologies AG from a “buy” rating to a “neutral” rating in a research note to investors on Monday, September 10th. Finally, analysts at Deutsche Bank downgraded shares of Infineon Technologies AG from a “buy” rating to a “hold” rating in a research note to investors on Monday, September 10th.

Infineon Technologies AG traded up 2.34% on Thursday, hitting $6.99. Infineon Technologies AG has a 52-week low of $6.08 and a 52-week high of $10.61. The company has a market cap of $7.550 billion and a price-to-earnings ratio of 14.05.

Infineon Technologies AG is a Germany-based company developing semiconductors and system solutions for automotive and industrial electronics, and chip card, as well as security applications.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We have upgraded our recommendation on Xerox to Neutral from Underperform with a target price of $7.75. The company reported adjusted profit of $0.26 per share in the second quarter of 2012, in line with the Zacks Consensus Estimate. The company’s DO, BPO and ITO business have been improving as reflected in its revenue growth in the last reported quarter. Further, it expects to grow through meaningful acquisitions. However, the presence of a large number of substitutes and strong peer pressure are major threats to the company. It has lowered its full year EPS guidance to $1.07-$1.12 from $1.12-$1.18 due to soft technology business. “

Other equities research analysts have also recently issued reports about the stock. Analysts at BMO Capital Markets reiterated a “market perform” rating on shares of Xerox Corp. in a research note to investors on Wednesday. They now have a $8.50 price target on the stock. Separately, analysts at Citigroup initiated coverage on shares of Xerox Corp. in a research note to investors on Monday, October 8th. They set a “neutral” rating and a $8.00 price target on the stock.

Xerox Corp. traded up 0.48% on Thursday, hitting $7.355. Xerox Corp. has a 52-week low of $6.36 and a 52-week high of $8.84. The company has a market cap of $9.614 billion and a price-to-earnings ratio of 8.09.

Xerox Corp. last announced its earnings results on Friday, July 20th. The company reported $0.26 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.26. The company’s quarterly revenue was down 1.3% on a year-over-year basis.

Xerox Corporation provides a portfolio of document technology, services and software, and the diverse array of business process and information technology outsourcing support.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “MEMC posted an impressive second quarter with both the top and bottom lines surpassing the Zacks Consensus Estimates. The improvement was solely based on higher solar systems sales. Considering the current market trend, it is difficult to predict whether the Solar Energy segment will sustain its growth momentum. The company itself seems dubious about the environment, which can be easily inferred from a weak third quarter guidance. Management’s commentary of expecting a better demand/supply situation in the semiconductor market and overall expense control are encouraging. Though high debt burden and solar tariff cuts are concerns, solar system sales trajectory looks impressive. We upgrade the stock from Underperform to Neutral.”

Shares of MEMC Electronic Materials traded up 3.21% during mid-day trading on Thursday, hitting $2.57. MEMC Electronic Materials has a 52 week low of $1.44 and a 52 week high of $6.80. The company’s market cap is $593.5 million.

MEMC Electronic Materials last announced its earnings results on Wednesday, August 8th. The company reported $0.14 earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.02) by $0.16. The company’s quarterly revenue was up 8.4% on a year-over-year basis.

MEMC Electronic Materials, Inc. (MEMC) is engaged in the development, manufacture, and sale of silicon wafers.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Aided by growth in revenue as well as positive operating leverage, U.S. Bancorp’s third quarter 2012 earnings per share outpaced the Zacks Consensus Estimate. Top line was supported by growth in net interest income and fee-based revenue. Higher mortgage banking revenue primarily contributed to this uptick. While the company’s results were impacted by a number of one-time items in the reported quarter, the impact of these items taken together was nil on its third quarter earnings per share. Nevertheless, its attractive core franchisee, diverse revenue stream and strong performance in the past years are impressive. Solid capital position and increase in lending activities augur well. Yet, regulatory issues along with the expectation of a continued low interest rate environment are likely to limit the stock’s upside potential in the upcoming quarters. Hence, after reviewing the results, we are retaining our Neutral recommendation on the shares.”

USB has been the subject of a number of other recent research reports. Analysts at FBR Capital reiterated an “outperform” rating on shares of US Bancorp in a research note to investors on Thursday. They now have a $36.00 price target on the stock. Separately, analysts at Susquehanna upgraded shares of US Bancorp from a “neutral” rating to a “positive” rating in a research note to investors on Thursday. They now have a $40.00 price target on the stock, up previously from $34.00. Finally, analysts at ISI Group raised their price target on shares of US Bancorp to $37.00 in a research note to investors on Wednesday.

US Bancorp traded down 0.23% on Thursday, hitting $34.12. US Bancorp has a 1-year low of $23.72 and a 1-year high of $35.46. The company has a market cap of $64.668 billion and a price-to-earnings ratio of 12.57.

US Bancorp last released its earnings data on Wednesday, October 17th. The company reported $0.74 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.74. The company’s revenue for the quarter was up 8.0% on a year-over-year basis. Analysts expect that US Bancorp will post $2.85 EPS for the current fiscal year.

U.S. Bancorp (U.S. Bancorp) is a multi-state financial services holding company. It provides a range of financial services, including lending and depository services, cash management, foreign exchange and trust and investment management services.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are downgrading our recommendation on Avnet from Neutral to Underperform. Earnings estimates for the company have declined significantly, as the weakened economy and currency fluctuation continues to hurt its businesses. Moreover, the competitive strides in the industry may have a detrimental impact on the company. However, Avnet’s diversified product ranges and notable acquisition strategy would surely have a positive impact on its businesses. Additionally, the company’s cost effective initiatives and share repurchase activity are also impressive. “

Avnet traded up 0.25% on Wednesday, hitting $28.07. Avnet has a 52-week low of $25.41 and a 52-week high of $37.03. The company has a market cap of $3.967 billion and a price-to-earnings ratio of 7.39.

Avnet last posted its quarterly earnings results on Wednesday, August 8th. The company reported $0.99 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.08 by $0.09. The company’s revenue for the quarter was down 8.8% on a year-over-year basis. On average, analysts predict that Avnet will post $3.30 earnings per share for the current fiscal year.

Other equities research analysts have also recently issued reports about the stock. Analysts at UBS AG cut their price target on shares of Avnet to $35.00 in a research note to investors on Monday. They now have a “buy” rating on the stock. Separately, analysts at Raymond James downgraded shares of Avnet from an “outperform” rating to a “market perform” rating in a research note to investors on Friday, October 12th. Finally, analysts at Brean Murray reiterated a “buy” rating on shares of Avnet in a research note to investors on Thursday, October 11th. They now have a $36.00 price target on the stock.

Avnet, Inc. (Avnet), together with its subsidiaries, is an industrial distributor of electronic components, enterprise computer and storage products and embedded subsystems.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Honda is well positioned to take advantage of stricter environment regulations given its long-term focus on hybrid vehicles. Given these factors and favorable model mix and effective cost reduction measures, the company anticipates a revival in sales and profits for fiscal 2013. In the first quarter of fiscal 2013, it revealed more than fourfold increase in profits to 131.72 billion ($1.66 billion) or 73.09 ($0.92) per share. However, unfavorable foreign currency translation effects due to appreciation of the Japanese yen against most of the foreign currencies continue to mar the company’s results. Further, we are worried about its declining cash flow. As such, we have downgraded the recommendation on the shares of the company to Neutral from Outperform with a target price of $33.00.”

HMC has been the subject of a number of other recent research reports. Analysts at UBS AG initiated coverage on shares of Honda Motor Co. in a research note to investors on Friday, October 12th. They set a “buy” rating on the stock. Separately, analysts at Credit Suisse downgraded shares of Honda Motor Co. from an “outperform” rating to a “neutral” rating in a research note to investors on Friday, October 5th. Finally, analysts at Deutsche Bank downgraded shares of Honda Motor Co. from a “buy” rating to a “hold” rating in a research note to investors on Tuesday, September 25th.

Shares of Honda Motor Co. remained flat at $31.43 during during mid-day trading trading on Wednesday. Honda Motor Co. has a 52 week low of $27.52 and a 52 week high of $39.35. The company has a market cap of $56.646 billion and a P/E ratio of 14.31.

Honda Motor Co, Ltd. (Honda) develops, produces and manufactures a variety of motor products, ranging from small general-purpose engines and scooters to specialty sports cars.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Yum! Brands remains on track in order to achieve its annual earning per share growth target through unit development, comparable-store sales growth, revitalization of the core brand of the U.S. Taco Bell and share repurchases as well as dividend payments. We believe that the company’s overseas expansion remains one of its key growth drivers. The company’s well-diversified growth model also includes rapid unit expansion throughout the world. Moreover, Yum!’s brand recognition, consistent performance and exposure to the emerging economies gives it an edge over most of its competitors. However, stiff competition from other quick-service restaurant operators, increased tax rate for full-fiscal 2012, concerns over European economies, slowdown in China, tough comparisons in the U.S. and YRI ahead and margin pressure pose near term offsets. Hence, we maintain a Neutral recommendation on the stock.”

Yum! Brands traded up 0.56% on Wednesday, hitting $71.35. Yum! Brands has a 1-year low of $51.24 and a 1-year high of $74.44. The company has a market cap of $32.250 billion and a price-to-earnings ratio of 20.86.

Yum! Brands last released its earnings data on Tuesday, October 9th. The company reported $0.99 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.97 by $0.02. The company had revenue of $3.57 billion for the quarter, compared to the consensus estimate of $3.64 billion. Yum! Brands’s revenue was up 9.0% compared to the same quarter last year. On average, analysts predict that Yum! Brands will post $3.28 earnings per share for the current fiscal year.

YUM has been the subject of a number of other recent research reports. Analysts at JPMorgan Chase reiterated an “overweight” rating on shares of Yum! Brands in a research note to investors on Wednesday, October 10th. They now have a $75.00 price target on the stock. Separately, analysts at Bank of America reiterated a “buy” rating on shares of Yum! Brands in a research note to investors on Wednesday, October 10th. Finally, analysts at Credit Agricole upgraded shares of Yum! Brands from an “outperform” rating to a “buy” rating in a research note to investors on Wednesday, October 10th. They now have a $80.00 price target on the stock, up previously from $76.00.

Yum! Brands, Inc. (YUM) is a quick service restaurant company based on number of system units, with approximately 37,000 units in more than 120 countries and territories.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Amphenol is optimistic about the accelerating proliferation of new electronics in most of its end markets, which the company expects to propel demand with time. Earnings estimates for 2012 have moved up after the company raised the guidance for full year 2012. We view this as a definite positive given the clouded economic environment. The ongoing revolution in electronics continues to create opportunities for Amphenol. The company serves a variety of end markets and the diversification in end markets enables the company to post strong results even amid an uncertain economic environment. Hence, we maintain our Neutral recommendation ahead of its third quarter results.”

Amphenol traded up 2.26% on Wednesday, hitting $61.53. Amphenol has a 52-week low of $40.99 and a 52-week high of $63.70. The company has a market cap of $9.906 billion and a price-to-earnings ratio of 19.37.

Amphenol last posted its quarterly earnings results on Wednesday, October 17th. The company reported $0.90 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.89 by $0.01. The company’s quarterly revenue was up 6.8% on a year-over-year basis. Analysts expect that Amphenol will post $3.42 EPS for the current fiscal year.

Several other analysts have also recently commented on the stock. Analysts at Macquarie reiterated an “outperform” rating on shares of Amphenol in a research note to investors on Monday, October 8th. They now have a $63.00 price target on the stock. Separately, analysts at RBC Capital reiterated a “top pick” rating on shares of Amphenol in a research note to investors on Tuesday, September 4th. They now have a $69.00 price target on the stock. Finally, analysts at Bank of America downgraded shares of Amphenol from a “buy” rating to a “neutral” rating in a research note to investors on Tuesday, August 28th. They now have a $65.00 price target on the stock.

Amphenol Corporation (Amphenol) is a designer, manufacturer and marketer of electrical, electronic and fiber optic connectors, interconnect systems and coaxial and high-speed specialty cable.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Johnson & Johnson’s third quarter results exceeded expectations with earnings coming in at $1.25 per share, 5 cents above the Zacks Consensus Estimate. Revenues increased 6.5% year-over-year to $17.1 billion, beating the Zacks Consensus Estimate of $16.9 billion. Despite the negative impact of currency fluctuation, Johnson & Johnson recorded growth on the back of strong product sales. The company raised its outlook for 2012. While we expect the company to continue facing headwinds in the form of pricing pressure, currency fluctuation, manufacturing issues and healthcare reform, we believe the company’s diversified business model, lack of cyclicality, and strong financial position will continue helping it pave its way through tough situations. We remain Neutral on the stock.”

A number of other analysts have also recently weighed in on JNJ. Analysts at Deutsche Bank raised their price target on shares of Johnson & Johnson from $72.00 to $75.00 in a research note to investors on Wednesday. They now have a “hold” rating on the stock. Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of Johnson & Johnson in a research note to investors on Friday, October 12th. They now have a $78.00 price target on the stock. Finally, analysts at Goldman Sachs downgraded shares of Johnson & Johnson from a “neutral” rating to a “sell” rating in a research note to investors on Tuesday, October 9th. They now have a $72.00 price target on the stock. They noted that the move was a valuation call.

Johnson & Johnson traded up 2.08% on Wednesday, hitting $71.00. Johnson & Johnson has a 52-week low of $61.05 and a 52-week high of $69.80. The company has a market cap of $195.7 billion and a price-to-earnings ratio of 22.09.

Johnson & Johnson last posted its quarterly earnings results on Tuesday, October 16th. The company reported $1.25 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.21 by $0.04. The company’s quarterly revenue was up 6.5% on a year-over-year basis. Analysts expect that Johnson & Johnson will post $5.07 EPS for the current fiscal year.

Johnson & Johnson is a holding company. The Company, along with its subsidiaries, is engaged in the research and development, manufacture and sale of a range of products in the healthcare field.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Grainger’s third quarter 2012 earnings increased 12% year over year to $2.81 per share, while revenues advanced 8% to $2.28 billion. Both fell short of the respective Zacks Consensus Estimates. Given the weak economy, Grainger trimmed its sales growth forecast in the range of 11% to 12% for 2012. Grainger remains focused on expanding its product offerings and growing the share of its private label products. Grainger also focuses on expansion programs for strengthening its businesses across its operating regions, mainly in Asia and Latin America. However, the recent slowdown in the sales raises our concern. Margins are expected to remain under pressure due to Grainger’s accelerated investments. We maintain our Neutral recommendation with a target price of $220.”

W.W. Grainger traded down 0.15% on Wednesday, hitting $209.27. W.W. Grainger has a 1-year low of $162.50 and a 1-year high of $221.84. The company has a market cap of $14.585 billion and a price-to-earnings ratio of 21.50.

W.W. Grainger last released its earnings data on Tuesday, October 16th. The company reported $2.81 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.90 by $0.09. W.W. Grainger’s revenue was up 7.8% compared to the same quarter last year. On average, analysts predict that W.W. Grainger will post $10.62 earnings per share for the current fiscal year.

A number of other analysts have also recently weighed in on GWW. Analysts at FBR Capital reiterated a “market perform” rating on shares of W.W. Grainger in a research note to investors on Wednesday. They now have a $215.00 price target on the stock. Separately, analysts at Deutsche Bank initiated coverage on shares of W.W. Grainger in a research note to investors on Friday, October 12th. They set a “hold” rating and a $233.00 price target on the stock. Finally, analysts at Wunderlich reiterated a “hold” rating on shares of W.W. Grainger in a research note to investors on Monday, October 8th. They now have a $208.00 price target on the stock.

W.W. Grainger, Inc. (Grainger) is a distributor of maintenance, repair and operating supplies and other related products and services used by businesses and institutions primarily in the United States and Canada.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “MannKind’s second quarter 2012 net loss of $0.23 per share was narrower than the year-ago loss of $0.37 and the Zacks Consensus Estimate of a loss of $0.25. We expect investor focus to remain on the fate of diabetes candidate, Afrezza, which received a second CRL from the FDA in January 2011. The FDA asked the company to conduct two additional trials with Afrezza. The management expects to complete the trials in the second quarter of 2013. Positive results would allow MannKind to file the NDA by the third quarter of 2013. The company believes its funds are sufficient to finance operations into the fourth quarter of 2012. However, we believe the company will look to raise funds shortly. Inability to raise sufficient funds will jeopardize Afrezza’s future. We remain Neutral on the stock.”

MannKind remained flat at $2.58 during trading on Wednesday. MannKind has a 1-year low of $1.57 and a 1-year high of $3.48. The company’s market cap is $491.0 million.

MannKind last released its earnings data on Tuesday, August 7th. The company reported ($0.23) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.24) by $0.01. Analysts expect that MannKind will post $-0.92 EPS for the current fiscal year.

Separately, analysts at JMP Securities upgraded shares of MannKind from a “market perform” rating to a “market outperform” rating in a research note to investors on Friday, August 10th.

MannKind Corporation (MannKind) is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are downgrading our recommendation on Vale from Neutral to Underperform based on the scenario of rising raw material costs, energy prices and alarming demand instability in the Chinese market, which is a main driver of global demand. Moreover, competitive world market and transportation cost of delivery across wide geographical client spread are also expected to pose potential risk for the stock. However, global economic recovery, rise in demand among the emerging nations, upward movement of worldwide metal spot prices as well as the company’s strategic acquisitions are expected to slightly offset the above risks.”

Vale traded up 2.16% on Wednesday, hitting $18.575. Vale has a 1-year low of $15.77 and a 1-year high of $26.87. The company has a market cap of $95.724 billion and a price-to-earnings ratio of 6.75.

A number of other firms have also recently commented on VALE. Analysts at Morgan Stanley downgraded shares of Vale from an “overweight” rating to an “equal weight” rating in a research note to investors on Thursday, October 4th. Separately, analysts at BB&T Capital Mkts initiated coverage on shares of Vale in a research note to investors on Wednesday, October 3rd. They set a “hold” rating on the stock. Finally, analysts at BB&T initiated coverage on shares of Vale in a research note to investors on Wednesday, October 3rd. They set a “hold” rating on the stock.

Vale S.A. is a metals and mining company. The Company is also a producer of iron ore and iron ore pellets.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Safeway’s third quarter EPS of $0.45 was $0.03 ahead of the Zacks Consensus Estimate and up 18.4% year over year. Sales continue to remain a drag with 0.2% year-over-year decline to $10.04 billion, marginally missing the Zacks Consensus estimate of $10.22 billion primarily due to disposition of Genuardi’s stores combined with a lower Canadian exchange rate, partially offset by higher fuel sales. Amid a difficult economy, ID sales are expected to improve in the fourth quarter on the back of successful rollout of “Just for U” loyalty program. Besides, volume trends are expected to improve further with easing of inflation. With a solid cash balance, Safeway rewards its shareholders through dividends and share repurchases. However, the company is facing margin compression. Moreover, highly leveraged balance sheet remains a matter of concern. We remain Neutral on the stock. “

Shares of Safeway traded up 2.32% during mid-day trading on Wednesday, hitting $16.29. Safeway has a 52 week low of $14.73 and a 52 week high of $23.16. The company has a market cap of $3.903 billion and a P/E ratio of 7.50.

Safeway last announced its earnings results on Thursday, October 11th. The company reported $0.45 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.43 by $0.02. The company had revenue of $10.05 billion for the quarter, compared to the consensus estimate of $10.24 billion. Safeway’s revenue was down .1% compared to the same quarter last year. On average, analysts predict that Safeway will post $2.00 earnings per share for the current fiscal year.

Other equities research analysts have also recently issued reports about the stock. Analysts at UBS AG reiterated a “sell” rating on shares of Safeway in a research note to investors on Friday, October 12th. They now have a $14.00 price target on the stock. Separately, analysts at Cowen reiterated an “outperform” rating on shares of Safeway in a research note to investors on Friday, October 12th. Finally, analysts at JPMorgan Chase reiterated a “neutral” rating on shares of Safeway in a research note to investors on Wednesday, October 10th. They now have a $17.00 price target on the stock.

Safeway Inc. (Safeway) is a food and drug retailer in North America. As of December 3 1, 2011, the Company had 1,678 stores.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are maintaining our Neutral recommendation on units of MarkWest Energy, as we see limited near term price upside. We continue to like MarkWest for its high-quality and diverse portfolio of midstream assets, as well as its proven track record of supporting producers in the growth of shale plays and its steady improvement in its liquidity/cash flow position. However, we think the current valuation is fair and adequately reflects the partnership’s future growth prospects. MarkWest’s core business – natural gas processing – is also faced with a higher degree of commodity price exposure than most MLPs. This is expected to further limit its ability to generate positive earnings surprises. As a result, our long-term total return expectation for MarkWest remains rather muted. “

Shares of MarkWest Energy Partners remained flat at $55.7175 during during mid-day trading trading on Wednesday. MarkWest Energy Partners has a 52 week low of $45.36 and a 52 week high of $61.60. The company has a market cap of $6.168 billion and a P/E ratio of 21.25.

MarkWest Energy Partners last announced its earnings results on Thursday, August 2nd. The company reported $1.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.42 by $1.05. The company’s quarterly revenue was up 11.4% on a year-over-year basis. Analysts expect that MarkWest Energy Partners will post $2.26 EPS for the current fiscal year.

Other equities research analysts have also recently issued reports about the stock. Analysts at Stephens initiated coverage on shares of MarkWest Energy Partners in a research note to investors on Friday, September 28th. They set an “overweight” rating and a $61.00 price target on the stock. Separately, analysts at Credit Suisse initiated coverage on shares of MarkWest Energy Partners in a research note to investors on Friday, August 10th. They set an “outperform” rating and a $59.00 price target on the stock. Finally, analysts at UBS AG cut their price target on shares of MarkWest Energy Partners to $57.00 in a research note to investors on Monday, August 6th. They now have a “buy” rating on the stock.

MarkWest Energy Partners, L.P. is a master limited partnership engaged in the gathering, processing and transportation of natural gas; the transportation, fractionation, storage and marketing of NGLs, and the gathering and transportation of crude oil.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Goldman’s third-quarter 2012 earnings per share of $2.85 significantly surpassed the Zacks Consensus Estimate of $2.18. Moreover, the reported earnings outpaced the prior-year quarter’s loss of $0.84 and prior quarter’s earnings of $1.78 per share. Amid challenging global markets and European debt crisis, the results were driven by Goldman’s record revenues with an elevation in client activity. Moreover, rise in global equity prices and positive impact of tighter credit spreads acted as tailwinds. Yet, escalated operating expenses acted as a headwind for the quarter. Additionally, regulatory issues coupled with fundamental pressure on the banking sector are expected to dent its financials in the upcoming quarters. After reviewing the results, we are maintaining our Neutral recommendation on the shares.”

Goldman Sachs traded up 0.94% on Wednesday, hitting $124.38. Goldman Sachs has a 1-year low of $86.90 and a 1-year high of $128.72. The company has a market cap of $61.742 billion and a price-to-earnings ratio of 18.43.

Goldman Sachs last released its earnings data on Tuesday, October 16th. The company reported $2.85 EPS for the quarter, beating the Thomson Reuters consensus estimate of $2.27 by $0.58. The company’s quarterly revenue was up 132.8% on a year-over-year basis. Analysts expect that Goldman Sachs will post $11.00 earnings per share for the current fiscal year.

GS has been the subject of a number of other recent research reports. Analysts at UBS AG raised their EPS on shares of Goldman Sachs in a research note to investors on Wednesday. They now have a “neutral” rating and a $125.00 price target on the stock. Separately, analysts at ISI Group raised their price target on shares of Goldman Sachs from $122.00 to $128.00 in a research note to investors on Wednesday. They now have a “hold” rating on the stock. Finally, analysts at FBR Capital raised their price target on shares of Goldman Sachs from $130.00 to $145.00 in a research note to investors on Wednesday. They now have an “outperform” rating on the stock.

The Goldman Sachs Group, Inc. (Goldman Sachs) is a global investment banking, securities and investment management firm that provides a range of financial services to a substantial and diversified client base that includes corporations, financial institutions, governments and high-net-worth individuals.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We downgrade our recommendation on FedEx Corporation to Underperform. The first quarter fiscal 2013 earnings outpaced the Zacks Consensus Estimate but were below the year-ago level due to lower revenue yield at FedEx Express, offsetting growth at the Freight and Ground segments. We remain concerned about the margin performance of Express segment, which is expected to remain subdued due to demand shift from premium to deferred products given economic volatilities. Domestic and international Express volumes are also expected to remain weak owing to poor demand trend. Despite the company’s effort in reducing cost, rising pension and depreciation expenses may impede near-term growth goals. Further, we remain cautious on the company’s expansion strategy in Europe given the current backdrop of the European economy. “

FedEx traded up 1.10% on Wednesday, hitting $92.93. FedEx has a 1-year low of $74.96 and a 1-year high of $97.19. The company has a market cap of $29.188 billion and a price-to-earnings ratio of 14.36.

FedEx last released its earnings data on Tuesday, September 18th. The company reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.05. The company had revenue of $10.79 billion for the quarter, compared to the consensus estimate of $10.70 billion. The company’s quarterly revenue was up 2.6% on a year-over-year basis. On average, analysts predict that FedEx will post $6.45 earnings per share for the current fiscal year.

Several other analysts have also recently commented on the stock. Analysts at Barclays Capital reiterated an “overweight” rating on shares of FedEx in a research note to investors on Friday, October 12th. They now have a $100.00 price target on the stock. Separately, analysts at Robert W. Baird raised their price target on shares of FedEx from $102.00 to $105.00 in a research note to investors on Friday, October 12th. They now have an “outperform” rating on the stock. Finally, analysts at Citigroup raised their price target on shares of FedEx from $99.00 to $108.00 in a research note to investors on Thursday, October 11th. They now have a “buy” rating on the stock.

FedEx Corporation (FedEx) is a holding company. The Company provides a portfolio of transportation, e-commerce and business services under the FedEx brand.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are downgrading our recommendation on United Continental to Underperform based on concerns over travel demand and pricing, which is expected to result in weak traffic in the third quarter. The company generated lackluster performance in the second quarter, missing the Zacks Consensus Estimate and below the year-ago earnings. Despite the company’s aggressive actions to improve profitability, we believe surging fuel prices and the threat of recession in Europe pose downside risks to the stock. Additionally, high non-fuel costs related to fleet optimization and product initiatives, high unionization, new regulations related to advertising, competitive threats and risks pertaining to the successful Continental integration could hurt the company’s profitability going forward.”

UAL has been the subject of a number of other recent research reports. Analysts at Barclays Capital reiterated an “equalweight” rating on shares of United Continental in a research note to investors on Friday, September 28th. Separately, analysts at Imperial Capital reiterated an “outperform” rating on shares of United Continental in a research note to investors on Thursday, September 27th. They now have a $31.00 price target on the stock. Finally, analysts at JPMorgan Chase cut their price target on shares of United Continental from $29.00 to $28.00 in a research note to investors on Wednesday, September 12th. They now have an “overweight” rating on the stock.

Shares of United Continental traded up 1.47% during mid-day trading on Wednesday, hitting $20.65. United Continental has a 52 week low of $15.51 and a 52 week high of $25.84. The company has a market cap of $6.863 billion and a P/E ratio of 17.38.

United Continental last announced its earnings results on Thursday, July 26th. The company reported $1.41 earnings per share for the quarter, missing the analysts’ consensus estimate of $1.72 by $0.31. United Continental’s revenue was up 1.3% compared to the same quarter last year. On average, analysts predict that United Continental will post $2.57 earnings per share for the current fiscal year.

United Continental Holdings, Inc. (UAL) is a holding company and its principal, wholly owned subsidiaries are United Air Lines, Inc.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Coca-Cola’s third-quarter earnings of $0.50 per share beat the Zacks Consensus Estimate by a penny. However, earnings declined almost 2% year over year largely hurt by currency headwinds. Revenues increased 1% as benefits from volume growth and positive pricing were largely offset by currency headwinds of 5%. Overall, Coca-Cola has solid long term fundamentals. We are encouraged by the company’s global reach, strong brand power, expanding presence outside the U.S. and its solid cash position. Moreover, the company’s acquisition of Coca-Cola Enterprises’ Bottling business and its productivity initiatives are expected to result in significant cost savings. However, soft economic conditions and tough currency environment ahead concerns us. We thus maintain a Neutral rating with a target price of $40.00.”

A number of other analysts have also recently weighed in on KO. Analysts at Deutsche Bank raised their price target on shares of Coca Cola from $40.00 to $42.00 in a research note to investors on Wednesday. They now have a “buy” rating on the stock. Separately, analysts at Citigroup raised their price target on shares of Coca Cola from $45.50 to $46.00 in a research note to investors on Wednesday. They now have a “buy” rating on the stock. Finally, analysts at Credit Agricole downgraded shares of Coca Cola from an “outperform” rating to an “underperform” rating in a research note to investors on Monday.

Coca Cola traded down 0.24% on Wednesday, hitting $37.81. Coca Cola has a 52-week low of $32.37 and a 52-week high of $40.665. The company has a market cap of $170.2 billion and a price-to-earnings ratio of 20.06.

Coca Cola last posted its quarterly earnings results on Tuesday, October 16th. The company reported $0.51 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.51. Coca Cola’s revenue was up .8% compared to the same quarter last year. Analysts expect that Coca Cola will post $2.00 EPS for the current fiscal year.

The Coca-Cola Company is a non-alcoholic beverage company. The Company owns or licenses and markets more than 500 non-alcoholic beverage brands, primarily sparkling beverages but also a variety of still beverages such as waters, enhanced waters, juices and juice drinks, ready-to-drink teas and coffees, and energy and sports drinks.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We have downgraded our long-term recommendation on Zumiez to Neutral’. Our view is based on the company’s declining comparable store sales transaction in fiscal 2012 so far, except in May. Further, the rate of upside in comparable store sales has been decelerating. Noticing this downward trend, we remain apprehensive about the company’s future comparable store sales performances. However, continuing with its store expansion and e-commerce strategies, Zumiez posted better-than-expected quarterly results for the second quarter of 2012. It posted earnings of $0.17 per share beating the Zacks Consensus Estimate of $0.13 and increasing over two-folds from the year-ago quarterly earnings of $0.08. Further, the acquisition of Blue Tomato facilitates Zumiez to tap the European market.”

A number of other analysts have also recently weighed in on ZUMZ. Analysts at Piper Jaffray reiterated a “neutral” rating on shares of Zumiez in a research note to investors on Wednesday, October 3rd. They now have a $27.00 price target on the stock. Separately, analysts at Janney Montgomery Scott reiterated a “neutral” rating on shares of Zumiez in a research note to investors on Wednesday, September 26th. Finally, analysts at William Blair reiterated an “outperform” rating on shares of Zumiez in a research note to investors on Wednesday, September 26th.

Shares of Zumiez traded down 2.90% during mid-day trading on Wednesday, hitting $26.615. Zumiez has a 52 week low of $20.74 and a 52 week high of $41.96. The company has a market cap of $834.5 million and a P/E ratio of 21.67.

Zumiez last announced its earnings results on Thursday, August 30th. The company reported $0.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.13 by $0.04. The company had revenue of $135.10 million for the quarter, compared to the consensus estimate of $135.52 million. Zumiez’s revenue was up 20.4% compared to the same quarter last year. Analysts expect that Zumiez will post $1.61 EPS for the current fiscal year.

Zumiez Inc. (Zumiez) is a specialty retailer of action sports related apparel, footwear, equipment and accessories operating under the Zumiez brand name.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are reaffirming our Neutral recommendation on Emerson Electric Co. with a $51 target price. Third quarter 2012 earnings improved 12.8% year over year. The Company’s solid operational execution and returns from the restructuring investments contributed to the overall growth. During the reported quarter, the company has shown strong underlying growth in Asia, Latin America and Canada and solid growth in the United States. However, growth in the Middle East/Africa and Europe was essentially flat. Project activity in oil and gas, chemical and power end markets gained momentum across all the product lines. However, we remain cautious for the time being due to the continued economic weakness in Europe and mixed global economic indicators.”

A number of other analysts have also recently weighed in on EMR. Analysts at Nomura reiterated a “buy” rating on shares of Emerson Electric in a research note to investors on Friday, October 12th. They now have a $57.00 price target on the stock. Separately, analysts at Deutsche Bank initiated coverage on shares of Emerson Electric in a research note to investors on Friday, October 12th. They set a “hold” rating and a $53.00 price target on the stock. Finally, analysts at Macquarie downgraded shares of Emerson Electric from an “outperform” rating to a “neutral” rating in a research note to investors on Monday, October 1st. They now have a $48.00 price target on the stock.

Shares of Emerson Electric traded up 0.80% during mid-day trading on Wednesday, hitting $49.27. Emerson Electric has a 52 week low of $43.59 and a 52 week high of $53.78. The company has a market cap of $35.835 billion and a P/E ratio of 14.81.

Emerson Electric last announced its earnings results on Tuesday, August 7th. The company reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.00 by $0.04. Emerson Electric’s revenue was up 3.1% compared to the same quarter last year. Analysts expect that Emerson Electric will post $3.34 EPS for the current fiscal year.

Emerson Electric Co is engaged in designing and supplying product technology and delivering engineering services and solutions in a range of industrial, commercial and consumer markets around the world.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Forest is facing tough times with Lexapro losing patent protection. Second quarter fiscal 2013 EPS of $0.08 was well below the year-earlier EPS of $0.91. Revenues declined 34.9% to $761 million, missing the Zacks Consensus Estimate of $779 million. Forest cut its fiscal 2013 outlook again following the release of second quarter results. More than Lexapro’s genericization, the cut in Namenda’s guidance is disappointing as Namenda is currently the main contributor to the company’s top line. Moreover, the performance of new products especially Teflaro, has been below expectations. However, we remain encouraged by the company’s progress with its pipeline candidates. We maintain a Neutral recommendation on the stock, which carries a Zacks #3 Rank (short-term Hold’ rating).”

Forest Laboratories traded down 0.23% on Wednesday, hitting $35.35. Forest Laboratories has a 52-week low of $28.47 and a 52-week high of $37.70. The company has a market cap of $9.392 billion and a price-to-earnings ratio of 12.30.

Forest Laboratories last posted its quarterly earnings results on Tuesday, October 16th. The company reported $0.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.02 by $0.06. Forest Laboratories’s revenue was down 34.9% compared to the same quarter last year. On average, analysts predict that Forest Laboratories will post $0.66 earnings per share for the current fiscal year.

Several other analysts have also recently commented on the stock. Analysts at Cowen downgraded shares of Forest Laboratories from an “outperform” rating to a “neutral” rating in a research note to investors on Tuesday. Separately, analysts at Cantor Fitzgerald reiterated a “buy” rating on shares of Forest Laboratories in a research note to investors on Friday, October 12th. They now have a $47.00 price target on the stock. Finally, analysts at Jefferies Group reiterated a “buy” rating on shares of Forest Laboratories in a research note to investors on Friday, October 5th. They now have a $41.00 price target on the stock.

Forest Laboratories, Inc. (Forest) develops, manufactures and sells branded forms of ethical drug products, most of which requires a physician’s prescription.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Fujifilm generated a net income of $31.2 million for 1Q13, down 82.5% year over year. Revenue was down 0.4% at $6.5 billion, due to the debt crisis in European countries. It should also be noted that Fuji faces a lot of competitions, which make it difficult to maintain its traditional businesses. Along with this, continuously rising prices of raw materials remain a concern. However, the company has adopted a number of cost cutting measures as well as technological advancements and diversification of its operations both regionally as well as on the basis of product offerings, in order to improve revenues. The company’s venture into new markets and setting up of new subsidiaries pave the way for a bright future. Thus, anticipating Fujifilm to perform in line with the market, we maintain a Neutral recommendation on the stock.”

FUJIFILM Holdings Corp. traded up 1.45% on Wednesday, hitting $17.53. FUJIFILM Holdings Corp. has a 52-week low of $15.75 and a 52-week high of $26.75. The company has a market cap of $8.444 billion and a price-to-earnings ratio of 21.31.

FUJIFILM Holdings Corporation is mainly engaged in the provision of imaging, information and document solutions.

To view Zacks’ full report, visit www.zacks.com

A number of other firms have also recently commented on GCI. Analysts at Benchmark Co. reiterated a “buy” rating on shares of Gannett in a research note to investors on Tuesday. They now have a $21.00 price target on the stock. Separately, analysts at JPMorgan Chase reiterated a “neutral” rating on shares of Gannett in a research note to investors on Friday, October 12th. They now have a $19.00 price target on the stock.

Shares of Gannett traded up 0.11% during mid-day trading on Wednesday, hitting $18.65. Gannett has a one year low of $10.22 and a one year high of $19.99. The company has a market cap of $4.316 billion and a P/E ratio of 10.12.

Gannett last issued its quarterly earnings data on Monday, October 15th. The company reported $0.56 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.53 by $0.03. The company’s quarterly revenue was up 3.4% on a year-over-year basis. On average, analysts predict that Gannett will post $2.22 earnings per share for the current fiscal year.

Gannett Co, Inc. is an international media and marketing solutions company, delivering content and services across an integrated, multi-platform portfolio.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are downgrading Intel shares from Neutral to Underperform following the company’s lowered expectations for the next quarter. We think that weakness in mature markets, economic headwinds in some emerging markets, and pressure from tablets and other competitors are taking a toll on the company. We think current trends overshadow Intel’s $0.04 positive surprise versus the Zacks Consensus in the second quarter that was driven by strength in server and software businesses and supported by a moderate PC business. However, we remain positive about Intel’s dominance in the high-margin server segment and promise of success in the mobile segment, although competition from ARM-based devices continues to intensify. We believe that Ultrabooks and Win-8 are wild cards this holiday season and could skew results either way. “

A number of other analysts have also recently weighed in on INTC. Analysts at Piper Jaffray reiterated a “neutral” rating on shares of Intel in a research note to investors on Tuesday. They now have a $22.00 price target on the stock. Separately, analysts at Roth Capital reiterated a “neutral” rating on shares of Intel in a research note to investors on Friday. They now have a $25.00 price target on the stock. Finally, analysts at Barclays Capital reiterated an “equalweight” rating on shares of Intel in a research note to investors on Wednesday, October 10th. They now have a $22.00 price target on the stock.

Intel traded up 2.85% on Tuesday, hitting $22.35. Intel has a 1-year low of $21.40 and a 1-year high of $29.27. The company has a market cap of $111.8 billion and a price-to-earnings ratio of 9.22.

Intel last released its earnings data on Tuesday, October 16th. The company reported $0.58 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.49 by $0.09. Intel’s revenue was down 5.5% compared to the same quarter last year. On average, analysts predict that Intel will post $2.11 earnings per share for the current fiscal year.

Intel Corporation designs and manufactures integrated digital technology platforms. A platform consists of a microprocessor and chipset.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are upgrading our recommendation on StanCorp to Neutral from Underperform as we expect the company to continue to deliver solid underwriting results and lower delinquency. The company is schedule to release its third quarter results on October 22 and we expect it to deliver earnings of 69 cents per share, improving sequentially though falling short of year ago earnings. StanCorp’s second quarter earnings lagged the Zacks Consensus Estimate and the year-ago results as the quarter experienced higher benefit ratio in the Insurance Services segment, largely due to less favorable claims experience in the group long-term disability business. StanCorp’s results were weighed upon by high unemployment and low interest rates. However, management remains focused on adopting pricing action on new as well as renewal business. The positives for StanCorp include premium growth, continued good investment performance, conservative underwriting practices, and focus on increasing shareholder value along with a strong capital position. “

A number of other analysts have also recently weighed in on SFG. Analysts at Morgan Stanley upgraded shares of StanCorp Financial Group from an “underweight” rating to an “equal weight” rating in a research note to investors on Thursday, August 9th. Analysts at UBS AG initiated coverage on shares of StanCorp Financial Group in a research note to investors on Wednesday, July 18th. They set a “sell” rating on the stock.

Shares of StanCorp Financial Group traded up 2.53% during mid-day trading on Tuesday, hitting $33.24. StanCorp Financial Group has a 52 week low of $28.74 and a 52 week high of $41.99. The company has a market cap of $1.467 billion and a P/E ratio of 10.06.

StanCorp Financial Group last announced its earnings results on Monday, July 23rd. The company reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.01. Analysts expect that StanCorp Financial Group will post $2.72 EPS for the current fiscal year.

StanCorp Financial Group, Inc. (StanCorp) is a holding company for its insurance and asset management subsidiaries.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are maintaining our Neutral recommendation on Transocean shares. We acknowledge that operational issues – such as fluctuating dayrates and high costs have held the company back. We also remain worried about the offshore driller’s high debt and its decision to halt its dividend. However, with its technologically-advanced and versatile offshore drilling fleet, strong backlog and considerable pricing power, the company offers an unmatched level of earnings and cash flow visibility. A recent court ruling, which absolves RIG of some of the cleanup cost related to the Deepwater Horizon incident, has also eased the overhang on the stock. Nevertheless, we expect Transocean shares to remain soft until it fully works its way through claims related to the BP oil spill.”

A number of other firms have also recently commented on RIG. Analysts at Macquarie upgraded shares of Transocean from a “neutral” rating to an “outperform” rating in a research note to investors on Monday. Separately, analysts at UBS AG reiterated a “neutral” rating on shares of Transocean in a research note to investors on Friday, September 28th. Finally, analysts at Goldman Sachs upgraded shares of Transocean from a “sell” rating to a “neutral” rating in a research note to investors on Wednesday, September 26th. They now have a $54.00 price target on the stock.

Shares of Transocean traded up 1.36% during mid-day trading on Tuesday, hitting $46.97. Transocean has a 52 week low of $38.21 and a 52 week high of $60.09. The company’s market cap is $16.881 billion.

Transocean last posted its quarterly earnings results on Wednesday, August 1st. The company reported $0.72 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.45 by $0.27. Transocean’s revenue was up 10.3% compared to the same quarter last year. Analysts expect that Transocean will post $2.94 EPS for the current fiscal year.

Transocean Ltd. (Transocean) is an international provider of offshore contract drilling services for oil and gas wells.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Macy’s comparable-store sales for the month of September increased 2.5% year over year, owing to the continued strength in its online business and improvement in women s segment. Going ahead, Macy s remains focused on improving comps and reducing operating expenses, through its “My Macy s program and expects comps growth of 3.7% for fiscal 2012. So far this year, Macy s has been performing well and has been taking a number of initiatives to bolster its sales, profitability and cash flows. These steps include integration of operations, consolidation of divisions as well as developing e-commerce business and online order fulfillment centers. Further, the company s recent venture with The Finish Line seems profitable as it will help it in attracting traffic. The company also seeks to expand both the Macy’s and Bloomingdale’s brands as the year brings enormous opportunity to enhance market share. However, secular headwinds and erratic consumer behavior still remain the causes for concern. “

Shares of Macy’s traded up 1.40% during mid-day trading on Tuesday, hitting $40.47. Macy’s has a 52 week low of $28.62 and a 52 week high of $42.17. The company has a market cap of $16.290 billion and a P/E ratio of 12.61.

Macy’s last announced its earnings results on Wednesday, August 8th. The company reported $0.67 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.64 by $0.03. The company’s quarterly revenue was up 3.0% on a year-over-year basis. On average, analysts predict that Macy’s will post $3.38 earnings per share for the current fiscal year.

A number of other analysts have also recently weighed in on M. Analysts at Atlantic Securities reiterated an “overweight” rating on shares of Macy’s in a research note to investors on Thursday, October 4th. They now have a $51.00 price target on the stock. Separately, analysts at Deutsche Bank reiterated a “buy” rating on shares of Macy’s in a research note to investors on Friday, September 28th. They now have a $43.00 price target on the stock. Finally, analysts at Barclays Capital raised their price target on shares of Macy’s from $42.00 to $45.00 in a research note to investors on Friday, August 31st. They now have an “overweight” rating on the stock.

Macy’s, Inc. (Macy’s) is a retail organization operating stores and Internet Websites under two brands (Macy’s and Bloomingdale’s) that sell a range of merchandise, including apparel and accessories (men’s, women’s and children’s), cosmetics, home furnishings and other consumer goods in 45 states, the District of Columbia, Guam and Puerto Rico.

To view Zacks’ full report, visit www.zacks.com

Amerisafe traded up 1.70% on Tuesday, hitting $27.47. Amerisafe has a 52-week low of $18.76 and a 52-week high of $28.40. The company has a market cap of $498.6 million and a price-to-earnings ratio of 19.43.

Amerisafe last posted its quarterly earnings results on Monday, July 30th. The company reported $0.18 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.40 by $0.22. The company’s revenue for the quarter was up 15.6% on a year-over-year basis. On average, analysts predict that Amerisafe will post $1.38 earnings per share for the current fiscal year.

AMERISAFE, Inc. (AMERISAFE) is a specialty provider of workers’ compensation insurance focused on small to mid-sized employers engaged in hazardous industries, principally construction, trucking and agriculture.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Despite posting a 14% drop in profits, TRW Automotive beat the Zacks Consensus Estimate by $0.17 in the second quarter of 2012. Revenues grew only 0.1%, as lower vehicle production in Europe and negative impact of currency movements largely offset the impact of strong demand for its products and higher vehicle production volumes in North America. However, TRW’s continued focus on innovative technologies could generate top- and bottom-line growth in near term. However, the broader economic environment remains a headwind. Considering all these aspects, we have maintained our Neutral recommendation on the shares of TRW and set a target price of $49.00.”

A number of other firms have also recently commented on TRW. Analysts at Jefferies Group reiterated a “buy” rating on shares of TRW Automotive Holdings Corp. in a research note to investors on Monday, October 1st. They now have a $55.00 price target on the stock. Separately, analysts at Goldman Sachs raised their price target on shares of TRW Automotive Holdings Corp. to $61.00 in a research note to investors on Monday, October 1st. Finally, analysts at Sterne Agee cut their price target on shares of TRW Automotive Holdings Corp. from $59.00 to $57.00 in a research note to investors on Wednesday, August 1st. They now have a “buy” rating on the stock.

TRW Automotive Holdings Corp. traded up 1.22% on Tuesday, hitting $47.34. TRW Automotive Holdings Corp. has a 1-year low of $28.85 and a 1-year high of $49.79. The company has a market cap of $5.777 billion and a price-to-earnings ratio of 6.01.

TRW Automotive Holdings Corp. last released its earnings data on Tuesday, July 31st. The company reported $1.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.18. The company’s revenue for the quarter was up .1% on a year-over-year basis. Analysts expect that TRW Automotive Holdings Corp. will post $6.01 EPS for the current fiscal year.

TRW Automotive Holdings Corp. (TRW Automotive) is a diversified supplier of automotive systems, modules and components to automotive original equipment manufacturers (OEMs) and related aftermarkets.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We adhere to our Neutral recommendation on Sasol Ltd. – a leading South African company following the lackluster fiscal year 2012 results, with earnings per share failing to meet our projection. Additionally, Sasol management remains wary of its performance in the coming months based on the unfavorable economic conditions. A stronger Rand/U.S. dollar exchange rate is another major area of concern. However, the company’s strategic initiatives to improve its operating level, superior technical expertise and compelling investment program offset the above-mentioned negative aspects to some extent. Sasol is also expected to reap benefits from its healthy balance sheet and strong cash position.”

Separately, analysts at Barclays Capital downgraded shares of Sasol Limited from an “overweight” rating to an “equal weight” rating in a research note to investors on Thursday, July 19th.

Sasol Limited traded up 1.67% on Tuesday, hitting $43.83. Sasol Limited has a 1-year low of $39.72 and a 1-year high of $54.42. The company has a market cap of $26.460 billion and a price-to-earnings ratio of 9.60.

Sasol Limited (Sasol) is an integrated energy and chemicals company. The Company mines coal in South Africa and produce gas and condensate in Mozambique and oil in Gabon, and its chemical manufacturing and marketing operations span the globe.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are upgrading our long-term recommendation on Kinder Morgan Inc., to Neutral from Underperform ahead of the third quarter results. The completion of the El Paso acquisition has enabled Kinder Morgan to leverage the extensive natural gas pipeline network and has given it access to major markets. Gradual dropdown of El Paso’s asset to its partnerships will further add value. The estimated rise in dividend for 2012 is also a positive. Further, higher exploration and production volumes along with continuous advancement on the Transmountain oil pipeline growth, terminal volume growth and upcoming new projects further enhances shareholders value. However, Kinder Morgan possesses limited exposure to the shale oil infrastructure which is undergoing a boom in recent times. “

A number of other analysts have also recently weighed in on KMI. Analysts at JPMorgan Chase raised their price target on shares of Kinder Morgan from $39.00 to $41.00 in a research note to investors on Wednesday, September 26th. They now have an “overweight” rating on the stock. Separately, analysts at Bank of America upgraded shares of Kinder Morgan from an “underperform” rating to a “neutral” rating in a research note to investors on Wednesday, September 12th. They now have a $36.00 price target on the stock. They noted that the move was a valuation call. Finally, analysts at Barclays Capital initiated coverage on shares of Kinder Morgan in a research note to investors on Friday, August 24th. They set an “overweight” rating and a $40.00 price target on the stock.

Shares of Kinder Morgan traded up 1.75% during mid-day trading on Tuesday, hitting $35.50. Kinder Morgan has a 52 week low of $26.91 and a 52 week high of $40.25. The company has a market cap of $36.821 billion and a P/E ratio of 276.90.

Kinder Morgan, Inc., formerly Kinder Morgan Holdco LLC, owns the general partner and approximately 11% of the limited partner interests of the Kinder Morgan Energy Partners, L.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Maintaining its track record of delivering earnings surprises, JPMorgan significantly surpassed the Zacks Consensus Estimate in the third quarter. Results mainly benefited from improved revenue and lower provision for credit losses. However, these were marginally offset by still high non-interest expenses. The earnings uptrend was a result of all business segments performing well. Further, marked recovery of the bond and equity market and healthy mortgage business helped the company overcome its difficulties to a great extent. However, during the quarter, asset quality deteriorated. After analyzing the results, we maintain our long term Neutral recommendation on the stock.”

Other equities research analysts have also recently issued reports about the stock. Analysts at JMP Securities raised their price target on shares of JPMorgan Chase to $31.00 in a research note to investors on Monday. They now have an “underperform” rating on the stock. Separately, analysts at Credit Agricole reiterated an “underperform” rating on shares of JPMorgan Chase in a research note to investors on Friday. They now have a $46.00 price target on the stock. Finally, analysts at Bank of America initiated coverage on shares of JPMorgan Chase in a research note to investors on Wednesday, October 10th. They set a “buy” rating on the stock.

Shares of JPMorgan Chase traded up 0.54% during mid-day trading on Tuesday, hitting $42.6083. JPMorgan Chase has a one year low of $28.28 and a one year high of $46.49. The company has a market cap of $172.5 billion and a P/E ratio of 8.96.

JPMorgan Chase last issued its quarterly earnings data on Friday, October 12th. The company reported $1.40 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.17 by $0.23. The company had revenue of $25.90 billion for the quarter, compared to the consensus estimate of $24.07 billion. JPMorgan Chase’s revenue was up 5.8% compared to the same quarter last year. Analysts expect that JPMorgan Chase will post $4.91 EPS for the current fiscal year.

JPMorgan Chase & Co (JPMorgan Chase) is a financial holding company. The Company is a global financial services firm and a banking institution in the United States, with global operations.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Linear Technology is a leading OEM of analog and mixed signal semiconductors. June quarter results missed the Zacks Consensus, and guidance too was soft. However, Linear is a very good defensive play in uncertain macro conditions, given its focus on core industrial, communications infrastructure and automotive markets, which enables it to generate solid cash flows from one quarter to the next. Therefore, we are optimistic about its solid business model, excellent products, ability to generate strong operating cash flows and dividend yield that should offset the effect of uncertain near-term demand and a high debt burden. We therefore have an Outperform rating on LLTC shares.”

LLTC has been the subject of a number of other recent research reports. Analysts at Barclays Capital reiterated an “equalweight” rating on shares of Linear Technology in a research note to investors on Wednesday, October 10th. They now have a $31.00 price target on the stock. Separately, analysts at ISI Group downgraded shares of Linear Technology from a “buy” rating to a “hold” rating in a research note to investors on Monday, October 8th. Finally, analysts at Raymond James downgraded shares of Linear Technology from a “market perform” rating to an “underperform” rating in a research note to investors on Friday, October 5th.

Linear Technology traded up 1.34% on Tuesday, hitting $32.47. Linear Technology has a 52-week low of $28.28 and a 52-week high of $34.50. The company has a market cap of $7.477 billion and a price-to-earnings ratio of 18.85.

Linear Technology last issued its quarterly earnings data on Tuesday, July 24th. The company reported $0.44 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.47 by $0.03. The company’s quarterly revenue was down 8.0% on a year-over-year basis. On average, analysts predict that Linear Technology will post $1.96 earnings per share for the current fiscal year.

Linear Technology Corporation (Linear Technology) designs, manufactures and markets a line of linear analog integrated circuits for companies worldwide.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Citigroup Inc. reported impressive third quarter 2012 results. Earnings per share came in at $1.06 for the quarter, comfortably surpassing the Zacks Consensus Estimate of $0.98 and the year-ago quarter’s earnings of $0.84 per share. Positive results were driven by lower loan loss provisions, higher Global Consumer Banking revenues and a drop in expenses. Notably, results in the reported quarter were impacted by credit valuation adjustment (CVA) and debt valuation adjustment (DVA) as well as by loss related to Morgan Stanley Smith Barney (MSSB) joint venture. Citigroup’s underlying franchises of the consumer businesses have remained strong, but revenues have continuously been under pressure for the past several quarters. Considering the tepid economic recovery, we believe that robust top-line expansion will remain elusive in the near term. After reviewing the results, we are maintaining our Neutral recommendation on the shares.”

C has been the subject of a number of other recent research reports. Analysts at JPMorgan Chase reiterated a “neutral” rating on shares of Citigroup in a research note to investors on Tuesday. They now have a $41.00 price target on the stock. Separately, analysts at JMP Securities raised their price target on shares of Citigroup to $26.00 in a research note to investors on Tuesday. They now have an “underperform” rating on the stock. Finally, analysts at Sterne Agee raised their price target on shares of Citigroup from $33.00 to $38.00 in a research note to investors on Tuesday. They now have a “neutral” rating on the stock.

Citigroup traded up 0.52% on Tuesday, hitting $36.85. Citigroup has a 52-week low of $23.30 and a 52-week high of $38.40. The company has a market cap of $108.1 billion and a price-to-earnings ratio of 10.62.

Citigroup last announced its earnings results on Monday, October 15th. The company reported $1.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.99 by $0.07. The company’s revenue for the quarter was up 2.7% on a year-over-year basis. On average, analysts predict that Citigroup will post $4.10 earnings per share for the current fiscal year.

Citigroup Inc. is a global diversified financial services holding company whose businesses provide consumers, corporations, governments and institutions with a broad range of financial products and services.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are reaffirming our Neutral recommendation on Danaher with a $59 target price. In the most recent quarter, the company reported good revenue and core revenue growth. Danaher is very optimistic about its Beckman Coulter acquisition and the company is already deriving better than expected synergies from the merger. Furthermore, the company is also able to drive organic growth and margin expansion, driven by its DBS system. However, due to dismal economic conditions in Europe, tougher comparables and stronger U.S. dollar the company lowered its guidance for fiscal 2012.”

Other equities research analysts have also recently issued reports about the stock. Analysts at Nomura reiterated a “buy” rating on shares of Danaher in a research note to investors on Friday. They now have a $63.00 price target on the stock. Separately, analysts at Deutsche Bank initiated coverage on shares of Danaher in a research note to investors on Friday. They set a “hold” rating and a $62.00 price target on the stock. Finally, analysts at Sanford C. Bernstein reiterated an “outperform” rating on shares of Danaher in a research note to investors on Friday, September 28th. They now have a $62.00 price target on the stock.

Danaher traded up 0.67% on Tuesday, hitting $56.6699. Danaher has a 1-year low of $43.69 and a 1-year high of $57.15. The company has a market cap of $39.406 billion and a price-to-earnings ratio of 17.34.

Danaher last released its earnings data on Thursday, July 19th. The company reported $0.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.80 by $0.04. The company’s revenue for the quarter was up 24.7% on a year-over-year basis. Analysts expect that Danaher will post $3.23 EPS for the current fiscal year.

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Schwab’s third quarter earnings marginally beat the Zacks Consensus Estimate. Results benefited from higher asset management and administration fees as well as balance sheet restructuring actions. However, higher operating expenses, increased provision for loan losses, lower net interest income and subdued trading revenue were the offsetting factors. After analyzing the results, we maintain our long term Neutral recommendation on the stock. “

Charles Schwab traded up 1.65% on Tuesday, hitting $13.245. Charles Schwab has a 52-week low of $10.67 and a 52-week high of $15.53. The company has a market cap of $16.876 billion and a price-to-earnings ratio of 19.68.

Charles Schwab last posted its quarterly earnings results on Monday, October 15th. The company reported $0.19 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.17 by $0.02. The company’s quarterly revenue was up 1.3% on a year-over-year basis. Analysts expect that Charles Schwab will post $0.69 EPS for the current fiscal year.

A number of other analysts have also recently weighed in on SCHW. Analysts at Macquarie reiterated a “neutral” rating on shares of Charles Schwab in a research note to investors on Tuesday. They now have a $12.00 price target on the stock. Separately, analysts at Keefe, Bruyette & Woods reiterated a “market perform” rating on shares of Charles Schwab in a research note to investors on Tuesday, October 9th. They now have a $15.00 price target on the stock. Finally, analysts at Raymond James reiterated an “underperform” rating on shares of Charles Schwab in a research note to investors on Friday, October 5th.

The Charles Schwab Corporation (CSC) is a savings and loan holding company. The Company engages, through its subsidiaries, in securities brokerage, banking, and related financial services.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We believe Panera Bread Co. remains well positioned to reinvigorate brands, revitalize comparable store sales and accelerate unit growth in the long run. The introduction of the new menu, increased positive impact from media support, traction to off-premises catering program, faster recovery of higher-end consumers and a more stable traffic growth compared to its restaurant peers promise future growth. The company is focused on enhancing shareholders’ value in terms of share repurchase activity. However, these positives are already reflected in the current valuation, leaving limited scope for further upside. Additionally, unfavorability in dough cost of sales to franchisees, tough comparison arising out of the initiation of My Panera loyalty card program and heightened competition will likely restrain the company’s operating margin growth in the near future. Hence, we downgrade the recommendation from Outperform to Neutral.”

Other equities research analysts have also recently issued reports about the stock. Analysts at Oppenheimer reiterated an “outperform” rating on shares of Panera Bread Company in a research note to investors on Wednesday, October 10th. Separately, analysts at BMO Capital Markets downgraded shares of Panera Bread Company from an “outperform” rating to a “market perform” rating in a research note to investors on Monday, October 8th. They now have a $180.00 price target on the stock. Finally, analysts at Raymond James downgraded shares of Panera Bread Company from a “market perform” rating to an “underperform” rating in a research note to investors on Friday, October 5th.

Shares of Panera Bread Company traded up 0.61% during mid-day trading on Tuesday, hitting $170.13. Panera Bread Company has a one year low of $104.28 and a one year high of $175.26. The company has a market cap of $4.968 billion and a P/E ratio of 32.66.

Panera Bread Company last issued its quarterly earnings data on Tuesday, July 24th. The company reported $1.50 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.43 by $0.07. The company’s quarterly revenue was up 17.6% on a year-over-year basis. Analysts expect that Panera Bread Company will post $5.80 EPS for the current fiscal year.

Panera Bread Company (Panera) s a national bakery-cafe concept with 1,541 Company-owned and franchise-operated bakery-cafe locations in42 states, the District of Columbia, and Ontario, Canada.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are initiating coverage on Acorda Therapeutics, Inc. with a Neutral recommendation. Acorda reported second quarter earnings of $0.13 per share, above the year-ago earnings of $0.07 but below the Zacks Consensus Estimate of $0.16 per share. Quarterly revenues increased 15.9% to $75.7 million, beating the Zacks Consensus Estimate of $73.0 million. Higher revenues were attributable to strong Ampyra sales. While we are pleased with the improvement in Ampyra sales, it remains to be seen whether the performance is sustainable. Moreover, we remain concerned about the company’s dependence on Ampyra for growth. The company’s pipeline, while interesting, is too early-stage in nature. We prefer to remain on the sidelines until we see a sustained improvement in Ampyra sales. The stock carries a Zacks #3 Rank (short-term Hold’ rating).”

Shares of Acorda Therapeutics traded down 0.64% during mid-day trading on Tuesday, hitting $23.46. Acorda Therapeutics has a 52 week low of $20.24 and a 52 week high of $27.74. The company has a market cap of $940.6 million and a P/E ratio of 22.02.

Acorda Therapeutics last announced its earnings results on Tuesday, July 31st. The company reported $0.27 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.27. The company’s revenue for the quarter was up 15.9% on a year-over-year basis. On average, analysts predict that Acorda Therapeutics will post $0.50 earnings per share for the current fiscal year.

Other equities research analysts have also recently issued reports about the stock. Analysts at RBC Capital reiterated an “outperform” rating on shares of Acorda Therapeutics in a research note to investors on Monday, October 8th. Separately, analysts at Leerink Swann reiterated an “outperform” rating on shares of Acorda Therapeutics in a research note to investors on Wednesday, August 22nd. Finally, analysts at Aegis initiated coverage on shares of Acorda Therapeutics in a research note to investors on Tuesday, August 21st. They set a “buy” rating and a $32.00 price target on the stock.

Acorda Therapeutics, Inc. (Acorda) is a commercial-stage biopharmaceutical company engaged in the identification, development and commercialization of therapies that improve neurological function in people with multiple sclerosis (MS), spinal cord injury (SCI) and other disorders of the nervous system.

To view Zacks’ full report, visit www.zacks.com

CenturyLink traded up 0.28% on Tuesday, hitting $38.90. CenturyLink has a 1-year low of $34.06 and a 1-year high of $43.43. The company has a market cap of $24.221 billion and a price-to-earnings ratio of 46.23.

CenturyLink last released its earnings data on Wednesday, August 8th. The company reported $0.65 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.61 by $0.04. The company’s revenue for the quarter was up 4.5% on a year-over-year basis. On average, analysts predict that CenturyLink will post $2.53 earnings per share for the current fiscal year.

A number of other analysts have also recently weighed in on CTL. Analysts at Raymond James reiterated a “strong buy” rating on shares of CenturyLink in a research note to investors on Tuesday. They now have a $48.00 price target on the stock. Separately, analysts at Macquarie reiterated an “outperform” rating on shares of CenturyLink in a research note to investors on Tuesday, October 9th. They now have a $44.00 price target on the stock. Finally, analysts at Wells Fargo & Co. reiterated an “outperform” rating on shares of CenturyLink in a research note to investors on Wednesday, October 3rd.

CenturyLink, Inc., formerly CenturyTel, Inc., together with its subsidiaries, is an integrated communications company engaged primarily in providing a range of communications services, including local and long distance voice, wholesale local network access, high-speed Internet access, other data services and video services.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Incyte’s second quarter 2012 earnings of $0.03 per share compared favorably with the year-ago loss of $0.41 per share. Results were boosted by higher revenues. We are pleased by the US and European approval of Jakafi (known as Jakavi in Europe) for patients with myelofibrosis. The company expects 2012 sales of Jakafi in the range of $120 – $135 million. We believe that the experience gained from marketing Jakafi should be helpful for future product launches. We see limited upside potential from current levels and hence retain our Neutral stance on the stock. The stock carries a Zacks #3 Rank (hold rating) in the short run. Our target price is $18.00.”

Shares of Incyte traded up 2.45% during mid-day trading on Tuesday, hitting $17.55. Incyte has a one year low of $11.76 and a one year high of $26.30. The company’s market cap is $2.295 billion.

Incyte last issued its quarterly earnings data on Thursday, August 2nd. The company reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.02) by $0.05. The company’s revenue for the quarter was up 414.9% on a year-over-year basis. On average, analysts predict that Incyte will post $-0.61 earnings per share for the current fiscal year.

A number of other analysts have also recently weighed in on INCY. Analysts at Jefferies Group reiterated a “buy” rating on shares of Incyte in a research note to investors on Wednesday, September 12th. Separately, analysts at Bank of America cut their price target on shares of Incyte from $26.00 to $24.00 in a research note to investors on Wednesday, September 5th. They now have a “buy” rating on the stock.

Incyte Corporation (Incyte) is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat serious unmet medical needs.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Smithfield’s first quarter 2013 earnings of $0.40 per share lagged the prior-year earnings by 42% as well as the Zacks Consensus Estimate by 11% due to a significant rise in costs leading to weak margins in the fresh pork businesses. Total sales remained flat at $3.1 billion, primarily due to soft sales in the hog production and international business. Total sales also lagged the Zacks Consensus Estimate of $3.13 billion. However, we are encouraged with the restructuring of the pork segment that is expected to increase pork production and build on the existing brands in the segment. Increased export volume of fresh pork is also impressive. Despite the positives, we believe the rising prices of raw materials are expected to outweigh the benefits from these initiatives in the near term and hurt margins. Thus, we prefer to remain on the sidelines on the stock with a target price of $21.00.”

Other equities research analysts have also recently issued reports about the stock. Analysts at Bank of America cut their price target on shares of Smithfield Foods from $19.00 to $17.00 in a research note to investors on Friday, August 31st. They now have an “underperform” rating on the stock. Separately, analysts at Morgan Stanley downgraded shares of Smithfield Foods from an “equal weight” rating to an “underweight” rating in a research note to investors on Tuesday, August 7th. Finally, analysts at Stephens downgraded shares of Smithfield Foods from an “overweight” rating to an “equal weight” rating in a research note to investors on Tuesday, July 17th.

Smithfield Foods traded up 0.29% on Monday, hitting $20.51. Smithfield Foods has a 52-week low of $17.55 and a 52-week high of $25.12. The company has a market cap of $3.066 billion and a price-to-earnings ratio of 9.61.

Smithfield Foods last posted its quarterly earnings results on Tuesday, September 4th. The company reported $0.40 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.45 by $0.05. The company had revenue of $3.09 million for the quarter, compared to the consensus estimate of $3.15 million. The company’s quarterly revenue was down .1% on a year-over-year basis. Analysts expect that Smithfield Foods will post $1.85 EPS for the current fiscal year.

Smithfield Foods, Inc., together with its subsidiaries, produces and markets a range of fresh meat and packaged meat products both domestically and internationally.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Cypress develops and manufactures a broad range of digital and mixed signal ICs. The company delivered a decent second quarter, with both revenue and earnings up sequentially due to strong demand for TrueTouch products and solid operating expense management. The product roadmap looks good and we believe that it could generate healthy touch revenue throughout this year. The company’s advanced technology, design win momentum, increased customer wins, more focused approach and cost reduction initiatives make us optimistic. However, a weak and uncertain macro environment and increased pricing pressure remain causes for concern. We therefore have a Neutral rating on CY shares.”

Cypress Semi traded up 2.94% on Monday, hitting $10.17. Cypress Semi has a 1-year low of $9.87 and a 1-year high of $20.50. The company has a market cap of $1.511 billion and a price-to-earnings ratio of 27.99.

Cypress Semi last released its earnings data on Thursday, July 19th. The company reported $0.18 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.18. The company’s quarterly revenue was down 21.1% on a year-over-year basis. On average, analysts predict that Cypress Semi will post $0.71 earnings per share for the current fiscal year.

A number of other firms have also recently commented on CY. Analysts at Feltl & Co. initiated coverage on shares of Cypress Semi in a research note to investors on Tuesday, August 28th. They set a “hold” rating and a $13.00 price target on the stock. Separately, analysts at Cantor Fitzgerald upgraded shares of Cypress Semi from a “sell” rating to a “hold” rating in a research note to investors on Monday, July 23rd. They now have a $11.00 price target on the stock. Finally, analysts at RBC Capital reiterated an “outperform” rating on shares of Cypress Semi in a research note to investors on Friday, July 20th.

Cypress Semiconductor Corporation (Cypress) delivers high-performance, mixed-signal and programmable solutions.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “The company is investing more in its core microcontroller business to augment its margins and overall growth going forward. Fast-growing touch-sensing technology is one of the major growth drivers for Atmel’s microcontroller business. The company’s strong relationships with Nokia, Motorola, HTC and Samsung are expected to bolster its business in future. Nevertheless, earnings estimates for Atmel have declined marginally as the weakened economy continues to hurt its businesses. The company’s high inventory level along with foreign exchange rate risk in the industry may negatively affect its financial results. Thus, we prefer to maintain our NEUTRAL recommendation on the stock.”

A number of other analysts have also recently weighed in on ATML. Analysts at UBS AG downgraded shares of Atmel from a “buy” rating to a “neutral” rating in a research note to investors on Monday, September 24th. They now have a $7.00 price target on the stock, down previously from $11.00. Separately, analysts at Canaccord Genuity reiterated a “buy” rating on shares of Atmel in a research note to investors on Thursday, September 20th. They now have a $8.00 price target on the stock. Finally, analysts at Nomura reiterated a “positive” rating on shares of Atmel in a research note to investors on Thursday, September 13th.

Shares of Atmel traded up 1.48% during mid-day trading on Monday, hitting $4.80. Atmel has a one year low of $4.72 and a one year high of $11.72. The company has a market cap of $2.113 billion and a P/E ratio of 12.35.

Atmel last issued its quarterly earnings data on Tuesday, July 31st. The company reported $0.08 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.08. The company’s revenue for the quarter was down 23.1% on a year-over-year basis. Analysts expect that Atmel will post $0.37 EPS for the current fiscal year.

Atmel Corporation (Atmel) is engaged in designing, developing and supplying of microcontrollers. Atmel offers a portfolio of touch products, which integrate its microcontrollers with touch-focused intellectual property (IP).

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are reiterating our recommendation on Western Union at Neutral prior to the third quarter earnings release scheduled on October 30, 2012. The Zacks Consensus estimates earnings of $0.45 per share which translates into growth of 12% year over year. We are optimistic about the company’s performance going forward, given its long-term growth momentum led by strategic investments in new products, services and technology. However, a rapid growth of other cheaper money transfer options may lead to competitive pressures. The company is focusing on three main areas – expanding the existing network and retaining as well as adding new customers to the consumer money transfer business creating a digital infrastructure to drive its electronic channels business, and finally developing the B2B segment apart from ensuring successful integration of the Travelex business. Given the pace at which the company is aggressively making acquisitions, expanding its agent network, rolling out new products and services, we expect it to achieve long-term growth much ahead of its peers.”

A number of other firms have also recently commented on WU. Analysts at Citigroup reiterated a “buy” rating on shares of The Western Union Company in a research note to investors on Wednesday, September 19th. They now have a $24.00 price target on the stock. Separately, analysts at Goldman Sachs reiterated a “buy/neutral” rating on shares of The Western Union Company in a research note to investors on Tuesday, September 4th. They now have a $22.00 price target on the stock. Finally, analysts at JPMorgan Chase downgraded shares of The Western Union Company from an “overweight” rating to a “neutral” rating in a research note to investors on Monday, August 13th.

The Western Union Company traded up 0.06% on Monday, hitting $17.89. The Western Union Company has a 1-year low of $15.79 and a 1-year high of $19.82. The company has a market cap of $10.777 billion and a price-to-earnings ratio of 9.18.

The Western Union Company last released its earnings data on Tuesday, July 24th. The company reported $0.46 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.43 by $0.03. The company’s quarterly revenue was up 4.3% on a year-over-year basis. Analysts expect that The Western Union Company will post $1.76 EPS for the current fiscal year.

The Western Union Company is engaged in money movement and payment services. Western Union services are available through a global network of more than 445,000 agent locations in more than 200 countries and territories, with approximately 85% of those locations outside of the United States.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are downgrading our recommendation on Gentiva to Neutral based on increased operating and interest expense burden, and expected negative impact of reimbursement rate cuts. The company’s second quarter earnings surpassed the Zacks Consensus Estimate but lagged the year-ago quarter’s earnings on the back of lower revenues, particularly in the Home Health segment. However, reduced debt and enhanced free cash balance improved financial leverage, while superior operating performance boosted net cash from operating activities. Additionally, the divestiture of some Louisiana branches has significantly augmented cash. Moreover, the steps taken to restructure operations should show results in the forthcoming quarters, while the strategic divestitures are expanding market share. Overall, we expect a modest growth potential for the company in the long term.”

Gentiva Health Services traded down 4.03% on Monday, hitting $10.2501. Gentiva Health Services has a 52-week low of $3.31 and a 52-week high of $12.85. The company’s market cap is $313.3 million.

Gentiva Health Services last posted its quarterly earnings results on Thursday, August 2nd. The company reported $0.35 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.28 by $0.07. The company’s quarterly revenue was down 4.7% on a year-over-year basis. Analysts expect that Gentiva Health Services will post $1.25 EPS for the current fiscal year.

GTIV has been the subject of a number of other recent research reports. Analysts at Piper Jaffray raised their price target on shares of Gentiva Health Services from $10.00 to $16.00 in a research note to investors on Wednesday, September 5th. They now have an “overweight” rating on the stock. Analysts at Deutsche Bank upgraded shares of Gentiva Health Services from a “hold” rating to a “buy” rating in a research note to investors on Thursday, July 26th. They now have a $12.50 price target on the stock, up previously from $8.00.

Gentiva Health Services, Inc. (Gentiva) provides home health and hospice services throughout the United States.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Wells Fargo & Company has reported earnings of $0.88 per share in third quarter 2012. Results improved from earnings per share of $0.82 in the prior quarter and $0.72 in the year-ago quarter. Also, it beat the Zacks Consensus Estimate by a penny. Higher non-interest income along with cost control measures acted as positives for the quarter. Moreover, decline in non-interest expenses reflected positive operating leverage. However, the quarter’s revenue lagged the prior-quarter’s results. After reviewing the results, we are maintaining our Neutral recommendation on the shares.”

Wells Fargo & Co. traded down 1.56% on Monday, hitting $33.715. Wells Fargo & Co. has a 1-year low of $23.19 and a 1-year high of $36.60. The company has a market cap of $178.3 billion and a price-to-earnings ratio of 10.77.

Wells Fargo & Co. last released its earnings data on Friday, October 12th. The company reported $0.88 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.87 by $0.01. The company had revenue of $21.20 billion for the quarter, compared to the consensus estimate of $21.47 billion. Wells Fargo & Co.’s revenue was up 8.0% compared to the same quarter last year. Analysts expect that Wells Fargo & Co. will post $3.33 EPS for the current fiscal year.

A number of other firms have also recently commented on WFC. Analysts at Oppenheimer cut their price target on shares of Wells Fargo & Co. to $38.00 in a research note to investors on Monday. They now have an “outperform” rating on the stock. Separately, analysts at Compass Point downgraded shares of Wells Fargo & Co. from a “buy” rating to a “neutral” rating in a research note to investors on Monday. They now have a $37.00 price target on the stock, down previously from $41.00. Finally, analysts at FBR Capital reiterated an “outperform” rating on shares of Wells Fargo & Co. in a research note to investors on Monday, October 8th. They now have a $39.00 price target on the stock.

Wells Fargo & Company is a bank holding company. The Company is a diversified financial services company.

To view Zacks’ full report, visit www.zacks.com

A number of other firms have also recently commented on TGT. Analysts at S&P Capital IQ reiterated a “strong-buy” rating on shares of Target Corp. in a research note to investors on Friday, October 5th. They now have a $78.00 price target on the stock. Separately, analysts at MKM Partners reiterated a “buy” rating on shares of Target Corp. in a research note to investors on Tuesday, October 2nd. They now have a $74.00 price target on the stock. Finally, analysts at Janney Montgomery Scott reiterated a “neutral” rating on shares of Target Corp. in a research note to investors on Monday, October 1st. They now have a $61.00 price target on the stock.

Shares of Target Corp. traded up 0.24% during mid-day trading on Monday, hitting $61.67. Target Corp. has a 52 week low of $47.25 and a 52 week high of $65.80. The company has a market cap of $40.387 billion and a P/E ratio of 14.10.

Target Corp. last announced its earnings results on Wednesday, August 15th. The company reported $1.06 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.01 by $0.05. The company’s quarterly revenue was up 3.3% on a year-over-year basis. Analysts expect that Target Corp. will post $4.38 EPS for the current fiscal year.

Target Corporation (Target) operates in three segments: U.S. Retail, U.S. Credit Card and Canadian. As a component of the U.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Omnicell reported an adjusted EPS of $0.13 in the second quarter of fiscal 2012 beating both the Zacks Consensus Estimate of $0.06 and the year-ago EPS of $0.08. Revenues increased 23.6% year over year to $75.4 million, exceeding the Zacks Consensus Estimate of $73 million. We are encouraged with the recent acquisition of MTS Medication enabling Omnicell’s foray into the non-acute care market. Accordingly the company increased its fiscal 2012 guidance. Omnicell operates in the niche automated medication industry and stands to benefit from favorable demographic trends and regulatory environments. The company’s entry in the Chinese and Middle East markets should bolster international growth. However, headwinds remain in the form of constrained hospital budgets and intense competition. We maintain a Neutral’ recommendation on the stock.”

Omnicell traded down 0.07% on Monday, hitting $13.53. Omnicell has a 1-year low of $12.33 and a 1-year high of $17.94. The company has a market cap of $450.6 million and a price-to-earnings ratio of 43.68.

Omnicell last released its earnings data on Wednesday, August 1st. The company reported $0.20 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.18 by $0.02. Omnicell’s revenue was up 23.6% compared to the same quarter last year. Analysts expect that Omnicell will post $0.79 EPS for the current fiscal year.

Separately, analysts at ThinkEquity initiated coverage on shares of Omnicell in a research note to investors on Friday, September 7th. They set a “buy” rating and a $18.00 price target on the stock.

Omnicell, Inc. (Omnicell) is a provider of automated solutions for hospital medication and supply management.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Lockheed Martin Corporation, the largest stand-alone defense contractor’s posted a strong second-quarter beat, an improved earnings guidance, an incremental dividend payout and a stable order backlog. Solid second-quarter earnings were supported by strong numbers from the Aeronautics, Electronic Systems and Space Systems segments. Over the longer run, we expect the company to register a stable performance thanks to a leveraged presence in the Army, Air Force, Navy and IT programs. Also, shareholder return will continue to be shored up by the company’s focus on debt repayment, its ongoing share repurchase program and the incremental dividend. However, we believe all these positive factors are already reflected on Lockheed Martin shares and are, therefore, moving back to a Neutral recommendation. “

Several other analysts have also recently commented on the stock. Analysts at RBC Capital reiterated an “outperform” rating on shares of Lockheed Martin in a research note to investors on Thursday, October 4th. They now have a $102.00 price target on the stock. Separately, analysts at JPMorgan Chase reiterated a “neutral” rating on shares of Lockheed Martin in a research note to investors on Monday, October 1st. They now have a $76.00 price target on the stock. Finally, analysts at Sanford C. Bernstein reiterated a “market perform” rating on shares of Lockheed Martin in a research note to investors on Friday, September 28th. They now have a $105.00 price target on the stock.

Shares of Lockheed Martin traded down 0.30% during mid-day trading on Monday, hitting $92.68. Lockheed Martin has a 52 week low of $72.37 and a 52 week high of $94.90. The company has a market cap of $29.861 billion and a P/E ratio of 10.81.

Lockheed Martin last released its earnings data on Tuesday, July 24th. The company reported $2.38 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.91 by $0.47. The company’s quarterly revenue was up 3.3% on a year-over-year basis. Analysts expect that Lockheed Martin will post $8.09 EPS for the current fiscal year.

Lockheed Martin Corporation is a global security company engaged in the research, design, development, manufacture, integration, and sustainment of advanced technology systems and products.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Marriot’s third quarter 2012 earnings were ahead of the Zacks Consensus Estimate. Going forward, the company’s strong pipeline, significant international exposure, solid balance sheet, continuous focus on rewarding shareholders through share buybacks and dividends, lower operating cost structure and increased market share, augur well for its earnings. Additionally, considering the increased global demand, renovation of properties, modest supply growth, accelerating group business and strong pricing environment, we expect top line to improve further. Marriott’s deal to manage Gaylord also remains strategically sound. However, we remain cautious on the stock based on the uncertainty over the U.S. presidential election, looming fiscal cliff, slower growth in China and Europe’s distressful economy. Additionally, increased competition and currency fluctuations remain major headwinds for the company. Thus, we remain Neutral on the stock. “

Several other analysts have also recently commented on the stock. Analysts at Goldman Sachs downgraded shares of Marriott from a “buy” rating to a “neutral” rating in a research note to investors on Thursday. Separately, analysts at Oddo & Cie reiterated a “reduce” rating on shares of Marriott in a research note to investors on Friday, October 5th. They now have a $33.00 price target on the stock. Finally, analysts at Nomura raised their price target on shares of Marriott to $48.00 in a research note to investors on Friday, October 5th. They now have a “buy” rating on the stock.

Shares of Marriott traded up 0.76% during mid-day trading on Monday, hitting $38.45. Marriott has a 52 week low of $27.53 and a 52 week high of $41.84. The company has a market cap of $12.133 billion and a P/E ratio of 24.11.

Marriott last announced its earnings results on Wednesday, October 3rd. The company reported $0.44 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.40 by $0.04. The company had revenue of $2.73 billion for the quarter, compared to the consensus estimate of $2.65 billion. Marriott’s revenue was down 5.0% compared to the same quarter last year. On average, analysts predict that Marriott will post $1.70 earnings per share for the current fiscal year.

Marriott International, Inc. is a diversified hospitality company. It is a lodging company with more than 3,700 properties in 73 countries and territories.

To view Zacks’ full report, visit www.zacks.com

Other equities research analysts have also recently issued reports about the stock. Analysts at TheStreet upgraded shares of American Public Education to a “buy” rating in a research note to investors on Monday, October 8th. Analysts at JPMorgan Chase initiated coverage on shares of American Public Education in a research note to investors on Tuesday, July 24th. They set an “overweight” rating on the stock.

American Public Education traded down 1.59% on Monday, hitting $37.19. American Public Education has a 1-year low of $24.88 and a 1-year high of $46.96. The company has a market cap of $662.2 million and a price-to-earnings ratio of 16.27.

American Public Education last released its earnings data on Wednesday, August 8th. The company reported $0.51 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.45 by $0.06. American Public Education’s revenue was up 22.7% compared to the same quarter last year. Analysts expect that American Public Education will post $2.24 EPS for the current fiscal year.

American Public Education, Inc. is a provider of online postsecondary education focusing on the needs of the military and public service communities.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Although TriQuint reported in-line results for the second quarter of 2012, earnings estimates have gone down drastically. The sequential decline in revenues was owing to lower demand from the company’s largest customer, Foxconn. While demand was weak in the second quarter, management expects business to rebound in the second half of 2012 with the ramp of Apple’s iPhone 5. The handset market has consolidated around a few top players. Meanwhile, the company continues to gain traction with major customers like Samsung. We believe the current level is an attractive entry point and hence upgrade our recommendation to Outperform.”

TriQuint Semiconductor traded down 3.76% on Friday, hitting $4.86. TriQuint Semiconductor has a 1-year low of $3.97 and a 1-year high of $7.76. The company has a market cap of $795.8 million and a price-to-earnings ratio of 117.44.

TriQuint Semiconductor last released its earnings data on Wednesday, July 25th. The company reported ($0.09) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.03. The company’s quarterly revenue was down 22.2% on a year-over-year basis. On average, analysts predict that TriQuint Semiconductor will post $-0.01 earnings per share for the current fiscal year.

Other equities research analysts have also recently issued reports about the stock. Analysts at Lazard Capital initiated coverage on shares of TriQuint Semiconductor in a research note to investors on Friday, October 5th. They set a “buy” rating and a $7.20 price target on the stock. Separately, analysts at Canaccord Genuity cut their price target on shares of TriQuint Semiconductor from $6.00 to $5.50 in a research note to investors on Monday, October 1st. They now have a “hold” rating on the stock. Finally, analysts at Brean Murray initiated coverage on shares of TriQuint Semiconductor in a research note to investors on Friday, September 28th. They set a “hold” rating on the stock.

TriQuint Semiconductor, Inc. (TriQuint) is a supplier of modules, components and foundry services to communications companies.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “DST Systems is one of the leading global providers of sophisticated information processing software and products to the financial services industry, primarily mutual funds. The company’s second quarter 2012 earnings missed the Zacks Consensus Estimates on the bottom line. Total revenue improved due to broad-based strength across business segments. We continue to believe that DST Systems’ massive scale of operations in Financial Services will attract new customers. Also, broad exposure to the insurance sector and synergies from acquisitions could be catalysts. Nevertheless, competition from Broadridge Financial Solutions and Advent Software, reduction in registered accounts, as well as a high debt burden are concerns. We maintain our Neutral recommendation on DST Systems.”

Dst Systems traded up 0.36% on Friday, hitting $56.31. Dst Systems has a 1-year low of $44.88 and a 1-year high of $58.00. The company has a market cap of $2.483 billion and a price-to-earnings ratio of 9.31.

Dst Systems last released its earnings data on Wednesday, August 1st. The company reported $0.77 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.97 by $0.20. The company’s revenue for the quarter was up 9.8% on a year-over-year basis. Analysts expect that Dst Systems will post $3.81 EPS for the current fiscal year.

Separately, analysts at Credit Suisse reiterated an “outperform” rating on shares of Dst Systems in a research note to investors on Thursday, September 13th. They now have a $65.00 price target on the stock.

DST Systems, Inc. (DST) offer sophisticated information processing and software services and products.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Maxim is an OEM of semiconductor analog and mixed signal ICs. June quarter earnings beat the Zacks Consensus Estimate and guidance was in line with expectations. Its decision to focus on the faster-growing consumer and computing markets helped results in the last quarter. However, legacy industrial and communications markets, which also make up a significant percentage of its results, were weak. Despite this weakness and the higher mix of lower-margin consumer revenue, we remain positive about Maxim’s history of innovation, product breadth, diverse end markets, growth opportunities and management execution. Consequently, we are reiterating our Neutral rating on MXIM shares. “

Other equities research analysts have also recently issued reports about the stock. Analysts at JPMorgan Chase upgraded shares of Maxim Integrated Products from an “underweight” rating to a “neutral” rating in a research note to investors on Monday. They now have a $26.00 price target on the stock, up previously from $23.00. Separately, analysts at Jefferies Group upgraded shares of Maxim Integrated Products from a “hold” rating to a “buy” rating in a research note to investors on Thursday, September 27th. They now have a $33.00 price target on the stock, up previously from $29.00. Finally, analysts at Needham & Company reiterated a “buy” rating on shares of Maxim Integrated Products in a research note to investors on Friday, September 7th.

Shares of Maxim Integrated Products traded down 0.50% during mid-day trading on Friday, hitting $26.73. Maxim Integrated Products has a 52 week low of $23.55 and a 52 week high of $30.00. The company has a market cap of $7.800 billion and a P/E ratio of 20.89.

Maxim Integrated Products last announced its earnings results on Thursday, July 26th. The company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.06. The company’s revenue for the quarter was down 3.4% on a year-over-year basis. On average, analysts predict that Maxim Integrated Products will post $1.78 earnings per share for the current fiscal year.

Maxim Integrated Products, Inc. (Maxim) designs, develops, manufactures and markets a range of linear and mixed-signal integrated circuits, commonly referred to as analog circuits, for a large number of customers in diverse geographical locations.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Sonoco’s second-quarter 2012 adjusted earnings per share decreased 3% to $0.58, but net sales increased 6.6% to $1.2 billion. While EPS was in line with the Zacks Consensus Estimate, revenue failed to beat the same. Sonoco has trimmed its 3Q12 EPS guidance citing operational problems in its North American papermaking operations, which led to unscheduled downtime and excess costs. Furthermore, Sonoco has experienced lower-than-expected volume in many of its consumer and industrial businesses. Volatile raw material prices and uncertainty among its customers, given the slow recovery in the U.S and ongoing European weakness, higher pension costs remain headwinds for the company in fiscal 2012. Accordingly, we have downgraded our recommendation on Sonoco from Neutral to Underperform with a target price of $28. “

Shares of Sonoco Products remained flat at $30.59 during during mid-day trading trading on Friday. Sonoco Products has a 52 week low of $28.61 and a 52 week high of $34.83. The company has a market cap of $3.079 billion and a P/E ratio of 15.53.

Sonoco Products last announced its earnings results on Thursday, July 19th. The company reported $0.58 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.58. The company’s quarterly revenue was up 6.7% on a year-over-year basis. Analysts expect that Sonoco Products will post $2.20 EPS for the current fiscal year.

A number of other firms have also recently commented on SON. Analysts at DA Davidson downgraded shares of Sonoco Products from a “buy” rating to a “neutral” rating in a research note to investors on Monday. They now have a $33.00 price target on the stock, down previously from $38.00. Separately, analysts at Barclays Capital reiterated an “equalweight” rating on shares of Sonoco Products in a research note to investors on Tuesday, September 11th. Finally, analysts at Robert W. Baird reiterated an “outperform” rating on shares of Sonoco Products in a research note to investors on Tuesday, September 11th. They now have a $35.00 price target on the stock.

Sonoco Products Company (Sonoco) is a manufacturer of industrial and consumer packaging products and a provider of packaging services, with 312 locations in 35 countries.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We have upgraded our recommendation on Pinnacle West Capital Corporation to Outperform from Neutral owing to the company’s strong financial position, improvement in credit rating along with steady inorganic growth strategy. We remain confident about Arizona’s fundamentals, which are allowing Pinnacle West to achieve higher levels as the economic environment improves. The company expects annual customer growth of approximately 2% for 2012 through 2015 will benefit its results. In addition, favorable renewable energy prospects and the recent rate case approval will ensure increased returns. However, we are skeptical about stringent regulations, and volatile weather conditions, which might negatively impact the company’s forthcoming performance. “

Pinnacle West Capital traded down 0.25% on Friday, hitting $52.71. Pinnacle West Capital has a 52-week low of $43.97 and a 52-week high of $54.66. The company has a market cap of $5.774 billion and a price-to-earnings ratio of 15.24.

Pinnacle West Capital last posted its quarterly earnings results on Thursday, August 2nd. The company reported $1.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.03 by $0.09. The company’s revenue for the quarter was up 9.9% on a year-over-year basis. Analysts expect that Pinnacle West Capital will post $3.43 EPS for the current fiscal year.

Pinnacle West Capital Corporation (Pinnacle West) is a holding company, which conducts business through its subsidiaries.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are reiterating our recommendation on the shares of Assurant prior to the third quarter earnings release due on October 24, 2012. The Zacks Consensus estimates third quarter earnings of $1.35 per share which would translate into earnings growth of 70.5% year over year We expect the company to perform favorably during the quarter. Assurant’s Specialty line of business will likely benefit from a growth in multi-housing loans. Its Solutions line will see higher top-line growth from increases in domestic as well as international businesses. Its Health business is expected to benefit from increased sales of voluntary and supplemental products and also from expense savings and the recent agreement with Aetna Signature Administration. Its Employee Benefits business is anticipated to witness top-line growth from increased sale of supplemental and voluntary products. A strong buyback program will further boost its bottom-line earnings. . . “

Other equities research analysts have also recently issued reports about the stock. Analysts at Macquarie reiterated an “underperform” rating on shares of Assurant in a research note to investors on Monday. They now have a $32.00 price target on the stock. Analysts at Goldman Sachs upgraded shares of Assurant from a “neutral” rating to a “buy” rating in a research note to investors on Wednesday, October 3rd. They now have a $45.00 price target on the stock, up previously from $43.00.

Shares of Assurant traded down 1.20% during mid-day trading on Friday, hitting $39.38. Assurant has a 52 week low of $32.41 and a 52 week high of $44.54. The company has a market cap of $3.193 billion and a P/E ratio of 6.40.

Assurant last released its earnings data on Wednesday, July 25th. The company reported $1.81 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.39 by $0.42. The company’s quarterly revenue was up 3.2% on a year-over-year basis. Analysts expect that Assurant will post $6.44 EPS for the current fiscal year.

Assurant, Inc. (Assurant) is a provider of specialized insurance products and related services in North America and selected international markets.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Autoliv reported a 14% fall in EPS to $1.33 and missed the Zacks Consensus Estimate by $0.06 in the second quarter of 2012 due to weak markets in Europe and South America as well as higher raw material prices. Consolidated sales increased a meager 1% and were lower than the Zacks Consensus Estimate as well. The company anticipates organic sales to grow 4% in the next quarter but consolidated sales to decline by 3% due to negative currency effects and the effect from the divestiture of Autoliv Mekan. Autoliv maintains a stable market share globally, supported by the increasing importance of vehicle safety needs. Furthermore, the company aims to tap huge market potential by expanding into low-cost countries. Therefore, we continue to recommend the shares as Neutral and set a target price of $65.00. “

A number of other analysts have also recently weighed in on ALV. Analysts at UBS AG downgraded shares of AUTOLIV INC from a “neutral” rating to a “sell” rating in a research note to investors on Friday, October 5th. They now have a $56.00 price target on the stock. Separately, analysts at ABG Sundal Collier raised their price target on shares of AUTOLIV INC from $72.00 to $75.00 in a research note to investors on Friday, September 28th. They now have a “buy” rating on the stock. Finally, analysts at Jefferies Group reiterated a “hold” rating on shares of AUTOLIV INC in a research note to investors on Monday, September 10th.

Shares of AUTOLIV INC traded down 0.21% during mid-day trading on Friday, hitting $61.40. AUTOLIV INC has a one year low of $47.67 and a one year high of $69.61. The company has a market cap of $5.858 billion and a P/E ratio of 11.04.

AUTOLIV INC last issued its quarterly earnings data on Friday, July 20th. The company reported $1.33 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.40 by $0.07. The company’s quarterly revenue was up 1.4% on a year-over-year basis. Analysts expect that AUTOLIV INC will post $6.03 EPS for the current fiscal year.

Autoliv, Inc. (Autoliv) is a holding company. Autoliv is the supplier of automotive safety systems, with a range of product offerings, including modules and components for passenger and driver-side airbags, side-impact airbag protection systems, seatbelts, steering wheels, safety electronics, whiplash protection systems and child seats, as well as night vision systems, radar and other active safety systems.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are maintaining our Neutral recommendation on Stone Energy. Stone Energy has a multi-year inventory of drilling prospects. The company is working on a strategy to fund its growth areas in Appalachia, the Rockies and the Deep Gas/Deepwater in the conventional shelf. It is actively engaged in horizontal well drilling in the Marcellus Shale and involved in various vertical tests in the Bakken Shale play. These are likely to add to revenues in the coming quarters. However, any delay in the operations of these wells will negatively affect the company’s earnings. Further, the company’s results are directly exposed to oil and gas prices, which are inherently volatile and subject to complex market forces. “

Separately, analysts at Capital One upgraded shares of Stone Energy from an “add” rating to a “strong-buy” rating in a research note to investors on Friday, August 3rd.

Shares of Stone Energy traded down 2.00% during mid-day trading on Friday, hitting $23.58. Stone Energy has a 52 week low of $20.27 and a 52 week high of $35.47. The company has a market cap of $1.139 billion and a P/E ratio of 6.62.

Stone Energy last announced its earnings results on Wednesday, August 1st. The company reported $0.62 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.84 by $0.22. Stone Energy’s revenue was down 5.7% compared to the same quarter last year. On average, analysts predict that Stone Energy will post $2.98 earnings per share for the current fiscal year.

Stone Energy Corporation (Stone Energy) is an independent oil and natural gas company engaged in the acquisition, exploration, exploitation, development and operation of oil and gas properties located primarily in the Gulf of Mexico (GOM).

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We downgrade our recommendation on SIRIUS XM to Neutral based-on its current valuation, which has soared nearly 70% in the last year. Meanwhile, the company continues with its strong performance primarily due to impressive management execution on the back of rising auto industry sales. Recently, SIRIUS XM declared that it achieved a record-high third quarter net subscribers’ addition. Despite price rise of its services, SIRIUS XM maintains its churn rate. Solid conversion rate and an effective marketing strategy helped the company to achieve this milestone. The company commands an estimated 70% market share of new cars sold in the U.S. in the face of growing competition from Pandora Media and Spotify. Beside its healthy subscription-based business, the company is slowly growing its advertising business. However, we believe all these positives are already reflected in the current valuation of the company. “

Sirius XM Radio traded up 0.92% on Friday, hitting $2.755. Sirius XM Radio has a 52-week low of $1.61 and a 52-week high of $2.79. The company has a market cap of $10.561 billion and a price-to-earnings ratio of 5.05.

Sirius XM Radio last posted its quarterly earnings results on Tuesday, August 7th. The company reported $0.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.02 by $0.46. Sirius XM Radio’s revenue was up 12.6% compared to the same quarter last year. On average, analysts predict that Sirius XM Radio will post $0.55 earnings per share for the current fiscal year.

Other equities research analysts have also recently issued reports about the stock. Analysts at Bank of America raised their price target on shares of Sirius XM Radio from $3.75 to $4.00 in a research note to investors on Thursday. They now have a “buy” rating on the stock. Separately, analysts at TD Securities raised their price target on shares of Sirius XM Radio from $4.50 to $5.50 in a research note to investors on Wednesday, October 3rd. They now have a “buy” rating on the stock. Finally, analysts at Citigroup raised their price target on shares of Sirius XM Radio to $3.00 in a research note to investors on Tuesday, October 2nd.

Sirius XM Radio Inc. broadcasts its music, sports, entertainment, comedy, talk, news, traffic and weather channels in the United States on a subscription fee basis through its two satellite radio systems.

To view Zacks’ full report, visit www.zacks.com

Several other analysts have also recently commented on the stock. Analysts at Nomura reiterated a “buy” rating on shares of Honeywell International in a research note to investors on Friday. They now have a $72.00 price target on the stock. Separately, analysts at Deutsche Bank initiated coverage on shares of Honeywell International in a research note to investors on Friday. They set a “buy” rating and a $72.00 price target on the stock.

Shares of Honeywell International traded down 0.28% during mid-day trading on Friday, hitting $60.12. Honeywell International has a 52 week low of $46.91 and a 52 week high of $62.00. The company has a market cap of $46.928 billion and a P/E ratio of 20.82.

Honeywell International last announced its earnings results on Wednesday, July 18th. The company reported $1.14 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.11 by $0.03. The company’s quarterly revenue was up 3.8% on a year-over-year basis. On average, analysts predict that Honeywell International will post $4.51 earnings per share for the current fiscal year.

Honeywell International Inc. (Honeywell) is a diversified technology and manufacturing company, serving customers worldwide with aerospace products and services, control, sensing and security technologies for buildings, homes and industry, turbochargers, automotive products, specialty chemicals, electronic and advanced materials, process technology for refining and petrochemicals, and energy efficient products and solutions for homes, business and transportation.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We reiterate our Neutral recommendation on Raven Industries with a target price of $29. The company’s second-quarter fiscal 2013 earnings were $0.32 per share, missing the Zacks Consensus Estimate of $0.38 per share. Sales increased 13% to $101.7 million, but fell short of the Zacks Consensus Estimate of $102 million. Raven aims at enhancing its product portfolio to increase its market share in the industry. Soaring demand for its geo membrane films will boost revenues in the next few quarters. Moreover, the acquisition of Vista Research will add to its growth. However, the drought condition prevailing in the U.S. and increased capital spending will pressure margins moving forward. “

Shares of Raven Industries traded down 0.14% during mid-day trading on Friday, hitting $27.81. Raven Industries has a 52 week low of $25.09 and a 52 week high of $37.73. The company has a market cap of $1.009 billion and a P/E ratio of 19.14.

Raven Industries, Inc. (Raven) is an industrial manufacturer providing a variety of products. The company markets its products worldwide and has its principal operations in the United States of America.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Optimer Pharma’s second quarter 2012 adjusted net loss of $0.01 was narrower than the year-ago loss of $0.52 and the Zacks Consensus loss Estimate of $0.60 per share. Higher revenues resulted in a narrower loss in the second quarter of 2012. Dificid sales increased, albeit modestly, in the second quarter. We are pleased with the company’s effort to expand Dificid’s market globally. However, we are concerned about Optimer’s dependence on a single product for growth. In the absence of a decent pipeline, Optimer has little to fall back on if Dificid performs below expectations. We see limited upside potential from current levels and hence retain our Neutral stance on the stock. “

Optimer Pharmaceutic traded down 0.35% on Friday, hitting $11.29. Optimer Pharmaceutic has a 1-year low of $10.00 and a 1-year high of $16.49. The company’s market cap is $536.9 million.

Optimer Pharmaceutic last released its earnings data on Tuesday, July 31st. The company reported ($0.01) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.07) by $0.06. The company’s quarterly revenue was up 150809.1% on a year-over-year basis. Analysts expect that Optimer Pharmaceutic will post $-1.38 EPS for the current fiscal year.

A number of other analysts have also recently weighed in on OPTR. Analysts at Jefferies Group reiterated a “buy” rating on shares of Optimer Pharmaceutic in a research note to investors on Tuesday. Separately, analysts at Ladenburg Thalmann downgraded shares of Optimer Pharmaceutic from a “buy” rating to a “neutral” rating in a research note to investors on Tuesday. Finally, analysts at Oppenheimer downgraded shares of Optimer Pharmaceutic from an “outperform” rating to a “market perform” rating in a research note to investors on Tuesday.

Optimer Pharmaceuticals, Inc. (Optimer) is a biopharmaceutical company focused on developing and commercializing hospital specialty products.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Strayer Education’s second quarter 2012 earnings of $1.85 per share missed the Zacks Consensus Estimate by a penny. It plunged 27% from the year-ago quarter due to revenue declines. Revenues fell 11% due to decline in enrollments and revenue/student in the quarter. However, the company’s new enrollments have increased for two consecutive quarters in contrast to declines at most peer companies. We are encouraged by Strayer’s strong brand position and its geographic expansion strategy of opening new campuses every year, both in new states and markets. Further, the company’s corporate alliances give it a competitive advantage and contribute significantly to growth. On the flip side, the company continues to suffer from a difficult regulatory environment as well as weak student demand. The third quarter outlook was also disappointing. We thus prefer to remain on the sidelines until we see substantial enrollment growth and improvement in the overall industry environment. We have a Neutral recommendation on the stock with a target price of $72. “

Strayer Education traded down 2.30% on Friday, hitting $67.12. Strayer Education has a 1-year low of $62.53 and a 1-year high of $120.00. The company has a market cap of $767.2 million and a price-to-earnings ratio of 9.25.

Strayer Education last released its earnings data on Thursday, July 26th. The company reported $1.85 EPS for the quarter, missing the Thomson Reuters consensus estimate of $1.86 by $0.01. Strayer Education’s revenue was down 10.7% compared to the same quarter last year. On average, analysts predict that Strayer Education will post $5.83 earnings per share for the current fiscal year.

Several other analysts have also recently commented on the stock. Analysts at Deutsche Bank initiated coverage on shares of Strayer Education in a research note to investors on Friday, September 7th. They set a “sell” rating and a $50.00 price target on the stock. Separately, analysts at Piper Jaffray downgraded shares of Strayer Education from a “neutral” rating to an “underweight” rating in a research note to investors on Friday, July 27th. Finally, analysts at JPMorgan Chase initiated coverage on shares of Strayer Education in a research note to investors on Tuesday, July 24th. They set an “overweight” rating on the stock.

Strayer Education, Inc. is a post-secondary education services corporation. The Company offers a range of academic programs through its wholly owned subsidiary Strayer University, Inc.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are maintaining our Outperform recommendation on Marathon Petroleum. Spun out of parent Marathon Oil Co. in 2011, the company is a leading refiner and marketer of petroleum products in the U.S. Our bullish investment theme stems from Marathon Petroleum’s scale advantage, impressive asset quality, and an extensive midstream/retail network that diversifies its portfolio and provides more stable revenue streams. We believe management’s recently commenced $2 billion share repurchase program and the proposed acquisition of BP’s Texas City refinery could further boost shareholder value. Marathon Petroleum’s low debt ratio and hefty cash balance add to the positive sentiment. All in all, we believe the company is well positioned going forward and view it as an attractive investment. “

Marathon Petroleum traded up 0.16% on Friday, hitting $54.75. Marathon Petroleum has a 52-week low of $30.24 and a 52-week high of $60.04. The company has a market cap of $18.522 billion and a price-to-earnings ratio of 7.81.

Marathon Petroleum last posted its quarterly earnings results on Tuesday, July 31st. The company reported $2.53 earnings per share for the quarter, beating the analysts’ consensus estimate of $2.46 by $0.07. Marathon Petroleum’s revenue was down 2.6% compared to the same quarter last year. Analysts expect that Marathon Petroleum will post $8.88 EPS for the current fiscal year.

A number of other analysts have also recently weighed in on MPC. Analysts at Barclays Capital reiterated an “overweight” rating on shares of Marathon Petroleum in a research note to investors on Tuesday. Separately, analysts at Oppenheimer raised their price target on shares of Marathon Petroleum from $60.00 to $70.00 in a research note to investors on Tuesday. They now have an “outperform” rating on the stock. They noted that the move was a valuation call. Finally, analysts at Credit Suisse downgraded shares of Marathon Petroleum from an “outperform” rating to a “neutral” rating in a research note to investors on Tuesday, September 18th. They now have a $65.00 price target on the stock, up previously from $63.00. They noted that the move was a valuation call.

Marathon Petroleum Corporation (Marathon Petroleum) is a petroleum product refiners, transporters and marketers in the United States.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Ingram Micro is one of the world’s largest distributors of IT products. The company’s second quarter 2012 results were decent with the top and bottom lines surpassing our estimates. Strong performance in North America and Latin America led to the beat. The third quarter outlook was mixed, reflecting improving IT spending, cessation of HDD pricing benefit and lower revenue generation from the fee-based logistics business. The company’s significant European exposure and debt burden are concerns. Moreover, the recent acquisition of Brightpoint, a leading distributor of wireless devices, will elevate the level of debt. Nevertheless, we think that its growing SMB exposure and improving profitability will be catalysts. Hence, we maintain a Neutral recommendation on the stock.”

Ingram Micro traded down 0.13% on Friday, hitting $14.85. Ingram Micro has a 1-year low of $14.42 and a 1-year high of $19.80. The company has a market cap of $2.229 billion and a price-to-earnings ratio of 8.25.

Ingram Micro last released its earnings data on Thursday, July 26th. The company reported $0.39 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.38 by $0.01. The company’s quarterly revenue was up .3% on a year-over-year basis. Analysts expect that Ingram Micro will post $1.83 EPS for the current fiscal year.

Several other analysts have also recently commented on the stock. Analysts at Citigroup initiated coverage on shares of Ingram Micro in a research note to investors on Monday. They set a “neutral” rating and a $17.00 price target on the stock. Separately, analysts at Credit Agricole initiated coverage on shares of Ingram Micro in a research note to investors on Tuesday, August 14th. They set an “underperform” rating on the stock. Finally, analysts at Needham & Company reiterated a “hold” rating on shares of Ingram Micro in a research note to investors on Friday, July 27th.

Ingram Micro Inc. (Ingram Micro) is a global information technology (IT) wholesale distributor, providing sales, marketing and logistics services for the IT industry worldwide.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Goodyear Tire & Rubber Company is one of the largest tire manufacturing companies worldwide. The company saw a 12% decline in profits to $0.57 per share in the second quarter of 2012 but beat the Zacks Consensus Estimate by $0.11 per share. Revenues dipped 8% to $5.2 billion and went below the Zacks Consensus Estimate of $5.7 billion due to weak economic conditions and unfavorable foreign currency translation. However, we are optimistic about Goodyear due to its focus on the emerging markets of Latin America, Eastern Europe and Asia. The company has targeted an additional $1 billion of gross savings by 2012 and achieve $1.6 billion of segment operating income in 2013. Due to these factors, we continue to recommend the shares of the company as Neutral and set a target price of $13.00.”

Several other analysts have also recently commented on the stock. Analysts at Goldman Sachs upgraded shares of Goodyear from a “neutral” rating to a “buy” rating in a research note to investors on Thursday, September 27th. They now have a $17.00 price target on the stock, up previously from $14.00. Separately, analysts at KeyBanc downgraded shares of Goodyear from a “buy” rating to a “hold” rating in a research note to investors on Friday, September 21st.

Shares of Goodyear traded down 1.21% during mid-day trading on Friday, hitting $12.29. Goodyear has a one year low of $9.24 and a one year high of $15.80. The company has a market cap of $3.008 billion and a P/E ratio of 12.27.

Goodyear last issued its quarterly earnings data on Tuesday, July 31st. The company reported $0.56 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.46 by $0.10. The company’s quarterly revenue was down 8.4% on a year-over-year basis. On average, analysts predict that Goodyear will post $1.87 earnings per share for the current fiscal year.

The Goodyear Tire & Rubber Company (Goodyear) is a manufacturer of tires. The Company, along with its United States and international subsidiaries and joint ventures, develops, manufactures, markets and distributes tires for applications.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We reiterate our Neutral recommendation on Forest Oil shares. The company’s effort to expand its liquid production in order to maximize its margin is gaining traction. Forest Oil has a growing upstream presence in the emerging basins of Texas, Canada and Mexico. Eagle Ford core acreage position in the Gonzales and Wilson Counties of the play has produced some of the most proven inexhaustible wells till date. Going forward, we believe that attractive economics in the new shallow oil zones in the Texas Panhandle, including the Missourian Wash and the Cleveland formations, will help it gain momentum. However, the company’s highly leveraged balance sheet and higher spending level remain our concern. Moreover, Forest Oil is highly exposed to volatile natural gas fundamentals, which might hamper the company’s performance. “

Forest Oil traded down 0.34% on Friday, hitting $8.80. Forest Oil has a 52-week low of $5.68 and a 52-week high of $17.22. The company’s market cap is $1.015 billion.

Forest Oil last posted its quarterly earnings results on Monday, July 30th. The company reported $0.06 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.06. The company’s revenue for the quarter was down 27.4% on a year-over-year basis. On average, analysts predict that Forest Oil will post $0.38 earnings per share for the current fiscal year.

Other equities research analysts have also recently issued reports about the stock. Analysts at Wells Fargo & Co. reiterated a “positive” rating on shares of Forest Oil in a research note to investors on Wednesday, September 12th. Separately, analysts at Howard Weil cut their price target on shares of Forest Oil from $17.00 to $9.00 in a research note to investors on Thursday, August 23rd. They now have a “market perform” rating on the stock. Finally, analysts at Jefferies Group reiterated a “hold” rating on shares of Forest Oil in a research note to investors on Tuesday, August 7th.

Forest Oil Corporation (Forest) is an independent oil and gas company engaged in the acquisition, exploration, development, and production of oil, natural gas, and natural gas liquids in North America.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “In line with the Zacks Consensus Estimate, Fastenal Company’s third quarter 2012 earnings of $0.37 per share grew 12.1% year over year, attributable to 12.2% revenue growth. Total revenue of $802.6 million however, marginally missed the Zacks Consensus Estimate in the third quarter of 2012. The daily sales have been consistently declining for the past three quarters of 2012 highlighting the rising uncertainty in the growth outlook of Fastenal’s end markets. Other than that, the company’s strategy of new store openings significantly hurt near-term profitability due to the start-up costs involved in opening a new store. These factors combined with margin pressures due to rising cost of fuel has forced us to recommend Underperform on shares of Fastenal and set a target price of $42.00. “

Other equities research analysts have also recently issued reports about the stock. Analysts at Janney Montgomery Scott reiterated a “neutral” rating on shares of Fastenal in a research note to investors on Friday. They now have a $43.00 price target on the stock. Separately, analysts at UBS AG reiterated a “neutral” rating on shares of Fastenal in a research note to investors on Friday. Finally, analysts at Wunderlich raised their price target on shares of Fastenal to $52.00 in a research note to investors on Friday.

Fastenal traded down 1.09% on Friday, hitting $45.39. Fastenal has a 52-week low of $32.88 and a 52-week high of $55.05. The company has a market cap of $13.442 billion and a price-to-earnings ratio of 34.25.

Fastenal last posted its quarterly earnings results on Thursday, October 11th. The company reported $0.37 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.37. The company had revenue of $802.58 million for the quarter, compared to the consensus estimate of $804.90 million. The company’s quarterly revenue was up 10.4% on a year-over-year basis. On average, analysts predict that Fastenal will post $1.45 earnings per share for the current fiscal year.

Fastenal Company (Fastenal) sells industrial and construction supplies in a wholesale and retail fashion.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “BMC reported sluggish first quarter 2013 results, with EPS falling short of our expectation and revenue remaining flat. However, the company witnessed substantial cloud bookings and increased SaaS customers. Most of its business segments grew and cash flow was decent. However, we are a bit apprehensive about the bleak business conditions in Europe. Moreover, growing competition from big players such as IBM Corp., Hewlett-Packard Company, EMC Corp. and CA Technologies will pose challenges for the company. We are therefore reiterating our Neutral recommendation on the shares. “

BMC Software traded up 0.57% on Friday, hitting $42.67. BMC Software has a 1-year low of $31.62 and a 1-year high of $45.70. The company has a market cap of $6.804 billion and a price-to-earnings ratio of 19.91.

BMC Software last released its earnings data on Tuesday, July 31st. The company reported $0.65 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.75 by $0.10. The company’s quarterly revenue was up .4% on a year-over-year basis. Analysts expect that BMC Software will post $3.49 EPS for the current fiscal year.

Several other analysts have also recently commented on the stock. Analysts at Longbow Research reiterated a “buy” rating on shares of BMC Software in a research note to investors on Tuesday, October 2nd. They now have a $48.00 price target on the stock. Separately, analysts at ThinkEquity upgraded shares of BMC Software from a “hold” rating to a “buy” rating in a research note to investors on Tuesday, September 18th. They now have a $50.00 price target on the stock, up previously from $37.00.

BMC Software, Inc. is a software vendor. The Company provides systems management, service management and automation solutions primarily for large enterprises.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We like Apache’s large geographically-diversified reserve base, its balanced exposure to natural gas and crude oil, and its multiyear trends in reserve replacement and production growth. A pristine balance sheet helps the company to capitalize on investment opportunities and strategic acquisitions, thereby further improving growth visibility. However, we see limited upside potential for shares, taking into consideration Apache’s sensitivity to gas/oil price volatility, its drilling results, costs, geo-political risks and project timing delays. As such, we expect Apache to perform in line with the broader market and, therefore, maintain our Neutral recommendation.”

A number of other firms have also recently commented on APA. Analysts at Macquarie reiterated an “outperform” rating on shares of Apache in a research note to investors on Friday, October 5th. They now have a $122.00 price target on the stock. Separately, analysts at RBC Capital reiterated a “sector perform” rating on shares of Apache in a research note to investors on Friday, September 28th. They now have a $105.00 price target on the stock. Finally, analysts at Barclays Capital reiterated an “overweight” rating on shares of Apache in a research note to investors on Thursday, August 30th. They now have a $117.00 price target on the stock.

Shares of Apache traded down 0.69% during mid-day trading on Friday, hitting $85.3801. Apache has a one year low of $77.93 and a one year high of $112.09. The company has a market cap of $33.402 billion and a P/E ratio of 10.36.

Apache last issued its quarterly earnings data on Thursday, August 2nd. The company reported $2.07 earnings per share for the quarter, missing the analysts’ consensus estimate of $2.57 by $0.50. Apache’s revenue was down 8.4% compared to the same quarter last year. On average, analysts predict that Apache will post $9.77 earnings per share for the current fiscal year.

Apache Corporation (Apache) is an independent energy company, which explores for, develops and produces natural gas, crude oil and natural gas liquids.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “International Paper’s merger with Temple-Inland will help increase its share in the North American corrugated-packaging market from 27% to 34%. Furthermore, through its joint ventures, International Paper has significant projects underway in Russia and China, which will help the company sustain its earnings growth. International Paper has hiked its quarterly dividend by 14% to $1.20. We expect International Paper to continue to utilize its sound cash flow by investing in capital projects, acquisitions, reducing its total debt and paying increased dividend. We have upgraded our recommendation from Neutral to Outperform on the successful implementation of an increase in containerboard prices and the accretive effect it will have on the earnings of the company with a target price of $45.00.”

International Paper Company traded down 1.10% on Friday, hitting $36.83. International Paper Company has a 1-year low of $24.80 and a 1-year high of $37.38. The company has a market cap of $16.107 billion and a price-to-earnings ratio of 15.05.

International Paper Company last announced its earnings results on Thursday, July 26th. The company reported $0.46 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.46. International Paper Company’s revenue was up 6.5% compared to the same quarter last year. On average, analysts predict that International Paper Company will post $2.58 earnings per share for the current fiscal year.

A number of other firms have also recently commented on IP. Analysts at BMO Capital Markets reiterated an “outperform” rating on shares of International Paper Company in a research note to investors on Wednesday. They now have a $48.00 price target on the stock. Separately, analysts at DA Davidson reiterated a “buy” rating on shares of International Paper Company in a research note to investors on Tuesday. They now have a $50.00 price target on the stock.

International Paper Company (International Paper) is a global paper and packaging company, with primary markets and manufacturing operations in North America, Europe, Latin America, Russia, Asia and North Africa.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Although the strong demand environment coupled with the company’s strategy of inorganic expansion is likely to propel long-term growth, Navigant s present performance does not inspire confidence. Its second-quarter 2012 results missed the Zacks Consensus Estimates on both lines. Consultant Utilization rate in the quarter fell substantially year over year. While Navigant Consulting has been able to post modest results in two of its segments namely, Financial, Risk & Compliance Advisory, and Healthcare, its other two segments Disputes, Investigations & Economics, and Energy were underperformers in the quarter. At the end of the second quarter, Navigant had zero cash balance. Hence, we downgrade the stock from Neutral’ to Underperform’ recommendation.”

Navigant Consulting traded down 0.28% on Friday, hitting $10.58. Navigant Consulting has a 1-year low of $9.63 and a 1-year high of $14.62. The company has a market cap of $545.9 million and a price-to-earnings ratio of 12.78.

Navigant Consulting last announced its earnings results on Thursday, July 26th. The company reported $0.21 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.24 by $0.03. The company’s quarterly revenue was up 5.2% on a year-over-year basis. On average, analysts predict that Navigant Consulting will post $0.90 earnings per share for the current fiscal year.

Navigant Consulting, Inc. is a specialty consulting firm that combines industry knowledge with technical expertise to enable companies to create and protect value in the complex and critical business risks and opportunities.

To view Zacks’ full report, visit www.zacks.com

Molina Healthcare traded up 1.10% on Thursday, hitting $23.79. Molina Healthcare has a 52-week low of $14.65 and a 52-week high of $36.83. The company’s market cap is $1.107 billion.

Molina Healthcare last posted its quarterly earnings results on Thursday, July 26th. The company reported ($0.80) earnings per share for the quarter, missing the analysts’ consensus estimate of $0.01 by $0.81. Molina Healthcare’s revenue was up 31.7% compared to the same quarter last year. Analysts expect that Molina Healthcare will post $-0.33 EPS for the current fiscal year.

MOH has been the subject of a number of other recent research reports. Analysts at Susquehanna upgraded shares of Molina Healthcare from a “neutral” rating to a “positive” rating in a research note to investors on Friday, September 21st. They now have a $30.00 price target on the stock. Separately, analysts at Jefferies Group downgraded shares of Molina Healthcare from a “hold” rating to an “underperform” rating in a research note to investors on Tuesday, September 18th. They now have a $19.00 price target on the stock, down previously from $20.00. Finally, analysts at Credit Suisse initiated coverage on shares of Molina Healthcare in a research note to investors on Thursday, August 30th. They set a “neutral” rating and a $25.00 price target on the stock.

Molina Healthcare, Inc. provides Medicaid-related solutions to meet the health care needs of low-income families and individuals, and to assist state agencies in their administration of the Medicaid program.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We downgrade our recommendation to Underperform from Neutral on Integrys Energy Group as we expect increasing retail competitive pressure in the northeastern US markets and risks from weather variations will weigh on margins. In addition, pending rate case approvals from the North Shore and People Gas business units could lead to lag in top-line growth. Pro-environment regulations set by Environmental Protection Agency will also pose serious challenges to the company’s growth prospects. Moreover, back-to-back weak financial results in the first and second quarters of 2012 make us skeptical of the company’s performance in the upcoming quarters. However, Integrys’ involvement in infrastructure expansion projects in Chicago and Columbia power plant could offer some relief in the near term.”

A number of other analysts have also recently weighed in on TEG. Analysts at SunTrust reiterated a “neutral” rating on shares of Integrys Energy Group in a research note to investors on Tuesday, October 2nd. Separately, analysts at DA Davidson upgraded shares of Integrys Energy Group from a “neutral” rating to a “buy” rating in a research note to investors on Monday, October 1st. They now have a $59.00 price target on the stock, up previously from $55.00.

Integrys Energy Group traded down 0.61% on Thursday, hitting $54.95. Integrys Energy Group has a 52-week low of $48.19 and a 52-week high of $61.92. The company has a market cap of $4.281 billion and a price-to-earnings ratio of 19.67.

Integrys Energy Group last posted its quarterly earnings results on Thursday, August 9th. The company reported $0.62 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.41 by $0.21. The company’s quarterly revenue was down 16.7% on a year-over-year basis. On average, analysts predict that Integrys Energy Group will post $3.14 earnings per share for the current fiscal year.

Integrys Energy Group, Inc. is a holding company for its regulated utility and non-regulated business units.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are upgrading our recommendation on the shares of Tower Group Inc. to Neutral’ from Underperform’ following the company’s recent investment in Canopius, which is expected to enhance its Bermuda reinsurance business and accrue to overall profitability. We also view favorably the acquisitions made by Tower Group over the last few years, in order to diversify its business mix. Adequate loss reserves, solid capitalization, moderate leverage, strong operating performance and disciplined underwriting are some of the other positives. Some of the headwinds faced by the company are execution risk associated with the recent investment in Canopius. Other concerning factors include the still soft property and casualty market, intense competition and business concentration in northeast U.S. “

A number of other analysts have also recently weighed in on TWGP. Analysts at FBR Capital upgraded shares of Tower Group from a “market perform” rating to an “outperform” rating in a research note to investors on Wednesday, August 1st. They now have a $24.00 price target on the stock. Analysts at Keefe, Bruyette & Woods downgraded shares of Tower Group from an “outperform” rating to a “market perform” rating in a research note to investors on Tuesday, July 31st. They now have a $22.00 price target on the stock.

Tower Group traded up 0.87% on Thursday, hitting $19.70. Tower Group has a 52-week low of $17.72 and a 52-week high of $24.64. The company has a market cap of $756.0 million and a price-to-earnings ratio of 49.07.

Tower Group last issued its quarterly earnings data on Monday, August 6th. The company reported ($0.39) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.42) by $0.03. The company’s revenue for the quarter was up 15.9% on a year-over-year basis. On average, analysts predict that Tower Group will post $1.45 earnings per share for the current fiscal year.

Tower Group, Inc. (Tower), through its subsidiaries, offers a range of commercial, personal and specialty property and casualty insurance products and services to businesses in various industries and to individuals.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Backed by strong sales growth coupled with operational efficiencies, Hibbett’s earnings of $0.30 per share for second-quarter fiscal 2013 surged 42.9% from the prior-year quarter, beating the Zacks Consensus Estimate of $0.27. Buoyed by better-than-expected results, the company raised its expectations for fiscal 2013. The company now forecasts earnings in the range of $2.57-$2.67 per share, up from $2.50 $2.65 forecasted earlier. Management also remains committed to expand its store network by 55 to 60 new stores in fiscal 2013. Moreover, Hibbett’s sharp focus on mid-sized and smaller markets and strategic mix of branded as well as localized merchandise provide it an edge over its rivals. Moreover, the company has a healthy balance sheet with no debt. Currently, we are maintaining a long-term Outperform recommendation on the stock.”

Several other analysts have also recently commented on the stock. Analysts at Credit Suisse initiated coverage on shares of Hibbett Sports in a research note to investors on Thursday, September 6th. They set a “neutral” rating on the stock. Separately, analysts at Piper Jaffray raised their price target on shares of Hibbett Sports to $59.00 in a research note to investors on Monday, August 20th. Finally, analysts at Robert W. Baird raised their price target on shares of Hibbett Sports from $57.00 to $60.00 in a research note to investors on Monday, August 20th. They now have a “neutral” rating on the stock.

Shares of Hibbett Sports traded up 0.35% during mid-day trading on Thursday, hitting $57.75. Hibbett Sports has a 52 week low of $36.31 and a 52 week high of $63.39. The company has a market cap of $1.510 billion and a P/E ratio of 23.47.

Hibbett Sports last announced its earnings results on Friday, August 17th. The company reported $0.30 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.27 by $0.03. The company’s quarterly revenue was up 8.0% on a year-over-year basis. On average, analysts predict that Hibbett Sports will post $2.68 earnings per share for the current fiscal year.

Hibbett Sports, Inc. is an operator of sporting goods retail stores in small to mid-sized markets predominately in the Southeast, Southwest, Mid-Atlantic and Midwest regions of the United States.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Costco continues to be a dominant warehouse club operator posting a healthy fourth-quarter 2012 results. The quarterly earnings of $1.39 per share beat the Zacks Consensus Estimate of $1.30, and rose 28.7% from the prior-year quarter buoyed by a double-digit growth in the top-line. Comparable-store sales for the quarter rose 5%, buoyed by a 6% and 2% jump in comparable-store sales in the U.S. and international locations, respectively. We believe that Costco is well positioned to weather the sluggish recovery in the economy given its focus on low prices. Besides, it would also maintain its growth momentum as evident from its monthly sales results. Costco’s comparable-store sales for September rose 6%, reflecting comps growth of 6% at its U.S. locations and 7% at its international outlets. However, aggressive pricing to counter competition, gain market share and drive traffic may depress sales and margins.”

Shares of Costco traded down 1.21% during mid-day trading on Thursday, hitting $100.33. Costco has a 52 week low of $78.81 and a 52 week high of $104.43. The company has a market cap of $43.377 billion and a P/E ratio of 28.35.

Costco last announced its earnings results on Wednesday, October 10th. The company reported $1.39 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.31 by $0.08. The company had revenue of $31.52 billion for the quarter, compared to the consensus estimate of $31.60 billion. The company’s quarterly revenue was up 11.9% on a year-over-year basis. Analysts expect that Costco will post $4.46 EPS for the current fiscal year.

Several other analysts have also recently commented on the stock. Analysts at Credit Suisse raised their price target on shares of Costco from $93.00 to $115.00 in a research note to investors on Wednesday. They now have an “outperform” rating on the stock. Separately, analysts at Robert W. Baird raised their price target on shares of Costco from $105.00 to $113.00 in a research note to investors on Tuesday. They now have an “outperform” rating on the stock. Finally, analysts at Jefferies Group raised their price target on shares of Costco from $89.00 to $91.00 in a research note to investors on Friday, October 5th. They now have a “hold” rating on the stock.

Costco Wholesale Corporation (Costco), with its subsidiaries operates membership warehouses that offer its members low prices on a limited selection of branded and selected private-label products in a range of merchandise categories.

To view Zacks’ full report, visit www.zacks.com

Telephone & Data Systems traded up 0.20% on Thursday, hitting $24.81. Telephone & Data Systems has a 1-year low of $19.20 and a 1-year high of $29.32. The company has a market cap of $2.695 billion and a price-to-earnings ratio of 16.96.

Telephone & Data Systems last released its earnings data on Friday, August 3rd. The company reported $0.39 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.44 by $0.05. Telephone & Data Systems’s revenue was up 3.4% compared to the same quarter last year. Analysts expect that Telephone & Data Systems will post $1.43 EPS for the current fiscal year.

Telephone and Data Systems, Inc. (TDS) is a diversified telecommunications service company with wireless operations provided by TDS’ 82%-owned subsidiary, United States Cellular Corporation (U.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are maintaining our Neutral recommendation on Marathon Oil stock, reflecting its sustainable growth prospects and outlook. Marathon is a leading energy firm with a large and geographically-diverse reserve base and solid project pipeline. Additionally, the company possesses a healthy balance sheet, which helps it to capitalize on investment opportunities. We also like the strong growth potential of Marathon’s high-margin liquids-rich unconventional plays, which diversify its portfolio and are expected to further drive its overall volumes. While being incrementally more positive on the company, we believe Marathon will take some time to fully absorb the outcome of the spin-off. Consequently, we would rather wait for a better entry point before accumulating shares.”

A number of other analysts have also recently weighed in on MRO. Analysts at Barclays Capital reiterated an “equalweight” rating on shares of Marathon Oil in a research note to investors on Friday, October 5th. They now have a $33.00 price target on the stock. Separately, analysts at Macquarie reiterated a “neutral” rating on shares of Marathon Oil in a research note to investors on Wednesday, October 3rd. They now have a $34.00 price target on the stock. Finally, analysts at Credit Suisse upgraded shares of Marathon Oil from a “neutral” rating to an “outperform” rating in a research note to investors on Wednesday, September 19th. They now have a $37.00 price target on the stock.

Shares of Marathon Oil traded up 0.34% during mid-day trading on Thursday, hitting $29.66. Marathon Oil has a one year low of $22.99 and a one year high of $35.49. The company has a market cap of $20.910 billion and a P/E ratio of 11.91.

Marathon Oil last issued its quarterly earnings data on Wednesday, August 1st. The company reported $0.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.63 by $0.04. The company’s quarterly revenue was up 1.0% on a year-over-year basis. Analysts expect that Marathon Oil will post $2.67 EPS for the current fiscal year.

Marathon Oil Corporation (Marathon Oil) is an international energy company engaged in exploration and production, oil sands mining and integrated gas with operations in the United States, Angola, Canada, Equatorial Guinea, Indonesia, the Iraqi Kurdistan Region, Libya, Norway, Poland and the United Kingdom.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are maintaining our Neutral recommendation on U.S. Cellular. The company’s second quarter 2012 earnings were below the Zacks Consensus Estimate and the year-ago level due to a higher tax rate and erosion in operating income. Apart from these headwinds, we believe that higher churn in the post paid segment, higher equipment subsidies and investment cost on network upgrades would continue to impact forthcoming results. Further, continued uncertainty in the economy, intense competition and pricing pressure would remain detrimental to customer accretion. However, we expect the company to register further growth in smartphone sales as it continues to launch new devices. Additionally, increased market penetration of the Belief plan, subscriber addition, expansion of 3G networks and expansion of Long-Term Evolution technology are also expected to bode well for the company’s profitability. “

United States Cellular Corporation traded up 1.70% on Thursday, hitting $37.69. United States Cellular Corporation has a 52-week low of $36.30 and a 52-week high of $48.30. The company has a market cap of $3.193 billion and a price-to-earnings ratio of 17.50.

United States Cellular Corporation last released its earnings data on Friday, August 3rd. The company reported $0.62 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.66 by $0.04. The company’s quarterly revenue was up 2.6% on a year-over-year basis. Analysts expect that United States Cellular Corporation will post $2.07 EPS for the current fiscal year.

United States Cellular Corporation (U.S. Cellular) is a wireless telecommunications service provider.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Synopsys delivered modest third quarter 2012 results, with revenue and operating performance remaining almost unchanged compared to the year-ago period. The improved performance was due to efficient cost management and guidance for the fourth quarter and fiscal 2012 were also encouraging. Synopsys’ financial strength, technology leadership and global support should continue to drive the innovation process. However, although Synopsys is gaining traction from new products and acquisitions, we believe these will take some time to have meaningful impact on its results. In the meantime, the integration of acquisitions will remain a distraction for management. We therefore have a Neutral recommendation on Synopsys shares.”

Shares of Synopsys traded up 0.16% during mid-day trading on Thursday, hitting $32.16. Synopsys has a 52 week low of $25.60 and a 52 week high of $34.20. The company has a market cap of $4.796 billion and a P/E ratio of 24.74.

Synopsys last announced its earnings results on Wednesday, August 22nd. The company reported $0.55 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.50 by $0.05. The company had revenue of $443.70 million for the quarter, compared to the consensus estimate of $443.94 million. The company’s quarterly revenue was up 14.7% on a year-over-year basis. Analysts expect that Synopsys will post $2.10 EPS for the current fiscal year.

A number of other firms have also recently commented on SNPS. Analysts at Griffin Securities raised their price target on shares of Synopsys to $36.00 in a research note to investors on Thursday, August 23rd. Separately, analysts at Needham & Company reiterated a “buy” rating on shares of Synopsys in a research note to investors on Thursday, August 23rd. Finally, analysts at JPMorgan Chase raised their price target on shares of Synopsys from $36.00 to $38.00 in a research note to investors on Thursday, August 23rd. They now have an “overweight” rating on the stock.

Synopsys, Inc. is engaged in providing technology solutions used to develop electronics and electronic systems.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Host Hotels reported modest third quarter 2012 results, with adjusted FFO in line with the Zacks Consensus Estimate. The company is the largest lodging REIT and operates luxury and upper-upscale hotels across hard-to-replicate areas which have the potential for significant capital appreciation. Most of its properties are operated under reputed brand names in the hospitality industry, which strengthens its leading position in the market. In addition, Host Hotels has a strong balance sheet to drive future growth. However, the continuous acquisition spree of Host Hotels involves significant upfront operating expenses and will continue to drag down margins till they get established. We maintain our Neutral recommendation on the stock.”

HST has been the subject of a number of other recent research reports. Analysts at MLV Capital raised their price target on shares of Host Hotels & Resorts from $18.00 to $20.00 in a research note to investors on Thursday. They now have a “buy” rating on the stock. Separately, analysts at Goldman Sachs downgraded shares of Host Hotels & Resorts from a “buy” rating to a “neutral” rating in a research note to investors on Thursday. They noted that the move was a valuation call. Finally, analysts at RBC Capital upgraded shares of Host Hotels & Resorts from an “outperform” rating to a “top pick” rating in a research note to investors on Wednesday. They now have a $19.00 price target on the stock.

Host Hotels & Resorts traded up 0.86% on Thursday, hitting $15.805. Host Hotels & Resorts has a 52-week low of $11.43 and a 52-week high of $17.57. The company has a market cap of $11.420 billion and a price-to-earnings ratio of 176.07.

Host Hotels & Resorts last posted its quarterly earnings results on Wednesday, October 10th. The company reported $0.21 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.21. The company had revenue of $1.20 billion for the quarter, compared to the consensus estimate of $1.21 billion. The company’s revenue for the quarter was up 6.5% on a year-over-year basis. Analysts expect that Host Hotels & Resorts will post $1.07 EPS for the current fiscal year.

Host Hotels & Resorts, Inc. (Host Inc.) operates as a self-managed and self-administered real estate investment trust (REIT).

To view Zacks’ full report, visit www.zacks.com

Alcoa traded up 0.92% on Thursday, hitting $8.79. Alcoa has a 52-week low of $7.97 and a 52-week high of $11.66. The company has a market cap of $9.378 billion and a price-to-earnings ratio of 126.23.

Alcoa last posted its quarterly earnings results on Tuesday, October 9th. The company reported $0.03 earnings per share for the quarter. The company had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.54 billion. Alcoa’s revenue was down 9.1% compared to the same quarter last year. Analysts expect that Alcoa will post $0.26 EPS for the current fiscal year.

Other equities research analysts have also recently issued reports about the stock. Analysts at Deutsche Bank reiterated a “hold” rating on shares of Alcoa in a research note to investors on Tuesday, October 2nd. Separately, analysts at Dahlman Rose downgraded shares of Alcoa from a “buy” rating to a “hold” rating in a research note to investors on Thursday, September 27th. Finally, analysts at Jefferies Group downgraded shares of Alcoa from a “buy” rating to a “hold” rating in a research note to investors on Tuesday, September 18th. They now have a $11.00 price target on the stock.

Alcoa Inc. (Alcoa) is engaged in the production and management of primary aluminum, fabricated aluminum, and alumina combined, through its participation in technology, mining, refining, smelting, fabricating, and recycling.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are maintaining our recommendation on Weatherford International Ltd. at Underperform following the delay in reporting of income taxes due to the material weakness in internal controls. Weatherford expects weather-related issues in Canada and a poor-margin Iraqi contract to hurt operations and lower average output in 2012. Low gas prices also remain a concern. Other risks faced by Weatherford are geopolitical, commodity and financial market risks. Given these headwinds, we expect shares of Weatherford to be under pressure in the near future. “

Several other analysts have also recently commented on the stock. Analysts at Jefferies Group initiated coverage on shares of Weatherford in a research note to investors on Wednesday, September 12th. They set an “underperform” rating on the stock. Separately, analysts at Credit Agricole initiated coverage on shares of Weatherford in a research note to investors on Wednesday, September 5th. They set an “outperform” rating and a $15.00 price target on the stock. Finally, analysts at UBS AG downgraded shares of Weatherford from a “buy” rating to a “neutral” rating in a research note to investors on Thursday, July 26th. They now have a $12.00 price target on the stock.

Shares of Weatherford traded up 2.17% during mid-day trading on Thursday, hitting $12.23. Weatherford has a 52 week low of $11.14 and a 52 week high of $18.33. The company has a market cap of $9.290 billion and a P/E ratio of 26.60.

Weatherford International Ltd. (Weatherford) is a provider of equipment and services used in the drilling, evaluation, completion, production and intervention of oil and natural gas wells.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “The AES Corporation has business exposure to 27 countries around the globe, which insulates it from any region-specific risk. With a base of fossil fuel plants, the company is predominantly involved in long-term contracts, which do not allow for any rate base growth in the near term for its regulated utilities. The company is investing a substantial chunk of funds for capacity expansion in the power hungry regions of Latin America and Asia. Also AES’ recent acquisition of DPL Inc. would boost its regulated electricity business in the North American market. Over the long term, we remain positive on the company and suggest that investors wait for a favorable entry point. This is reflected in our Neutral recommendation on the stock with a target price of $11.00.”

Shares of The Aes Corporation traded down 1.30% during mid-day trading on Wednesday, hitting $10.64. The Aes Corporation has a one year low of $10.14 and a one year high of $14.01. The company has a market cap of $7.959 billion and a P/E ratio of 58.59.

The Aes Corporation last released its earnings data on Monday, August 6th. The company reported $0.18 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.27 by $0.09. The Aes Corporation’s revenue was down 5.5% compared to the same quarter last year. Analysts expect that The Aes Corporation will post $1.22 EPS for the current fiscal year.

AES has been the subject of a number of other recent research reports. Analysts at Macquarie reiterated a “neutral” rating on shares of The Aes Corporation in a research note to investors on Thursday, October 4th. They now have a $12.75 price target on the stock. Separately, analysts at Citigroup raised their price target on shares of The Aes Corporation from $16.00 to $17.00 in a research note to investors on Wednesday, August 29th. They now have a “buy” rating on the stock. Finally, analysts at ISI Group initiated coverage on shares of The Aes Corporation in a research note to investors on Monday, August 6th. They set a “hold” rating on the stock.

The AES Corporation (AES) is a global power company. As of December 31, 2009, AES owns a portfolio of electricity generation and distribution businesses on five continents in 29 countries, with total capacity of approximately 40,300 Megawatts (MW) and distribution networks serving over 11 million people.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Regeneron Pharmaceuticals’ second quarter 2012 adjusted earnings of $0.71 per share blew past the Zacks Consensus Estimate of $0.25. Higher revenues, driven by strong sales of eye drug, Eylea, boosted earnings in the second quarter of 2012. Encouraged by the strong performance of Eylea, the company increased its forecast for 2012 US Eylea sales for the second successive quarter. The label expansion of Eylea in the US into the CRVO indication has further boosted its sales potential. Moreover, the US approval of oncology drug, Zaltrap, is another positive for Regeneron. However, we believe the current price reflects all the positive news and are reverting to a Neutral recommendation on the stock.”

Several other analysts have also recently commented on the stock. Analysts at Robert W. Baird raised their price target on shares of Regeneron Pharms from $150.00 to $175.00 in a research note to investors on Thursday, October 4th. They now have an “outperform” rating on the stock. Separately, analysts at Bank of America raised their price target on shares of Regeneron Pharms to $172.00 in a research note to investors on Monday, September 24th. Finally, analysts at Goldman Sachs raised their price target on shares of Regeneron Pharms to $170.00 in a research note to investors on Monday, September 24th.

Shares of Regeneron Pharms traded up 0.20% during mid-day trading on Wednesday, hitting $152.78. Regeneron Pharms has a one year low of $49.58 and a one year high of $164.07. The company’s market cap is $14.451 billion.

Regeneron Pharms last issued its quarterly earnings data on Wednesday, July 25th. The company reported $0.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.45 by $0.45. The company’s quarterly revenue was up 181.5% on a year-over-year basis. Analysts expect that Regeneron Pharms will post $2.68 EPS for the current fiscal year.

Regeneron Pharmaceuticals, Inc. (Regeneron) is an integrated biopharmaceutical company, which discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Computer Sciences is one of the leading players in the information technology (IT) services industry. CSC reported modest first quarter 2013 results, with the bottom line exceeding the Zacks Consensus Estimate, but revenue declining on a year-over-year basis. The company displayed a lackluster operating performance, whereas the new business awards improved meaningfully. Intense competition in the IT and cloud computing space from both small and big players such as Accenture plc and Hewlett-Packard Company, its European exposure and strained federal budgets coupled with the troubled NHS contract prompt our bearish outlook on the stock. We therefore have a Neutral recommendation on CSC.”

Computer Sciences traded up 0.16% on Wednesday, hitting $31.33. Computer Sciences has a 52-week low of $22.19 and a 52-week high of $34.74. The company’s market cap is $4.866 billion.

Computer Sciences last released its earnings data on Wednesday, August 8th. The company reported $0.26 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.22 by $0.04. Computer Sciences’s revenue was down 1.9% compared to the same quarter last year. Analysts expect that Computer Sciences will post $2.17 EPS for the current fiscal year.

Other equities research analysts have also recently issued reports about the stock. Analysts at Janney Montgomery Scott reiterated a “neutral” rating on shares of Computer Sciences in a research note to investors on Wednesday. They now have a $27.00 price target on the stock. Separately, analysts at Barclays Capital reiterated an “equalweight” rating on shares of Computer Sciences in a research note to investors on Tuesday, September 11th. Finally, analysts at BMO Capital Markets reiterated a “market perform” rating on shares of Computer Sciences in a research note to investors on Tuesday, September 11th. They now have a $33.00 price target on the stock.

Computer Sciences Corporation (CSC) is engaged in the information technology (IT) and professional services industry.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “PetMed reported $69 million as revenues during the first quarter of fiscal 2013, lagging both the year-ago quarter and the Zacks Consensus Estimate. This was primarily due to drop in new order and reorder sales and decline in customer additions. Lower margins also adversely affected the company’s net income. PetMed is striving to expand its product portfolio to better serve its customers. Amidst a challenging advertising scenario due to the upcoming presidential election, PetMed is focusing on the online medium for better outcome. Although the company is undertaking several initiatives to revive its top line, any benefit in the near term can be ruled out. We reiterate our Neutral recommendation on the stock.”

Separately, analysts at Northcoast Research downgraded shares of PetMed Express from a “buy” rating to a “neutral” rating in a research note to investors on Monday, September 17th.

PetMed Express traded down 3.29% on Wednesday, hitting $9.99. PetMed Express has a 1-year low of $8.91 and a 1-year high of $14.03. The company has a market cap of $196.2 million and a price-to-earnings ratio of 13.26.

PetMed Express last released its earnings data on Monday, July 23rd. The company reported $0.20 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.23 by $0.03. The company’s revenue for the quarter was down 6.2% on a year-over-year basis. On average, analysts predict that PetMed Express will post $0.72 earnings per share for the current fiscal year.

PetMed Express, Inc. and its subsidiaries, doing business as 1-800-PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses direct to the consumer.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Anticipating negative impact on the company’s future financial performance due to Brazilian government’s decision to raise taxes on beer, we are maintaining our long-term Underperform recommendation on AmBev. To shield against the higher taxes, AmBev might inflate its prices in an effort to somewhat offset the negative impact, which may result in lower volumes. Consequently, the net income may be pulled down. Moreover, the company reported a lower-than-expected second-quarter 2012 earnings of $0.29 per share, missing the Zacks Consensus Estimate of $0.35. Intense competition from global and regional players, coupled with seasonal nature of business, may undermine the company’s future operating performance as well.”

Separately, analysts at Citigroup initiated coverage on shares of Companhia De Bebidas in a research note to investors on Friday, July 20th. They set a “buy” rating and a $45.00 price target on the stock.

Companhia De Bebidas traded up 0.20% on Wednesday, hitting $39.96. Companhia De Bebidas has a 52-week low of $31.31 and a 52-week high of $44.63. The company has a market cap of $124.6 billion and a price-to-earnings ratio of 28.18.

Companhia de Bebidas das Americas – AmBev (AmBev) is a Brazil-based company. AmBev and its subsidiaries produce, distribute and sell beer, carbonated soft drinks (CSDs) and other non-alcoholic and non-carbonated products in 14 countries across the Americas.

To view Zacks’ full report, visit www.zacks.com

Shares of Lowe’s traded down 0.77% during mid-day trading on Wednesday, hitting $30.89. Lowe’s has a one year low of $20.24 and a one year high of $32.29. The company has a market cap of $35.232 billion and a P/E ratio of 20.86.

Lowe’s last posted its quarterly earnings results on Monday, August 20th. The company reported $0.68 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.71 by $0.03. The company’s quarterly revenue was down 2.0% on a year-over-year basis. Analysts expect that Lowe’s will post $1.65 EPS for the current fiscal year.

Several other analysts have also recently commented on the stock. Analysts at Piper Jaffray reiterated a “neutral” rating on shares of Lowe’s in a research note to investors on Monday. They now have a $25.00 price target on the stock. Separately, analysts at Deutsche Bank raised their price target on shares of Lowe’s from $30.00 to $35.00 in a research note to investors on Friday, October 5th. They now have a “buy” rating on the stock. Finally, analysts at RBC Capital reiterated an “outperform” rating on shares of Lowe’s in a research note to investors on Monday, October 1st. They now have a $33.00 price target on the stock.

Lowe’s Companies, Inc. (Lowe’s) is a home improvement retailer. As of February 3, 2012, Lowe’s operated 1,745 stores, consisted of 1,712 stores across 50 United States, 31 stores in Canada and two stores in Mexico.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are upgrading Alkermes to Outperform following the revised adjusted earnings guidance provided by the company for fiscal 2013. Alkermes now expects to end fiscal 2013 with adjusted earnings in the range of $0.69 – $0.84, as opposed to the previously forecasted range of $0.62-$0.77 per share. The guidance was boosted following the successful completion of the refinancing of Alkermes’ previously outstanding senior secured bank debt. Alkermes has been performing well since the purchase of Elan’s EDT unit last year, thanks to the expanded portfolio. Moreover, the US approval of type II diabetes drug, Bydureon, is a major positive for Alkermes as the drug offers significant commercial potential. We are also pleased by the pipeline progress at Alkermes. We believe that there is significant scope for stock price appreciation from current levels. “

A number of other firms have also recently commented on ALKS. Analysts at Lazard Capital reiterated a “buy” rating on shares of Alkermes in a research note to investors on Wednesday, September 26th. They now have a $23.00 price target on the stock. Analysts at Jefferies Group reiterated a “buy” rating on shares of Alkermes in a research note to investors on Wednesday, July 18th. They now have a $24.00 price target on the stock.

Shares of Alkermes traded down 4.05% during mid-day trading on Wednesday, hitting $19.20. Alkermes has a one year low of $13.88 and a one year high of $21.12. The company’s market cap is $2.512 billion.

Alkermes last issued its quarterly earnings data on Thursday, July 26th. The company reported $0.39 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.16 by $0.23. The company’s revenue for the quarter was up 145.9% on a year-over-year basis. On average, analysts predict that Alkermes will post $0.78 earnings per share for the current fiscal year.

Alkermes, Inc. is an integrated biotechnology company. The Company is engaged in the business of developing, manufacturing and commercializing medicines for the treatment of prevalent, chronic diseases.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Companhia Brasileira de Distribuicao or P o de A car’s second quarter 2012 earnings of $0.31 per share lagged the Zacks Consensus estimate of $0.24 by 29.2%. However, it shot up by 40.9% from the year-ago results on the back of solid top-line growth and strong margins. We are encouraged by the company’s acquisitions to increase their market share in the e-commerce business. In addition, the company’s numerous stores opened to cater to consumer needs favors the growth. Even though the company is the biggest retailer in Brazil, it faces fierce competition from rivals. Moreover, high rates of inflation and foreign exchange fluctuation prompt us to rate the stock Neutral, with a target price of $50.00.”

Companhia Brasileira de Distribuicao traded down 0.02% on Wednesday, hitting $47.29. Companhia Brasileira de Distribuicao has a 1-year low of $31.77 and a 1-year high of $49.98. The company has a market cap of $12.429 billion and a price-to-earnings ratio of 27.45.

Companhia Brasileira De Distribuicao (CBD) is a Brazil-based food retailer. The Company operates in three segments: retail, cash-and-carry, and electronics and home appliances.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “MICROS’ well-diversified business portfolio is likely to augment its growth in the future. The company’s core strength in highest quality products and service stand the company in good stead. The company is likely to gain from its major contract-wins and buy-back activities. Earnings estimates have also marginally increased of late. Even with such upsides, certain lingering drawbacks continue to position MICROS in a precarious spot. The competitive pressure, foreign currency fluctuation and global economic turmoil are expected to jeopardize MICROS’ businesses in the future. Hence, we find it wise to retain our Neutral recommendation on the stock for now.”

A number of other analysts have also recently weighed in on MCRS. Analysts at Needham & Company reiterated a “buy” rating on shares of Micros Systems in a research note to investors on Tuesday, October 2nd. They now have a $70.00 price target on the stock. Separately, analysts at Compass Point reiterated a “neutral” rating on shares of Micros Systems in a research note to investors on Tuesday, August 28th. Finally, analysts at Jefferies Group reiterated a “buy” rating on shares of Micros Systems in a research note to investors on Friday, August 24th.

Shares of Micros Systems traded up 0.49% during mid-day trading on Wednesday, hitting $46.73. Micros Systems has a one year low of $42.98 and a one year high of $58.49. The company has a market cap of $3.748 billion and a P/E ratio of 22.91.

Micros Systems last posted its quarterly earnings results on Thursday, August 23rd. The company reported $0.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.60 by $0.08. The company had revenue of $302.50 million for the quarter, compared to the consensus estimate of $302.31 million. The company’s revenue for the quarter was up 10.4% on a year-over-year basis. Analysts expect that Micros Systems will post $2.42 EPS for the current fiscal year.

MICROS Systems, Inc. (MICROS) is a designer, manufacturer, marketer, and servicer of enterprise information solutions for the global hospitality and retail industries.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are maintaining our Neutral recommendation on CNOOC Ltd. During the first half of 2012, the company posted lackluster performance with lower production and rising costs. Its production declined 5% year over year, mainly due to the overhaul of Penglai 19-3 oilfield production at Bohai, scheduled maintenance and the divestiture of the ONWJ block in Indonesia. Its 42% year-over-year interim dividend cut as well as lack of visibility on approval of the Nexen deal by international regulators will also likely be an overhang on the stock. However, CNOOC’s growth profile should get a boost over the next 3 to 5 years from the resumption of operations in Penglai post-spill, 16 development projects in offshore China, international growth from recent acquisitions, as well as intensive exploration and development programs with its partners. “

Other equities research analysts have also recently issued reports about the stock. Analysts at Nomura downgraded shares of CNOOC from a “buy” rating to a “neutral” rating in a research note to investors on Tuesday. Finally, analysts at Deutsche Bank downgraded shares of CNOOC from a “buy” rating to a “hold” rating in a research note to investors on Wednesday, August 22nd.

Shares of CNOOC traded up 0.75% during mid-day trading on Wednesday, hitting $199.98. CNOOC has a one year low of $163.32 and a one year high of $234.00. The company has a market cap of $89.284 billion and a P/E ratio of 8.90.

CNOOC Limited, incorporated on August 20, 1999, is an investment holding company. The Company, through its subsidiaries, is engaged in the exploration, development, production and sales of crude oil and natural gas and other petroleum products.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Over the last few years, Unisys has been restructuring its business to improve profitability. This restructuring strategy includes slashing jobs to reduce costs, divesting non-core businesses and revamping its sales strategy, while also investing further on a few higher-growth areas, such as outsourcing. Unisys is currently focusing on business opportunities in fewer but more profitable markets in the information technology (IT) marketplace. Earnings estimates have moved up significantly in the last 90 days. We believe the efforts of the restructuring program undertaken by management in the last few years will pay off in 2013. As of now, we maintain our neutral recommendation on the stock.”

Separately, analysts at Susquehanna raised their price target on shares of Unisys from $19.00 to $23.00 in a research note to investors on Monday, August 20th. They now have a “neutral” rating on the stock.

Shares of Unisys traded up 1.44% during mid-day trading on Wednesday, hitting $21.91. Unisys has a one year low of $14.40 and a one year high of $27.43. The company has a market cap of $963.1 million and a P/E ratio of 4.54.

Unisys last issued its quarterly earnings data on Tuesday, July 24th. The company reported $0.99 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.47 by $0.52. Unisys’s revenue was down 1.7% compared to the same quarter last year. Analysts expect that Unisys will post $3.05 EPS for the current fiscal year.

Unisys Corporation (Unisys) is a worldwide information technology (IT) company. The Company provides a portfolio of IT services, software and technology.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are upgrading our recommendation on the shares of shares of Manulife Financial Corp. to Outperform from Neutral following the recent announcement by the company to expand into Korea, which marks an expansion in its key Asian market. The company has also set up a head office in Cambodia. We believe further penetration in Asian markets will fuel long term earnings growth for the company. Manulife has achieved a great deal in reducing its exposures to potential equity markets as well as interest rates risk. It has also reduced its exposure towards interest sensitive products. However, Manulife’s capital position has suffered due to the decline in the global equity markets and low bond yields. Although the current capital level is well above the regulatory requirement, we believe that it may become necessary for the company to raise capital if the current adverse macroeconomic condition persists in the upcoming months. “

Shares of Manulife Financial traded down 1.14% during mid-day trading on Wednesday, hitting $12.09. Manulife Financial has a one year low of $9.82 and a one year high of $14.21. The company’s market cap is $21.943 billion.

Manulife Financial last issued its quarterly earnings data on Thursday, August 9th. The company reported ($0.18) EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.33 by $0.51. On average, analysts predict that Manulife Financial will post $1.32 earnings per share for the current fiscal year.

Manulife Financial Corporation (MFC) is a Canada-based financial services group serving customers in 22 countries and territories around the world.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Medivation received a major boost in late August when the FDA approved the company’s prostate cancer treatment, Xtandi, several months ahead of the target date. Xtandi, which was launched in the US in September, could very well be a game-changer for Medivation. The prostate cancer market represents huge commercial potential. The company has consistently presented impressive data on Xtandi. Based on the data we have seen so far, we believe the product has blockbuster potential. We are upgrading Medivation to Neutral. We expect investor focus to remain on the commercialization of Xtandi. We would be more positive on the name once we gain visibility on the launch trajectory. Medivation holds a Zacks #3 Rank (short-term Hold’ rating). “

Several other analysts have also recently commented on the stock. Analysts at Citigroup raised their price target on shares of Medivation from $64.50 to $70.00 in a research note to investors on Wednesday, October 3rd. They now have a “buy” rating on the stock. Separately, analysts at Maxim Group initiated coverage on shares of Medivation in a research note to investors on Friday, September 28th. They set a “buy” rating on the stock. Finally, analysts at Summer Street reiterated a “buy” rating on shares of Medivation in a research note to investors on Thursday, September 27th.

Shares of Medivation traded down 0.95% during mid-day trading on Wednesday, hitting $54.39. Medivation has a one year low of $7.965 and a one year high of $58.83. The company’s market cap is $4.007 billion.

Medivation last issued its quarterly earnings data on Thursday, August 9th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by $0.38. The company’s revenue for the quarter was up 173.2% on a year-over-year basis. On average, analysts predict that Medivation will post $-0.64 earnings per share for the current fiscal year.

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of small molecule drugs to treat serious diseases for which there are limited treatment options.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Monsanto posted weak financial results in 4Q12 with a loss per share of $0.44 due to poor seasonal growth of seeds. However, the results were strong in fiscal 2012, with earnings per share from ongoing business of $3.70 surging above $2.96 EPS of fiscal 2011. The company generated revenues of $13.5 billion in 2012, up from $11.8 billion in 2011 based on volume and a mix benefit across segments. Gross margin was recorded at 52%, up slightly from 51% recorded in 2011. Monsanto’s biotechnology research and innovations position it as a market leader. We believe the company’s focus on increase in production supported by innovation and technology upgradation will capture profitability in the upcoming results. At current levels, we prefer remaining on sidelines and thus maintain a Neutral recommendation on the stock.”

Shares of Monsanto traded down 1.49% during mid-day trading on Wednesday, hitting $89.16. Monsanto has a 52 week low of $67.09 and a 52 week high of $92.20. The company has a market cap of $47.567 billion and a P/E ratio of 23.87.

Monsanto last released its earnings data on Wednesday, October 3rd. The company reported ($0.44) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.43) by $0.01. The company had revenue of $2.11 billion for the quarter, compared to the consensus estimate of $2.25 billion. Monsanto’s revenue was down 6.1% compared to the same quarter last year. Analysts expect that Monsanto will post $4.39 EPS for the current fiscal year.

A number of other firms have also recently commented on MON. Analysts at Deutsche Bank reiterated a “buy” rating on shares of Monsanto in a research note to investors on Thursday, October 4th. They now have a $100.00 price target on the stock. Separately, analysts at Susquehanna reiterated a “positive” rating on shares of Monsanto in a research note to investors on Thursday, October 4th. They now have a $115.00 price target on the stock. Finally, analysts at JPMorgan Chase reiterated an “overweight” rating on shares of Monsanto in a research note to investors on Wednesday, October 3rd. They now have a $101.00 price target on the stock.

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We believe Questar will be able to generate meaningful earnings and dividend growth in the coming years through strong operational performances by its business units. Other positives in the Questar story include its sole emphasis on natural gas markets, its focus on long-term contracts and the efficient managerial team. An above-average credit quality adds to the bullish sentiment. However, we remain worried about the current low natural gas price environment that is likely to restrict near-term growth prospects at Questar Pipeline. This compels us to maintain our Neutral recommendation on Questar shares. We also believe that upside potential will remain limited until the company has fully reaped the benefits of the spin-off.”

Questar traded down 0.20% on Wednesday, hitting $20.21. Questar has a 1-year low of $18.23 and a 1-year high of $21.47. The company has a market cap of $3.551 billion and a price-to-earnings ratio of 17.16.

Questar last announced its earnings results on Wednesday, July 25th. The company reported $0.22 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.22. The company’s revenue for the quarter was down 15.5% on a year-over-year basis. On average, analysts predict that Questar will post $1.18 earnings per share for the current fiscal year.

STR has been the subject of a number of other recent research reports. Analysts at UBS AG upgraded shares of Questar from a “neutral” rating to a “buy” rating in a research note to investors on Monday, September 24th. They now have a $24.00 price target on the stock, up previously from $21.00. Finally, analysts at Barclays Capital downgraded shares of Questar from an “overweight” rating to an “equal weight” rating in a research note to investors on Tuesday, July 17th. They noted that the move was a valuation call.

Questar Corporation (Questar) is a natural gas-focused energy company with five lines of business: gas and oil exploration and production, midstream field services, energy marketing, interstate gas transportation, and retail gas distribution.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “The Medicines Co. reported second quarter EPS of $0.38, well above the year-ago EPS of $0.18. We expect Angiomax to continue performing well. The settlement agreements regarding Angiomax are also positive events. Moreover, we are pleased to see management actively pursuing in-licensing deals and acquisitions to drive growth. The AstraZeneca deal is a smart move by the company. We are also pleased with the signing of the GAIN Act, which should ensure an additional five years of exclusivity for oritavancin. While we are pleased with the company’s efforts to develop its pipeline, we were disappointed to hear about the discontinuation of the development of phase II candidate, MDCO-2010. Shares were down more than 5% on the news. We are moving back to a Neutral recommendation on the stock. We prefer to remain on the sidelines until we see data on oritavancin and Cangrelor.”

Separately, analysts at Bank of America initiated coverage on shares of The Medicines Compan in a research note to investors on Wednesday, August 22nd. They set a “neutral” rating and a $29.00 price target on the stock.

The Medicines Compan traded up 0.41% on Wednesday, hitting $24.29. The Medicines Compan has a 52-week low of $17.26 and a 52-week high of $26.95. The company has a market cap of $1.312 billion and a price-to-earnings ratio of 11.78.

The Medicines Compan last posted its quarterly earnings results on Wednesday, July 25th. The company reported $0.46 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.22 by $0.24. The Medicines Compan’s revenue was up 13.5% compared to the same quarter last year. Analysts expect that The Medicines Compan will post $0.90 EPS for the current fiscal year.

The Medicines Company is a global pharmaceutical company focused on advancing the treatment of critical care patients through the delivery of medicines to the global hospital marketplace.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We continue to maintain our Neutral recommendation on General Electric with a $24 target price. Overall, the company reported a modest second quarter 2012 with earnings growth of 12% year over year and overall order growth of 14%. However, the top line and margins continue to be under pressure. In addition, GE’s Industrial business and GE Capital’s loan defaults remained a drag on the company’s results for the quarter. However, with growing demand for energy alternatives to fossil fuels and increasing orders for its jet engines, we believe that GE is geared up for a profitable fiscal 2012. The company also generates strong cash flows that allow management to invest in product innovations, acquisitions and business development.”

A number of other analysts have also recently weighed in on GE. Analysts at William Blair reiterated a “market perform” rating on shares of General Electric in a research note to investors on Tuesday, October 2nd. They now have a $22.00 price target on the stock. Separately, analysts at Barclays Capital reiterated an “overweight” rating on shares of General Electric in a research note to investors on Friday, September 28th. Finally, analysts at JPMorgan Chase reiterated an “overweight” rating on shares of General Electric in a research note to investors on Friday, September 28th. They now have a $24.00 price target on the stock.

Shares of General Electric traded down 0.09% during mid-day trading on Wednesday, hitting $22.60. General Electric has a one year low of $14.68 and a one year high of $23.18. The company has a market cap of $238.6 billion and a P/E ratio of 19.62.

General Electric last issued its quarterly earnings data on Friday, July 20th. The company reported $0.38 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.37 by $0.01. General Electric’s revenue was up 2.5% compared to the same quarter last year. On average, analysts predict that General Electric will post $1.55 earnings per share for the current fiscal year.

General Electric Company (GE) is a diversified technology and financial services company. The products and services of the Company range from aircraft engines, power generation, water processing, and household appliances to medical imaging, business and consumer financing and industrial products.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We upgrade our recommendation to Outperform on Shaw Communications mainly based on the company’s improving EBITDA margin and free cash flow due to the discontinuation of promotional activities. The problem for Shaw Communications was, whenever the company tried to reduce its promotional activities it lost a large amount of pricier subscribers. On the other hand, higher promotional activities are impairing its bottom line and free cash flow. It seems management has finally found out an appropriate trade-off between these two situations. Moreover, Shaw Communications launched “Shaw Go”, an innovative TV Everywhere service, which will be available on iPad 2 and iPhone 5. Initially, this service will only offer the company’s Movie Central applications. However, in the near future, the company will offer streaming live TV, on-demand content and several family-focused programs through Shaw Go. “

Shares of Shaw Communications remained flat at $20.66 during during mid-day trading trading on Wednesday. Shaw Communications has a one year low of $18.25 and a one year high of $21.63. The company has a market cap of $9.134 billion and a P/E ratio of 13.28.

Separately, analysts at CIBC cut their price target on shares of Shaw Communications from $23.00 to $22.00 in a research note to investors on Monday, September 10th. They now have an “outperform” rating on the stock.

Shaw Communications Inc. (Shaw) is a diversified Canadian communications company. Shaw is engaged in the business of providing broadband cable television, Internet, Digital Phone, telecommunications services (through Shaw Business Solutions), satellite direct-to-home services (through Shaw Direct) and engaging programming content (through Shaw Media).

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are upgrading our recommendation on SM Energy to Neutral from Underperform. The company’s asset mix, good organic production growth outlook as well as ample liquidity bodes well for its future growth. SM Energy’s strong balance sheet will likely assist expansion through new development and acquisitions. The company’s holdings in the Eagle Ford, Bakken, Niobrara, Haynesville and Granite Wash will provide with multiple years of drilling inventory. However, certain risks that could potentially impact the company’s operations include lack of service rig availability, dry holes, mechanical failures and adverse weather conditions.”

Other equities research analysts have also recently issued reports about the stock. Analysts at Imperial Capital downgraded shares of SM Energy from an “outperform” rating to an “outperform” rating in a research note to investors on Monday, September 17th. They now have a $61.00 price target on the stock, up previously from $58.00. Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of SM Energy in a research note to investors on Monday, September 10th. Finally, analysts at Canaccord Genuity reiterated a “buy” rating on shares of SM Energy in a research note to investors on Friday, August 31st. They now have a $106.00 price target on the stock.

Shares of SM Energy traded down 1.80% during mid-day trading on Wednesday, hitting $53.42. SM Energy has a 52 week low of $39.44 and a 52 week high of $88.50. The company has a market cap of $3.480 billion and a P/E ratio of 23.01.

SM Energy last released its earnings data on Wednesday, August 1st. The company reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.32 by $0.05. Analysts expect that SM Energy will post $0.82 EPS for the current fiscal year.

SM Energy Company (SM Energy) is an independent energy company. The Company is engaged in the acquisition, exploration, development, and production of crude oil, natural gas, and natural gas liquids (referred to as oil, gas, and NGLs) in onshore North America.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are reaffirming our Neutral recommendation on Pitney Bowes Inc. with a target price of $14. The company’s second-quarter 2012 results were mixed, as its revenue declined by 5% year over year, however earnings surged 2% year over year. Further, weakness in the Production Mail and Management Services segments as well as fall in the Small and Medium Business Solutions (SMB) recurring revenue streams were the negative contributors. However, this was partially offset by increased equipments sales in its SMB segments. The company, however, is making continued investments to expand in the emerging markets. During the quarter, the company incurred huge capital expenditures, which in turn, affected its free cash flow.”

Shares of Pitney Bowes traded down 1.03% during mid-day trading on Wednesday, hitting $13.43. Pitney Bowes has a 52 week low of $12.64 and a 52 week high of $21.20. The company has a market cap of $2.695 billion and a P/E ratio of 3.96.

Pitney Bowes last announced its earnings results on Thursday, August 2nd. The company reported $0.50 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.50. Pitney Bowes’s revenue was down 5.2% compared to the same quarter last year. Analysts expect that Pitney Bowes will post $2.02 EPS for the current fiscal year.

Other equities research analysts have also recently issued reports about the stock. Analysts at Northcoast Research reiterated a “buy” rating on shares of Pitney Bowes in a research note to investors on Monday, September 24th. They now have a $19.00 price target on the stock. Finally, analysts at Brean Murray downgraded shares of Pitney Bowes from a “buy” rating to a “hold” rating in a research note to investors on Tuesday, July 31st.

Pitney Bowes Inc. is a provider of mail processing equipment and integrated mail solutions. The Company offers a range of equipment, supplies, software and services for end-to-end mailstream solutions, which enable its customers to optimize the flow of physical and electronic mail, documents and packages across their operations.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Tessera is a provider of back-end technology for semiconductor manufacturing. Its technology enables miniaturization of electronic goods, which is a driver of IC sales in the market today. Consequently, the host of patents, new technologies, customer wins, volume production at customers and the licensing model that supports attractive margins are encouraging factors. However, protection of intellectual property (IP) for a company this small is a challenge, as are the inherent pricing pressures in the sluggish DRAM market. Tessera has been scoring legal wins in recent times, which could force some companies to renew their licenses. However, there is significant near-term risk to revenue, leading us to reiterate our Underperform rating on the shares.”

Shares of Tessera Technologies traded down 2.02% during mid-day trading on Tuesday, hitting $13.56. Tessera Technologies has a one year low of $12.77 and a one year high of $20.52. The company’s market cap is $704.4 million.

Tessera Technologies last issued its quarterly earnings data on Thursday, July 26th. The company reported $0.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.13. The company’s revenue for the quarter was down 13.2% on a year-over-year basis.

Other equities research analysts have also recently issued reports about the stock. Analysts at Bank of America downgraded shares of Tessera Technologies from a “neutral” rating to an “underperform” rating in a research note to investors on Friday, August 10th.

Tessera Technologies, Inc. (Tessera) develops, licenses and manufactures technologies in two areas: Micro-electronics, and Imaging & Optics.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Priceline.com is one of the leading online travel companies in the world. Priceline’s second quarter earnings easily beat the Zacks Consensus although forward guidance disappointed. While order growth continues, the rate of growth has slowed down, which is the main reason for the softer-than-expected guidance. The secular growth trend in the online travel space, Priceline’s international growth opportunities, good execution, prudent marketing strategy and strong financial position are likely to drive upside to the shares. Of course, currency issues, macro headwinds and occupancy tax-related litigation remain overhangs on the shares. We are therefore reiterating our Neutral recommendation. “

Shares of Priceline traded down 1.56% during mid-day trading on Tuesday, hitting $621.14. Priceline has a one year low of $438.76 and a one year high of $774.96. The company has a market cap of $30.948 billion and a P/E ratio of 26.32.

Priceline last posted its quarterly earnings results on Tuesday, August 7th. The company reported $7.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.37 by $0.48. The company’s revenue for the quarter was up 20.3% on a year-over-year basis. Analysts expect that Priceline will post $30.23 EPS for the current fiscal year.

Several other analysts have also recently commented on the stock. Analysts at Bank of America raised their price target on shares of Priceline from $615.00 to $650.00 in a research note to investors on Wednesday, October 3rd. They now have a “neutral” rating on the stock. Separately, analysts at Benchmark Co. reiterated a “buy” rating on shares of Priceline in a research note to investors on Monday, October 1st. They now have a $725.00 price target on the stock. Finally, analysts at Piper Jaffray reiterated an “overweight” rating on shares of Priceline in a research note to investors on Tuesday, September 25th. They now have a $675.00 price target on the stock.

priceline.com Incorporated is an online travel company that offers its customers hotel room reservations at over 210,000 hotels worldwide through the Booking.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Alexion Pharmaceuticals’ second quarter 2012 adjusted earnings of $0.41 breezed past the Zacks Consensus Estimate by $0.11 on the back of strong Soliris sales. Second quarter 2012 earnings increased 78.3% from the year-ago period. Soliris sale were boosted by new patient additions for the aHUS and PNH indications. While encouraged by Soliris’ performance, we remain concerned about the company’s overdependence on a single product for growth. Moreover, we believe that the sales potential represented by the aHUS indication is limited given the small aHUS patient population. Based on these factors, we remain Neutral on the stock, which carries a Zacks #3 Rank (short-term Hold’ rating).”

A number of other analysts have also recently weighed in on ALXN. Analysts at Oppenheimer raised their EPS on shares of Alexion Pharmaceuticals in a research note to investors on Friday. They now have an “outperform” rating and a $134.00 price target on the stock. Separately, analysts at Canaccord Genuity raised their price target on shares of Alexion Pharmaceuticals from $115.00 to $132.00 in a research note to investors on Monday, September 24th. They now have a “buy” rating on the stock. Finally, analysts at Barclays Capital reiterated an “overweight” rating on shares of Alexion Pharmaceuticals in a research note to investors on Friday, September 14th.

Shares of Alexion Pharmaceuticals traded down 2.88% during mid-day trading on Tuesday, hitting $111.92. Alexion Pharmaceuticals has a one year low of $62.02 and a one year high of $119.54. The company has a market cap of $21.607 billion and a P/E ratio of 114.21.

Alexion Pharmaceuticals last issued its quarterly earnings data on Wednesday, July 25th. The company reported $0.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.11. The company’s revenue for the quarter was up 50.6% on a year-over-year basis. On average, analysts predict that Alexion Pharmaceuticals will post $1.89 earnings per share for the current fiscal year.

Alexion Pharmaceuticals, Inc. (Alexion) is a biopharmaceutical company focused on serving patients with severe and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “With product launches, possible acquisitions, strategic partnerships, resolution of litigation and a strong financial condition, JAKKS Pacific is well poised for long-term growth. However, a tough retail environment leading to lower domestic product sales and a decline in product orders before the crucial holiday season compel the company to cut its fiscal guidance. Additionally, higher input costs, unfavorable product mix and wage inflation in China add further worry. The uncertainty around the upcoming presidential election and the fiscal cliff in the U.S. along with global economic turmoil due to the Eurozone crisis will likely keep consumers preoccupied and less inclined towards entertainment activities. Hence, we downgrade the stock recommendation from Neutral to Underperform.”

A number of other analysts have also recently weighed in on JAKK. Analysts at Ascendiant Capital Markets cut their price target on shares of JAKKS Pacific to $17.00 in a research note to investors on Monday, October 1st. Separately, analysts at Stifel Nicolaus cut their price target on shares of JAKKS Pacific from $20.00 to $18.00 in a research note to investors on Monday, October 1st. They now have a “buy” rating on the stock. Finally, analysts at KeyBanc downgraded shares of JAKKS Pacific from a “buy” rating to a “hold” rating in a research note to investors on Monday, October 1st. They noted that the move was a valuation call.

Shares of JAKKS Pacific traded up 0.29% during mid-day trading on Tuesday, hitting $13.78. JAKKS Pacific has a 52 week low of $12.18 and a 52 week high of $19.76. The company’s market cap is $356.1 million.

JAKKS Pacific last announced its earnings results on Tuesday, July 17th. The company reported $0.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.11 by $0.05. JAKKS Pacific’s revenue was up 10.2% compared to the same quarter last year. Analysts expect that JAKKS Pacific will post $0.70 EPS for the current fiscal year.

JAKKS Pacific, Inc. (JAKKS) is engaged in the development, production and marketing of consumer products, including toys and related products, stationery and writing instruments and pet toys and related products, some of which are based on entertainment properties and character licenses.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Mylan’s second quarter 2012 EPS of $0.60, up 15% y/y, beat the Zacks Consensus Estimate by 5 cents. Higher revenues and gross margin expansion drove earnings. Mylan maintained its 2012 EPS guidance of $2.45 – $2.55. Our 2012 estimate of $2.52 per share is towards the upper end of the guidance range. . We are encouraged by Mylan’s geographic reach and product depth along with a robust generic product pipeline. However, the company’s performance in the EMEA region is concerning. Additionally, with most large branded drugs due to lose patent exclusivity within 2017-2018, we have little visibility on the growth prospects for generic companies like Mylan beyond that time frame.”

Shares of Mylan traded down 1.55% during mid-day trading on Tuesday, hitting $24.17. Mylan has a one year low of $17.02 and a one year high of $24.88. The company has a market cap of $9.810 billion and a P/E ratio of 19.15.

Mylan last issued its quarterly earnings data on Thursday, July 26th. The company reported $0.60 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.55 by $0.05. Mylan’s revenue was up 7.4% compared to the same quarter last year. Analysts expect that Mylan will post $2.52 EPS for the current fiscal year.

A number of other firms have also recently commented on MYL. Analysts at Canaccord Genuity reiterated a “hold” rating on shares of Mylan in a research note to investors on Friday. They now have a $25.00 price target on the stock. Finally, analysts at Guggenheim initiated coverage on shares of Mylan in a research note to investors on Tuesday, September 18th. They set a “neutral” rating and a $26.00 price target on the stock.

Mylan Inc. (Mylan) is a pharmaceutical company, which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “FEMSA’s bottom line surged 28.8% in the second quarter of 2012, reflecting a double-digit net income growth at Coca-cola Femsa and FEMSA Comercio. Moreover, the company’s divestitures of brewery operations offer FEMSA greater financial and strategic flexibility to pursue opportunities in its core businesses. Furthermore, the company is initiating prudent steps to diversify its product portfolio while expanding its convenience store chain, which augurs well for future operating performance. Besides, FEMSA has a strong balance sheet with lower debt-to-capitalization ratio, offering financial flexibility to drive future growth. However, stiff competition from private players coupled with rising commodity costs remain matters of concern. Currently, we are maintaining a long-term Neutral recommendation on the stock.”

Fomento Economico Mexicano traded down 0.91% on Tuesday, hitting $94.04. Fomento Economico Mexicano has a 52-week low of $61.61 and a 52-week high of $95.64. The company has a market cap of $33.650 billion and a price-to-earnings ratio of 26.58.

Several other analysts have also recently commented on the stock. Analysts at Morgan Stanley upgraded shares of Fomento Economico Mexicano from an “equal weight” rating to an “overweight” rating in a research note to investors on Friday, August 17th. Separately, analysts at Deutsche Bank downgraded shares of Fomento Economico Mexicano from a “buy” rating to a “hold” rating in a research note to investors on Monday, July 30th. Finally, analysts at Citigroup initiated coverage on shares of Fomento Economico Mexicano in a research note to investors on Friday, July 20th. They set a “neutral” rating and a $94.00 price target on the stock.

Fomento Economico Mexicano, S.A.B. de C.V. (FEMSA) is a holding company. It conducts its operations through principal holding companies, each of which it refers to as a principal sub-holding company.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We downgraded our recommendation on Staples to Underperform following dismal second-quarter 2012 results. The quarterly earnings of $0.18 per share missed the Zacks Consensus Estimate of $0.22 and fell 18% from the prior-year quarter due to lower-than-expected sales trends in North America and continuing softness in Europe and Australia. The company witnessed fall in computer sales and sluggish trends in core categories. Total sales dropped 6% to $5,498.5 million, and came below the Zacks Consensus Estimate of $5,721 million. Consequently, management lowered its guidance, and now expects sales for fiscal 2012 to remain flat compared with the prior year, while the bottom line is expected to increase in low single digits. We remain cautious about the macroeconomic environment and a sluggish job market, with small businesses and consumers still remaining watchful on their spending. Going forward, Staples intends to concentrate more on augmenting store productivity by generating incremental sales per store, accelerate growth in adjacent categories, and streamlining cost structure.”

Staples traded down 0.77% on Tuesday, hitting $11.61. Staples has a 52-week low of $10.57 and a 52-week high of $16.93. The company has a market cap of $7.922 billion and a price-to-earnings ratio of 8.81.

Staples last posted its quarterly earnings results on Wednesday, August 15th. The company reported $0.18 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.22 by $0.04. The company’s revenue for the quarter was down 5.5% on a year-over-year basis. Analysts expect that Staples will post $1.36 EPS for the current fiscal year.

Several other analysts have also recently commented on the stock. Analysts at Barclays Capital reiterated an “equalweight” rating on shares of Staples in a research note to investors on Monday, October 1st. They now have a $13.00 price target on the stock. Separately, analysts at Nomura reiterated a “neutral” rating on shares of Staples in a research note to investors on Thursday, September 27th. They now have a $12.00 price target on the stock. Finally, analysts at S&P Capital IQ reiterated a “buy” rating on shares of Staples in a research note to investors on Wednesday, September 26th. They now have a $14.00 price target on the stock.

Staples, Inc. (Staples) is an office products company. Staples operates in three business segments: North American Delivery, North American Retail and International Operations.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Biogen’s second quarter EPS of $1.82 was well above the Zacks Consensus Estimate of $1.56 and the year-ago EPS of $1.35. Higher revenues and a lower share count boosted earnings. Revenues increased 17.6% to $1.4 billion, well above the Zacks Consensus Estimate of $1.3 billion. Biogen increased its earnings outlook for 2012 and now expects EPS to exceed $6.20. Key products, Avonex and Tysabri, should continue contributing significantly to sales. BG-12 should help drive long-term growth. We are also pleased with Biogen’s efforts to streamline its pipeline. However, we believe all these positive factors are already reflected in the stock price and are, therefore, moving back to a Neutral recommendation. We expect competition in the MS market to increase with the recent approval of Sanofi’s Aubagio. “

Biogen Idec traded down 0.71% on Tuesday, hitting $150.15. Biogen Idec has a 1-year low of $98.11 and a 1-year high of $157.18. The company has a market cap of $35.487 billion and a price-to-earnings ratio of 27.40.

Biogen Idec last released its earnings data on Tuesday, July 24th. The company reported $1.82 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.56 by $0.26. The company’s quarterly revenue was up 17.6% on a year-over-year basis. On average, analysts predict that Biogen Idec will post $6.41 earnings per share for the current fiscal year.

A number of other analysts have also recently weighed in on BIIB. Analysts at RBC Capital reiterated an “outperform” rating on shares of Biogen Idec in a research note to investors on Monday. They now have a $150.00 price target on the stock. Separately, analysts at Credit Suisse raised their price target on shares of Biogen Idec from $165.00 to $175.00 in a research note to investors on Monday. They now have an “outperform” rating on the stock. Finally, analysts at Oppenheimer downgraded shares of Biogen Idec from an “outperform” rating to a “market perform” rating in a research note to investors on Thursday, October 4th. They now have a $145.00 price target on the stock.

Biogen Idec Inc. (Biogen Idec) is a global biotechnology company. The Company discovers, develops, manufactures and markets therapies for the treatment of neurodegenerative diseases, hemophilia and autoimmune disorders.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “TI is one of the largest suppliers of analog and DSP integrated circuits. June quarter earnings exceeded the Zacks Consensus, although guidance was disappointing due to increased caution at distributors and reduced visibility. Despite these concerns, it is hard to ignore the company’s compelling product line, market share gains and strategic refocus. The shares have lost more than 12% in the last six months and current prices appear to reflect the uncertainty in demand, significant capacity (that will pressure earnings) and the risks associated with a high debt level. We therefore upgrade the shares from Underperform to Neutral.”

Shares of Texas Instruments traded down 2.50% during mid-day trading on Tuesday, hitting $27.29. Texas Instruments has a one year low of $26.06 and a one year high of $34.24. The company has a market cap of $31.049 billion and a P/E ratio of 20.51.

Texas Instruments last issued its quarterly earnings data on Monday, July 23rd. The company reported $0.44 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.40 by $0.04. Texas Instruments’s revenue was down 3.6% compared to the same quarter last year. On average, analysts predict that Texas Instruments will post $1.65 earnings per share for the current fiscal year.

Other equities research analysts have also recently issued reports about the stock. Analysts at ISI Group downgraded shares of Texas Instruments from a “buy” rating to a “hold” rating in a research note to investors on Monday. Separately, analysts at Pacific Crest downgraded shares of Texas Instruments from an “outperform” rating to a “sector perform” rating in a research note to investors on Wednesday, October 3rd. They now have a $23.00 price target on the stock. Finally, analysts at Susquehanna downgraded shares of Texas Instruments from a “positive” rating to a “neutral” rating in a research note to investors on Monday, October 1st.

Texas Instruments Inc. (TI) designs and makes semiconductors, which it sells to electronics designers and manufacturers globally.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Dendreon’s second quarter 2012 loss of $0.63 per share was narrower than the year-ago loss of $0.79 per share. However, loss was wider than the Zacks Consensus Estimate by 4 cents. We are concerned about the sequential decline in Provenge sales in the second quarter. Based on Provenge s disappointing track record, we do not expect sales to improve significantly in the near future. We are also concerned about competition in the prostate cancer market given the presence of J&J’s Zytiga and the new entrant in the form of Medivation and Astellas’ Xtandi. Dendreon plans to mitigate cost through layoffs and by closing a manufacturing plant. We remain on the sidelines until we see a meaningful improvement in Provenge sales.”

Several other analysts have also recently commented on the stock. Analysts at WallachBeth initiated coverage on shares of Dendreon in a research note to investors on Wednesday, September 5th. They set a “buy” rating on the stock. Separately, analysts at Cantor Fitzgerald reiterated a “hold” rating on shares of Dendreon in a research note to investors on Wednesday, September 5th. Finally, analysts at Robert W. Baird reiterated a “neutral” rating on shares of Dendreon in a research note to investors on Wednesday, August 29th.

Dendreon traded down 1.98% on Tuesday, hitting $4.45. Dendreon has a 1-year low of $4.17 and a 1-year high of $17.04. The company’s market cap is $665.4 million.

Dendreon Corporation (Dendreon) is a biotechnology company focused on the discovery, development and commercialization of therapeutics that may improve cancer treatment options for patients.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We believe that Carnival’s strong balance sheet as well as solid cash generating ability should position it well and also promises above-average long-term growth in an improving economy, marked with slow industry capacity growth. Carnival is recovering at a good pace from the Costa disaster and expects the Costa cruises to swing back to profitability in 2013. It has also been experiencing a rise in North American brands bookings and pricing for the first half of 2013 and continues to be focused on enhancing shareholders’ value and expanding in the Asian market. Its cost containment efforts are also paying off. However, the sluggish European economy that led to an uncertain consumer confidence in Europe, adverse currency translations and higher overall unit costs excluding fuel in 2013 pose major threats to the company. Hence, we maintain our Neutral recommendation on the stock.”

Carnival traded down 0.89% on Tuesday, hitting $36.82. Carnival has a 52-week low of $29.15 and a 52-week high of $39.00. The company has a market cap of $28.609 billion and a price-to-earnings ratio of 20.37.

Carnival last posted its quarterly earnings results on Tuesday, September 25th. The company reported $1.53 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.44 by $0.09. The company had revenue of $4.68 billion for the quarter, compared to the consensus estimate of $4.68 billion. The company’s quarterly revenue was down 7.4% on a year-over-year basis. Analysts expect that Carnival will post $1.86 EPS for the current fiscal year.

A number of other analysts have also recently weighed in on CCL. Analysts at Morgan Stanley raised their price target on shares of Carnival to $37.00 in a research note to investors on Monday, October 1st. Separately, analysts at Nomura reiterated a “buy” rating on shares of Carnival in a research note to investors on Wednesday, September 26th. Finally, analysts at Jefferies Group downgraded shares of Carnival from a “buy” rating to a “hold” rating in a research note to investors on Wednesday, September 26th. They now have a $37.50 price target on the stock. They noted that the move was a valuation call.

Carnival Corporation is a cruise company. The Company’s cruise brand operates in two segments: North America and Europe, Australia & Asia (EAA).

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Cabot Oil & Gas was the best performing S&P stock for 2011, gaining almost 100% during the period. The natural gas producer defied weak commodity prices to set a scorching pace in a year that saw the overall index decline 0.6%. Most of the gain was driven by its exposure to the high-return Marcellus and Eagle Ford Shale plays, as well as its above-average production growth. A relatively low risk profile and longer reserve lives are other positives in the Cabot story. But given natural gas’ weak fundamentals and Cabot’s high exposure to the commodity, we do not believe that the stock will be able to sustain the momentum in the near future. Cabot’s steep valuation and miniscule payout also keep us worried. Considering these factors, we are maintaining our Neutral recommendation on the company’s shares. “

A number of other firms have also recently commented on COG. Analysts at Sanford C. Bernstein reiterated an “outperform” rating on shares of Cabot Oil & Gas in a research note to investors on Monday. They now have a $50.00 price target on the stock. Separately, analysts at Canaccord Genuity reiterated a “buy” rating on shares of Cabot Oil & Gas in a research note to investors on Monday, October 1st. They now have a $69.00 price target on the stock. Finally, analysts at Canaccord Genuity reiterated a “buy” rating on shares of Cabot Oil & Gas in a research note to investors on Monday, September 17th. They now have a $69.00 price target on the stock.

Shares of Cabot Oil & Gas traded down 0.86% during mid-day trading on Monday, hitting $43.90. Cabot Oil & Gas has a one year low of $28.84 and a one year high of $47.25. The company has a market cap of $9.218 billion and a P/E ratio of 85.15.

Cabot Oil & Gas last issued its quarterly earnings data on Tuesday, July 24th. The company reported $0.05 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.07 by $0.02. The company’s quarterly revenue was up 10.4% on a year-over-year basis. On average, analysts predict that Cabot Oil & Gas will post $0.47 earnings per share for the current fiscal year.

Cabot Oil & Gas Corporation is an independent oil and gas company engaged in the development, exploitation and exploration of oil and gas properties located in North America.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We reaffirm our long-term Neutral recommendation on Grupo Televisa ahead of its third-quarter 2012 financial results. In the second-quarter 2012, all the five business segments of Televisa generated considerable revenue growth. Moreover, Teleisa is continuously generating higher royalties from its Univision venture in the U.S. We are quite optimistic regarding the newly formed Televisa-Iusacell venture in the Mexican wireless market. The company at present controls four free-to-air broadcast channels, the largest of the two satellite TV channels, and three cable TV units offering triple-play TV, voice and Internet services. Undoubtedly, a foothold in the lucrative mobile market will make the company a highly integrated broadcasting and telecom operator in Mexico. Meanwhile the stock price has soared nearly 28% in the last year. We believe Televisa is currently fairly valued and will not provide above market gain anytime soon. “

Grupo Televisa S.A. traded up 0.59% on Monday, hitting $23.93. Grupo Televisa S.A. has a 52-week low of $18.60 and a 52-week high of $24.88. The company has a market cap of $13.669 billion and a price-to-earnings ratio of 23.46.

Other equities research analysts have also recently issued reports about the stock. Analysts at Scotia Capital downgraded shares of Grupo Televisa S.A. from an “outperform” rating to a “sector perform” rating in a research note to investors on Friday, September 14th. Analysts at Goldman Sachs upgraded shares of Grupo Televisa S.A. from a “sell” rating to a “neutral” rating in a research note to investors on Tuesday, July 31st.

Grupo Televisa, S.A.B. is a media company. The Company operates broadcast channels in Mexico and complement its network coverage through affiliated stations.

To view Zacks’ full report, visit www.zacks.com

Several other analysts have also recently commented on the stock. Analysts at RBC Capital reiterated an “outperform” rating on shares of Limited Brands in a research note to investors on Friday. They now have a $54.00 price target on the stock. Separately, analysts at Jefferies Group raised their price target on shares of Limited Brands from $45.00 to $48.00 in a research note to investors on Friday. They now have a “hold” rating on the stock. Finally, analysts at Atlantic Securities reiterated an “overweight” rating on shares of Limited Brands in a research note to investors on Thursday. They now have a $55.00 price target on the stock.

Shares of Limited Brands traded down 0.65% during mid-day trading on Monday, hitting $50.23. Limited Brands has a 52 week low of $37.57 and a 52 week high of $52.20. The company has a market cap of $14.437 billion and a P/E ratio of 21.22.

Limited Brands last announced its earnings results on Wednesday, August 15th. The company reported $0.50 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.47 by $0.03. Limited Brands’s revenue was down 2.4% compared to the same quarter last year. On average, analysts predict that Limited Brands will post $2.87 earnings per share for the current fiscal year.

Limited Brands, Inc. operates is a specialty retailer of women’s intimate and other apparel, beauty and personal care products and accessories.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “General Motors is benefiting from its focus on the emerging markets and expects further improvement from its major expansion plan across the globe. Furthermore, improved macroeconomic conditions in the U.S. and pent-up demand in the industry will boost sales based on diversified lineups. In the most recent quarter, the company saw a sharp 41% fall in profits to $0.90 per share. Nevertheless, profits exceeded the Zacks Consensus Estimate by $0.15 per share. Therefore, we have upgraded our recommendation on the shares of the company to Neutral from Underperform and set a target price of $26.00.”

Other equities research analysts have also recently issued reports about the stock. Analysts at Jefferies Group reiterated a “hold” rating on shares of General Motors in a research note to investors on Thursday. Separately, analysts at Stifel Nicolaus initiated coverage on shares of General Motors in a research note to investors on Thursday, September 27th. They set a “hold” rating on the stock. Finally, analysts at Buckingham Research upgraded shares of General Motors from a “neutral” rating to a “buy” rating in a research note to investors on Tuesday, September 18th. They now have a $35.00 price target on the stock.

Shares of General Motors traded down 0.40% during mid-day trading on Monday, hitting $24.70. General Motors has a 52 week low of $18.72 and a 52 week high of $27.68. The company has a market cap of $38.679 billion and a P/E ratio of 8.84.

General Motors last announced its earnings results on Thursday, August 2nd. The company reported $0.90 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.79 by $0.11. General Motors’s revenue was down 4.6% compared to the same quarter last year. On average, analysts predict that General Motors will post $3.14 earnings per share for the current fiscal year.

General Motors Company (GM) is a global automotive company. It develops, produces and markets cars, trucks and parts worldwide.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Genworth stays focused on streamlining its businesses, with the ultimate goal of maximizing shareholders’ net worth. Though its second quarter earnings lagged the Zacks Consensus Estimate, it rebounded from the year-ago loss. Second quarter results benefited from substantial lower loss at Global Mortgage Insurance. However, declines in Insurance and Wealth Management were partial offsets. Top line lagged the year-ago numbers largely due to lower premiums and lower net investment income, though it exceeded our expectations. The IPO of the Australian Mortgage insurance is also pushed forward to early 2013. The IPO was rescheduled due to a soft operational performance in Australian mortgage insurance business in the first quarter of 2012. However, the company has undertaken reserve strengthening that helped better numbers in the second quarter. We retain our Neutral recommendation on Genworth Financial. “

Shares of Genworth Financial traded down 0.09% during mid-day trading on Monday, hitting $5.385. Genworth Financial has a 52 week low of $4.06 and a 52 week high of $9.68. The company has a market cap of $2.647 billion and a P/E ratio of 8.22.

Genworth Financial last announced its earnings results on Tuesday, July 31st. The company reported $0.16 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.18 by $0.02. The company’s quarterly revenue was down 5.0% on a year-over-year basis. On average, analysts predict that Genworth Financial will post $0.64 earnings per share for the current fiscal year.

A number of other firms have also recently commented on GNW. Analysts at Macquarie initiated coverage on shares of Genworth Financial in a research note to investors on Monday, September 24th. They set a “neutral” rating and a $7.00 price target on the stock. Analysts at UBS AG initiated coverage on shares of Genworth Financial in a research note to investors on Wednesday, July 18th. They set a “neutral” rating and a $5.50 price target on the stock.

Genworth Financial, Inc. (Genworth) is a financial security company dedicated to providing insurance, wealth management, investment and financial solutions to more than 15 million customers, with a presence in more than 25 countries.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Driven by strong same-store sales performance along with improved margins, Dillard’s second-quarter 2012 earnings of $0.63 per share surged over two-folds from the prior-year quarter, and outpaced the Zacks Consensus Estimate of $0.49. Moreover, total revenue grew 3.3% year over year to $1,525.2 million and beat the Zacks Consensus Estimate of 1,466 million. Further, management is undertaking restructuring initiatives and inventory reduction efforts to reduce costs while boosting its profitability. We believe Dillard’s healthy balance sheet and adequate cash flows allow it to make shareholder-friendly moves, such as acquisitions, dividends and share repurchases. Moreover, we anticipate Dillard’s wholly-owned Captive Insurance Company and REIT will help it manage risks more efficiently while enhancing its liquidity position. Currently, we maintain a long-term Outperform recommendation on the stock.”

Dillard’s traded down 1.71% on Monday, hitting $74.815. Dillard’s has a 52-week low of $42.54 and a 52-week high of $79.23. The company has a market cap of $3.526 billion and a price-to-earnings ratio of 7.82.

Dillard’s last posted its quarterly earnings results on Wednesday, August 8th. The company reported $0.63 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.46 by $0.17. The company’s revenue for the quarter was up 3.3% on a year-over-year basis. On average, analysts predict that Dillard’s will post $6.00 earnings per share for the current fiscal year.

A number of other analysts have also recently weighed in on DDS. Analysts at Knight initiated coverage on shares of Dillard’s in a research note to investors on Friday, September 14th. They set a “buy” rating on the stock. Analysts at JPMorgan Chase raised their price target on shares of Dillard’s from $65.00 to $70.00 in a research note to investors on Monday, August 6th. They now have a “neutral” rating on the stock.

Dillard’s, Inc. (Dillard’s) is engaged in apparel and home furnishing retail business. As of January 30, 2010, the Company operated 309 Dillard’s stores, including 12 clearance centers and one Internet store offering a selection of merchandise, including fashion apparel for women, men and children, accessories, cosmetics, home furnishings and other consumer goods.

To view Zacks’ full report, visit www.zacks.com

Thoratec traded down 0.69% on Monday, hitting $36.1699. Thoratec has a 1-year low of $27.84 and a 1-year high of $38.07. The company has a market cap of $2.128 billion and a price-to-earnings ratio of 27.47.

Thoratec last released its earnings data on Wednesday, August 1st. The company reported $0.45 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.45. The company’s revenue for the quarter was up 6.7% on a year-over-year basis. On average, analysts predict that Thoratec will post $1.73 earnings per share for the current fiscal year.

THOR has been the subject of a number of other recent research reports. Analysts at Wedbush upgraded shares of Thoratec from a “neutral” rating to an “outperform” rating in a research note to investors on Thursday. Separately, analysts at UBS AG upgraded shares of Thoratec from a “neutral” rating to a “buy” rating in a research note to investors on Wednesday, October 3rd. They now have a $39.00 price target on the stock, up previously from $35.00. They noted that the move was a valuation call. Finally, analysts at WallachBeth initiated coverage on shares of Thoratec in a research note to investors on Monday, October 1st. They set a “hold” rating and a $37.00 price target on the stock.

Thoratec Corporation is a manufacture of mechanical circulatory support (MCS) with a product portfolio to treat a range of clinical needs for advanced heart failure patients.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Texas Capital’s second-quarter 2012 operating earnings surpassed the Zacks Consensus Estimate by $0.05 per share. Quarterly results benefited from an increase in the top line aided by an augmentation in both net interest income as well as non-interest income. Yet, it was partially offset by higher expenses. The company’s business model remains a chief growth driver. In addition, the gain in market share from its competitors and organic growth is impressive. Its efforts to hire experienced bankers and expand its presence are encouraging. Though the resultant expenses that continue to mount remain a concern, we believe that with an eventual improvement in the Texan economy, the company would be poised to experience a further increase in earnings. “

Texas Capital traded down 1.24% on Monday, hitting $50.98. Texas Capital has a 52-week low of $24.56 and a 52-week high of $52.17. The company has a market cap of $1.943 billion and a price-to-earnings ratio of 19.21.

Texas Capital last posted its quarterly earnings results on Wednesday, July 25th. The company reported $0.76 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.70 by $0.06. Analysts expect that Texas Capital will post $3.01 EPS for the current fiscal year.

Texas Capital Bancshares, Inc. is a financial holding company. The Company is the parent of Texas Capital Bank, National Association (the Bank).

To view Zacks’ full report, visit www.zacks.com

Shares of Mechel traded up 2.18% during mid-day trading on Monday, hitting $7.03. Mechel has a one year low of $5.08 and a one year high of $14.49. The company’s market cap is $2.926 billion.

Other equities research analysts have also recently issued reports about the stock. Analysts at HSBC cut their price target on shares of Mechel from $15.80 to $10.60 in a research note to investors on Thursday, August 23rd. They now have an “overweight” rating on the stock. Analysts at Credit Suisse downgraded shares of Mechel from a “neutral” rating to an “underperform” rating in a research note to investors on Friday, August 10th.

Mechel OAO is an integrated mining, steel, ferroalloys and power company. The Company operates in four segments: mining, steel, ferroalloys and power.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Duke Energy Corporation’s U.S. electricity and gas operations (spread over the Carolinas, Florida, Indiana, Kentucky and Ohio) generate a relatively stable and growing earnings stream. Looking ahead, our bullish outlook for the company is supported by its recently concluded merger proceedings with Progress Energy Inc., paving the way for the largest U.S. utility. In addition, it’s strong balance sheet, ongoing capital expansion projects and above industry average dividend yield add visibility to the story. However, valuation continues to be restrained by a number of factors, including the present unfavorable macro backdrop, predominantly fossil-fuel based generation assets, tepid demand for electricity, a sudden change of its CEO and pending regulatory cases.”

Several other analysts have also recently commented on the stock. Analysts at Argus upgraded shares of Duke Energy from a “hold” rating to a “buy” rating in a research note to investors on Monday, October 1st. They now have a $72.00 price target on the stock. Separately, analysts at Macquarie reiterated an “outperform” rating on shares of Duke Energy in a research note to investors on Tuesday, September 4th. They now have a $70.00 price target on the stock. Finally, analysts at Barclays Capital reiterated an “in-line” rating on shares of Duke Energy in a research note to investors on Wednesday, August 22nd.

Shares of Duke Energy traded up 0.27% during mid-day trading on Monday, hitting $65.1569. Duke Energy has a 52 week low of $58.74 and a 52 week high of $71.13. The company has a market cap of $45.879 billion and a P/E ratio of 19.33.

Duke Energy last announced its earnings results on Thursday, August 2nd. The company reported $0.27 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.96 by $0.69. The company’s revenue for the quarter was up .8% on a year-over-year basis. Analysts expect that Duke Energy will post $4.28 EPS for the current fiscal year.

Duke Energy Corporation (Duke Energy) is an energy company. Duke Energy’s segments are U.S. Franchised Electric and Gas (USFE&G), Commercial Power and International Energy.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Following lower-than-expected second-quarter 2012 results, we have downgraded our long-term recommendation on Citi Trends to Neutral. Citi Trends’ loss of $0.54 per share fared worse than the Zacks Consensus Estimate loss of $0.44. Moreover, the company’s net sales of $132.3 million marginally fell short of the Zacks Consensus Estimate of $133 million. We believe the ongoing sluggishness in the economy and rising commodity prices may act as an impediment. Besides, intense competition from other retailers, seasonal nature of business, and risks associated with sourcing merchandise from developing countries may further undermine the company’s growth prospects. However, we believe Citi Trends’ extensive focus on store expansion strategy may provide an impetus. Further, the company has taken prudent steps to reduce inventory shrinkages, which we believe, will help it improve operational performance.”

Citi Trends traded up 0.24% on Monday, hitting $12.50. Citi Trends has a 1-year low of $7.87 and a 1-year high of $16.42. The company’s market cap is $183.4 million.

Citi Trends last released its earnings data on Wednesday, August 15th. The company reported ($0.54) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.44) by $0.10. The company’s quarterly revenue was up 1.6% on a year-over-year basis. On average, analysts predict that Citi Trends will post $0.12 earnings per share for the current fiscal year.

Several other analysts have also recently commented on the stock. Analysts at Oppenheimer reiterated a “perform” rating on shares of Citi Trends in a research note to investors on Thursday, August 16th. Analysts at MKM Partners cut their price target on shares of Citi Trends from $13.00 to $11.00 in a research note to investors on Thursday, August 16th. They now have a “neutral” rating on the stock.

Citi Trends, Inc. is a retailer of urban fashion apparel and accessories for the entire family. The Company offers branded apparel from national brands, as well as private label apparel, accessories and a limited assortment of home decor items.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Heinz’s first quarter 2013 adjusted earnings of $0.87 per share beat the Zacks Consensus by 4.8%. Earnings also exceeded the prior-year earnings by 10.1% largely due to a lower-than-expected tax rate, organic sales growth and productivity improvements. Though reported revenues declined 1.5% due to currency headwinds, organic revenues grew 4.8%. Overall, we believe Heinz’s robust brand portfolio, continued strong growth in emerging markets, strong marketing investments and ongoing cost saving efforts will boost long-term growth. However, continued sluggishness in its largest segment, the North American consumer business, is a significant concern. Though management’s effort to turn around this business is encouraging, we prefer to stay on the sidelines until the company shows some success from its efforts. We therefore remain Neutral with a target price of $60.00. “

H.J. Heinz Company traded down 0.19% on Monday, hitting $56.98. H.J. Heinz Company has a 52-week low of $49.75 and a 52-week high of $58.31. The company has a market cap of $18.247 billion and a price-to-earnings ratio of 19.31.

H.J. Heinz Company last posted its quarterly earnings results on Wednesday, August 29th. The company reported $0.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.80 by $0.07. The company had revenue of $2.79 million for the quarter, compared to the consensus estimate of $2.84 million. The company’s revenue for the quarter was down 1.4% on a year-over-year basis. Analysts expect that H.J. Heinz Company will post $3.51 EPS for the current fiscal year.

Several other analysts have also recently commented on the stock. Analysts at Deutsche Bank reiterated a “buy” rating on shares of H.J. Heinz Company in a research note to investors on Thursday, September 6th. Separately, analysts at Jefferies Group reiterated a “hold” rating on shares of H.J. Heinz Company in a research note to investors on Thursday, September 6th. They now have a $57.00 price target on the stock. Finally, analysts at JPMorgan Chase reiterated a “neutral” rating on shares of H.J. Heinz Company in a research note to investors on Tuesday, September 4th. They now have a $52.00 price target on the stock.

H. J. Heinz Company together with its subsidiaries is engaged in manufacturing and marketing a range of food products throughout the world.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Following the footsteps of the previous quarter results, CRA International’s second quarter 2012 results were also discouraging. The earnings lagged the Zacks Consensus Estimate significantly, owing to the weak management consulting business, resulting from poor performance of the Chemicals practice and Middle East operations. Moreover, we remain concerned about the ongoing economic uncertainty in Europe, cautious spending by clients, stiff competition and currency fluctuations. However, company’s litigation business remains firm based on strong lead flow, an improved conversion rate and solid demand resulting in new projects. Moreover, the company’s growth initiatives and healthy cash balance with no long-term debt augur well. Additionally, management is undertaking restructuring actions to improve profitability and boost performance. Hence, we upgrade our stance on the stock from Underperform to Neutral.”

CRA International traded up 0.87% on Monday, hitting $17.41. CRA International has a 1-year low of $13.41 and a 1-year high of $27.93. The company has a market cap of $178.8 million and a price-to-earnings ratio of 19.46.

Separately, analysts at William Blair downgraded shares of CRA International from an “outperform” rating to a “market perform” rating in a research note to investors on Friday, July 27th.

CRA International, Inc. is a global consulting firm, which offers economic, financial, and business management consulting expertise and applies analytic techniques and in-depth industry knowledge to complex engagements for a range of clients.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “McGraw-Hill’s second-quarter 2012 earnings of $0.85 per share beat the Zacks Consensus Estimate of $0.76, and rose 25% year-over-year. The strong performance of S&P Capital IQ/S&P Indices and Commodities & Commercial helped to alleviate the volatility in the global credit market, thereby boosting the profitability. The cost containment efforts also provided cushion to the bottom-line. Management now expects earnings to be at the higher end of the guidance range of $3.25 to $3.35 per share in fiscal 2012. Total revenue dropped 1% to $1,547 million and also fell short of the Zacks Consensus Estimate of $1,587 million. Education segment revenue fell 12% due to 20% decline in revenue at School Education Group. Elementary high school markets remains challenging due to low funding levels. Given the macroeconomic environment, we believe that management’s decision to split the company into two is prudent, as it would provide the new entities a level playing field in their core business areas.”

Shares of Mcgraw-Hill traded down 1.02% during mid-day trading on Monday, hitting $55.26. Mcgraw-Hill has a one year low of $40.50 and a one year high of $55.94. The company has a market cap of $15.484 billion and a P/E ratio of 17.68.

Mcgraw-Hill last issued its quarterly earnings data on Thursday, July 26th. The company reported $0.85 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.76 by $0.09. The company’s quarterly revenue was down .6% on a year-over-year basis. Analysts expect that Mcgraw-Hill will post $3.37 EPS for the current fiscal year.

MHP has been the subject of a number of other recent research reports. Analysts at UBS AG initiated coverage on shares of Mcgraw-Hill in a research note to investors on Wednesday, October 3rd. They set a “buy” rating and a $64.00 price target on the stock. Separately, analysts at Piper Jaffray reiterated an “overweight” rating on shares of Mcgraw-Hill in a research note to investors on Friday, September 28th. They now have a $60.00 price target on the stock, up previously from $57.00. Finally, analysts at Raymond James initiated coverage on shares of Mcgraw-Hill in a research note to investors on Friday, September 21st. They set an “outperform” rating and a $60.00 price target on the stock.

The McGraw-Hill Companies, Inc. is a global information services provider serving the financial, education, commercial and commodities markets.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “McGraw-Hill’s second-quarter 2012 earnings of $0.85 per share beat the Zacks Consensus Estimate of $0.76, and rose 25% year-over-year. The strong performance of S&P Capital IQ/S&P Indices and Commodities & Commercial helped to alleviate the volatility in the global credit market, thereby boosting the profitability. The cost containment efforts also provided cushion to the bottom-line. Management now expects earnings to be at the higher end of the guidance range of $3.25 to $3.35 per share in fiscal 2012. Total revenue dropped 1% to $1,547 million and also fell short of the Zacks Consensus Estimate of $1,587 million. Education segment revenue fell 12% due to 20% decline in revenue at School Education Group. Elementary high school markets remains challenging due to low funding levels. Given the macroeconomic environment, we believe that management’s decision to split the company into two is prudent, as it would provide the new entities a level playing field in their core business areas.”

A number of other analysts have also recently weighed in on MHP. Analysts at UBS AG initiated coverage on shares of Mcgraw-Hill in a research note to investors on Wednesday, October 3rd. They set a “buy” rating and a $64.00 price target on the stock. Separately, analysts at Piper Jaffray reiterated an “overweight” rating on shares of Mcgraw-Hill in a research note to investors on Friday, September 28th. They now have a $60.00 price target on the stock, up previously from $57.00. Finally, analysts at Raymond James initiated coverage on shares of Mcgraw-Hill in a research note to investors on Friday, September 21st. They set an “outperform” rating and a $60.00 price target on the stock.

Shares of Mcgraw-Hill traded down 1.02% during mid-day trading on Monday, hitting $55.26. Mcgraw-Hill has a one year low of $40.50 and a one year high of $55.94. The company has a market cap of $15.484 billion and a P/E ratio of 17.68.

Mcgraw-Hill last issued its quarterly earnings data on Thursday, July 26th. The company reported $0.85 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.76 by $0.09. Mcgraw-Hill’s revenue was down .6% compared to the same quarter last year. On average, analysts predict that Mcgraw-Hill will post $3.37 earnings per share for the current fiscal year.

The McGraw-Hill Companies, Inc. is a global information services provider serving the financial, education, commercial and commodities markets.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “SLM Corp.’s second-quarter 2012 core earnings per share lagged the Zacks Consensus Estimate. Results were negatively affected by non-cash loan premium amortization in the quarter. Also, higher funding costs and a decline in federally guaranteed student loan balances were the dampeners. Yet, lower loan loss provision, reduced operating expenses and higher debt repurchase gains partly mitigated the negative impact in the quarter. Despite challenges, we believe that its leading position in the student lending market, diversifying efforts, cost containment measures and increasing private student loan originations would help the company navigate well through the current cycle. In addition, federal student loan asset acquisition serves as a positive catalyst. Capital deploying efforts are impressive and we believe that the regulatory issues would be manageable on the company’s part. “

Several other analysts have also recently commented on the stock. Analysts at Barclays Capital reiterated an “overweight” rating on shares of SLM in a research note to investors on Tuesday, October 2nd. Separately, analysts at Janney Montgomery Scott reiterated a “buy” rating on shares of SLM in a research note to investors on Monday, September 17th. Finally, analysts at FBR Capital reiterated an “outperform” rating on shares of SLM in a research note to investors on Friday, September 7th.

Shares of SLM traded up 0.48% during mid-day trading on Monday, hitting $16.75. SLM has a 52 week low of $11.97 and a 52 week high of $16.94. The company has a market cap of $7.862 billion and a P/E ratio of 9.89.

SLM last posted its quarterly earnings results on Wednesday, July 18th. The company reported $0.59 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.54 by $0.05. The company’s quarterly revenue was down 14.1% on a year-over-year basis. Analysts expect that SLM will post $2.15 EPS for the current fiscal year.

SLM Corporation, known as Sallie Mae, is engaged in the business of originating, servicing and collecting student loans and/or their parents to finance the cost of their education.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are reiterating our Neutral recommendation on the shares of Reinsurance Group of America prior to the third quarter earnings release scheduled on October 22, 2012. During the second quarter the company lagged the Zacks Consensus Estimate but improved year over year. The company has diversified its operations and holds a significant position in the U.S. The acquisition of ReliaStar has further consolidated its position as a leader in the North American market. The company also has a strong presence in the Canadian market. An expanding international business also boosts Reinsurance Group’s long-term growth. The company is poised to benefit from consolidations within the life reinsurance industry. However, headwinds such as reliance on retrocession, increased retention and compliance with Solvency II requirements in the European region, remain a concern. Nevertheless, a stable balance sheet and strong ratings enhance our confidence in the company.”

Separately, analysts at Evercore Partners initiated coverage on shares of Reinsurance Group of America in a research note to investors on Wednesday, September 19th. They set an “equal weight” rating on the stock.

Shares of Reinsurance Group of America traded down 0.45% during mid-day trading on Monday, hitting $58.208. Reinsurance Group of America has a 52 week low of $48.33 and a 52 week high of $60.69. The company has a market cap of $4.291 billion and a P/E ratio of 7.33.

Reinsurance Group of America last announced its earnings results on Thursday, July 26th. The company reported $1.65 EPS for the quarter, missing the Thomson Reuters consensus estimate of $1.75 by $0.10. The company’s quarterly revenue was up 7.8% on a year-over-year basis. On average, analysts predict that Reinsurance Group of America will post $6.96 earnings per share for the current fiscal year.

Reinsurance Group of America, Incorporated (RGA) is an insurance holding company. The Company is primarily engaged in traditional individual and group life, annuity, critical illness and financial reinsurance.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Raymond James’ fiscal third quarter (ended June 30, 2012) earnings slightly lagged the Zacks Consensus Estimate. The earnings were lower-than-expected primarily due to higher operating expenses, partially offset by improving top line. Nevertheless, an increase in assets under management (AUM) and assets under administration were the positives. We anticipate synergies from its recent acquisition of Morgan Keegan. Moreover, the company’s capital strength and its efforts to boost revenue by recruiting experienced advisors are expected to be accretive to its financials in the upcoming quarters. However, the ever-increasing non-interest expenses, low interest rates, regulatory issues and sluggish economic recovery are expected to put the company’s profitability under pressure in the near term.”

Raymond James traded up 1.24% on Friday, hitting $37.50. Raymond James has a 1-year low of $25.87 and a 1-year high of $38.95. The company has a market cap of $5.176 billion and a price-to-earnings ratio of 17.30.

Raymond James last released its earnings data on Wednesday, July 25th. The company reported $0.64 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.66 by $0.02. The company’s revenue for the quarter was up 27.7% on a year-over-year basis. On average, analysts predict that Raymond James will post $2.44 earnings per share for the current fiscal year.

Separately, analysts at Sandler O’Neill upgraded shares of Raymond James from a “hold” rating to a “buy” rating in a research note to investors on Friday, July 27th.

Raymond James Financial, Inc. (RJF) is a holding company whose subsidiaries are engaged in various financial services businesses in the United States of America and Canada.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Bemis Company’s second-quarter EPS increased 6% to $0.54, and was ahead of the Zacks Consensus Estimate. However, net sales declined 4.2% year over year to $1.3 billion, in line with the Zacks Consensus Estimate. Unit volumes in the Flexible Packaging segment declined, affecting the company’s financial performance during the quarter. Weak volume, cautious consumer spending environment, weakening European economic outlook and rising food costs remain major causes of concern. However, savings from the Bemis cost reduction program due to the closure of unproductive facilities will help offset these pressures. In addition, moderation in resin costs should help stabilize margins. We maintain our Neutral recommendation with a target price of $33.00.”

Other equities research analysts have also recently issued reports about the stock. Analysts at Citigroup downgraded shares of Bemis from a “buy” rating to a “neutral” rating in a research note to investors on Tuesday, September 11th. They now have a $34.00 price target on the stock, down previously from $36.00. Analysts at JPMorgan Chase initiated coverage on shares of Bemis in a research note to investors on Monday, September 10th. They set a “neutral” rating and a $37.00 price target on the stock.

Bemis traded up 0.76% on Friday, hitting $31.97. Bemis has a 1-year low of $27.21 and a 1-year high of $33.48. The company has a market cap of $3.302 billion and a price-to-earnings ratio of 20.25.

Bemis last released its earnings data on Thursday, July 26th. The company reported $0.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.52 by $0.02. The company’s revenue for the quarter was down 4.2% on a year-over-year basis. Analysts expect that Bemis will post $2.03 EPS for the current fiscal year.

Bemis Company, Inc. (Bemis) is a manufacturer of flexible packaging products and pressure sensitive materials, selling to customers throughout the United States, Canada, Mexico, South America, Europe, and Asia.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Watsco reported second quarter earnings per share of $1.15, up 6% year over year and revenues of $1.01 billion, which increased 15% year over year. However, both fell short of the respective Zacks Consensus Estimates. Watsco has immense potential in the replacement market of air conditioners and heating systems in the U.S, as nearly 89 million of them are more than 10 years old. Backed by its solid balance sheet, Watsco can continue to increase its dividend and make additional investments going forward. Watsco also stands to benefit from a recovery in the housing market. However, based on the lowering of its guidance due to profit issues at the Canadian joint venture with Carrier, we downgrade our recommendation from Outperform to Neutral with a target price of $84.00.”

A number of other firms have also recently commented on WSO. Analysts at JPMorgan Chase raised their price target on shares of Watsco, Incorporated from $70.00 to $78.00 in a research note to investors on Monday, September 10th. They now have an “overweight” rating on the stock. Separately, analysts at UBS AG initiated coverage on shares of Watsco, Incorporated in a research note to investors on Tuesday, July 31st. They set a “buy” rating and a $105.00 price target on the stock. They noted that the move was a valuation call. Finally, analysts at Lazard Capital initiated coverage on shares of Watsco, Incorporated in a research note to investors on Tuesday, July 31st. They set a “neutral” rating on the stock. They noted that the move was a valuation call.

Shares of Watsco, Incorporated traded up 0.53% during mid-day trading on Friday, hitting $80.12. Watsco, Incorporated has a 52 week low of $55.62 and a 52 week high of $80.34. The company has a market cap of $2.541 billion and a P/E ratio of 28.11.

Watsco, Incorporated last announced its earnings results on Wednesday, July 25th. The company reported $1.15 earnings per share for the quarter, missing the analysts’ consensus estimate of $1.31 by $0.16. Watsco, Incorporated’s revenue was up 14.5% compared to the same quarter last year. On average, analysts predict that Watsco, Incorporated will post $3.19 earnings per share for the current fiscal year.

Watsco, Inc. (Watsco) is the distributor of air conditioning, heating and refrigeration equipment and related parts and supplies (HVAC/R) in the HVAC/R distribution industry.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Prudential Financial Inc.’s core operating earnings for the second quarter 2012 came in at $1.34 per share, much lower than the Zacks Consensus Estimate of $1.55. Moreover, the results dwindled 14.7% on a year-over-year basis. The lackluster earnings were primarily the outcome of higher claims experience and expense levels, partially offset by revenue growth and a lower share count. Despite the current subdued earnings, we remain upbeat about the company’s long-term performance. It has been focusing on its underlying businesses by making significant acquisitions and shedding non-core businesses. It carries a strong brand name and has been a niche player in the life insurance and retirement market. Moreover, the changing demography of the U.S. population bodes well for the company’s retirement business. Additionally, its International business segment has been performing strongly over the past several years and is expected to maintain this trend going forward. A solid balance sheet along with sound capital management policies makes the stock favorable for the investors. “

A number of other analysts have also recently weighed in on PRU. Analysts at Barclays Capital reiterated an “equalweight” rating on shares of Prudential Financial in a research note to investors on Monday. They now have a $62.00 price target on the stock. Separately, analysts at Sterne Agee reiterated a “buy” rating on shares of Prudential Financial in a research note to investors on Friday, September 28th. They now have a $78.00 price target on the stock. Finally, analysts at RBC Capital reiterated an “outperform” rating on shares of Prudential Financial in a research note to investors on Friday, September 28th. They now have a $84.00 price target on the stock.

Prudential Financial traded up 1.65% on Friday, hitting $56.70. Prudential Financial has a 52-week low of $44.47 and a 52-week high of $65.17. The company has a market cap of $26.422 billion and a price-to-earnings ratio of 7.80.

Prudential Financial last released its earnings data on Wednesday, August 1st. The company reported $1.34 EPS for the quarter, missing the Thomson Reuters consensus estimate of $1.54 by $0.20. The company’s quarterly revenue was up 12.9% on a year-over-year basis. Analysts expect that Prudential Financial will post $6.30 EPS for the current fiscal year.

Prudential Financial, Inc. (Prudential Financial) is a financial services company. Prudential Financial has operations in the United States, Asia, Europe and Latin America.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are reiterating our Neutral recommendation on the shares of Cincinnati Financial Corp. The company performed favorably during the previous quarter. Though the Commercial Lines segment is gradually seeing improving rates, it is expected to remain under pressure due to stiff competition and a still weak pricing environment. Its Personal line is witnessing gradually improving business conditions. Also, the Life segment is performing favorably. Cincinnati is likely to witness limited investment growth owing to regular low yields for investment options. However, management is appointing agencies and expanding product offerings to compensate the decline in businesses. Low leverage, solid capital, consistent cash flow generation, share repurchases and dividend increase are among the other positives. However, we expect pressure on the top line until the soft insurance market cycle reverses completely.”

Other equities research analysts have also recently issued reports about the stock. Analysts at RBC Capital reiterated a “sector perform” rating on shares of Cincinnati Financial in a research note to investors on Friday. They now have a $38.00 price target on the stock. Analysts at Sandler O’Neill reiterated a “hold” rating on shares of Cincinnati Financial in a research note to investors on Monday, September 24th. They now have a $40.00 price target on the stock.

Cincinnati Financial traded up 0.55% on Friday, hitting $38.71. Cincinnati Financial has a 52-week low of $25.69 and a 52-week high of $40.22. The company has a market cap of $6.291 billion and a price-to-earnings ratio of 23.03.

Cincinnati Financial last posted its quarterly earnings results on Thursday, July 26th. The company reported $0.17 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.12 by $0.05. The company’s quarterly revenue was up 4.6% on a year-over-year basis. Analysts expect that Cincinnati Financial will post $1.50 EPS for the current fiscal year.

Cincinnati Financial Corporation is engaged in property casualty insurance marketed through independent insurance agents in 37 states.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Ameriprise’s second quarter 2012 operating earnings significantly lagged the Zacks Consensus Estimate. Lower-than-expected earnings were primarily driven by reduced top line, which was partly offset by lower operating expenses. Moreover, assets under management (AUM) and assets under administration (AUA) deteriorated marginally in the quarter. Consistent capital deployment activities should continue to boost investors confidence in the stock. Though the slow market recovery is alarming, improvement in retail client activity and decent growth in Advice & Wealth Management and Asset Management businesses would propel operating leverage in the upcoming quarters. However, escalating expenses, existing low interest rate environment and the ongoing outflows related to the integration of Columbia Management will keep Ameriprise’s financials under pressure in the near future.”

Several other analysts have also recently commented on the stock. Analysts at Barclays Capital reiterated an “overweight” rating on shares of Ameriprise Financial in a research note to investors on Monday. They now have a $68.00 price target on the stock. Separately, analysts at UBS AG raised their price target on shares of Ameriprise Financial from $60.00 to $69.00 in a research note to investors on Friday, September 21st. They now have a “buy” rating on the stock. Finally, analysts at RBC Capital reiterated a “top pick” rating on shares of Ameriprise Financial in a research note to investors on Tuesday, September 4th. They now have a $74.00 price target on the stock.

Shares of Ameriprise Financial traded up 0.10% during mid-day trading on Friday, hitting $57.83. Ameriprise Financial has a 52 week low of $39.04 and a 52 week high of $60.47. The company has a market cap of $12.186 billion and a P/E ratio of 13.67.

Ameriprise Financial last released its earnings data on Wednesday, July 25th. The company reported $1.39 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.35 by $0.04. The company’s revenue for the quarter was down 4.2% on a year-over-year basis. On average, analysts predict that Ameriprise Financial will post $5.53 earnings per share for the current fiscal year.

Ameriprise Financial, Inc. (Ameriprise Financial) is a holding company. The Company provides financial planning, products and services that are designed to be utilized as solutions for its clients’ cash and liquidity, asset accumulation, income, protection, and estate and wealth transfer needs.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are changing our recommendation for Plum Creek from Neutral to Outperform based on upward earnings estimate revisions. Plum Creek reported strong second quarter 2012 results with earnings beating the Zacks Consensus Estimate by $0.04. Plum Creek is the largest publicly-held timber REIT, with a diversified timber and land base that enables it to benefit from large economies of scale. In addition, the upsurge in demographic trends driving housing markets and demand for real estate properties across the country provides a strong economic backdrop for the company to demonstrate solid financial performance in the future. However, cyclical nature of the business, cutthroat competition, and strict environment policies undermines its long-term growth potential to some extent. “

Plum Creek Timber traded up 0.83% on Friday, hitting $42.74. Plum Creek Timber has a 52-week low of $34.22 and a 52-week high of $44.99. The company has a market cap of $6.903 billion and a price-to-earnings ratio of 38.89.

A number of other analysts have also recently weighed in on PCL. Analysts at DA Davidson downgraded shares of Plum Creek Timber from a “buy” rating to a “neutral” rating in a research note to investors on Monday. They now have a $45.00 price target on the stock. They noted that the move was a valuation call. Separately, analysts at Bank of America upgraded shares of Plum Creek Timber from an “underperform” rating to a “neutral” rating in a research note to investors on Friday, September 14th. They now have a $47.00 price target on the stock.

Plum Creek Timber Company, Inc. (Plum Creek) is a private timberland owner in the United States. As of December 31, 2009, Plum Creek owned 7 million acres of timberlands located in 19 states.

To view Zacks’ full report, visit www.zacks.com

Several other analysts have also recently commented on the stock. Analysts at Macquarie reiterated a “neutral” rating on shares of Hudson City Bancorp in a research note to investors on Tuesday. They now have a $8.00 price target on the stock. Separately, analysts at RBC Capital upgraded shares of Hudson City Bancorp from a “sector perform” rating to an “outperform” rating in a research note to investors on Tuesday, August 28th. They now have a $8.75 price target on the stock. Finally, analysts at Raymond James upgraded shares of Hudson City Bancorp from an “underperform” rating to an “outperform” rating in a research note to investors on Tuesday, August 28th.

Shares of Hudson City Bancorp traded up 0.86% during mid-day trading on Friday, hitting $8.225. Hudson City Bancorp has a 52 week low of $5.09 and a 52 week high of $8.18. The company’s market cap is $4.084 billion.

Hudson City Bancorp last announced its earnings results on Wednesday, July 25th. The company reported $0.15 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.14 by $0.01. On average, analysts predict that Hudson City Bancorp will post $0.57 earnings per share for the current fiscal year.

Hudson City Bancorp, Inc. (Hudson City Bancorp) serves as the holding company of its only subsidiary, Hudson City Savings Bank.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Theravance suffered a loss of $0.42 per share in the second quarter 2012. The loss, slightly narrower than the Zacks Consensus loss Estimate of $0.44, was wider than the year-ago loss of $0.31 per share. The wider year-over-year loss was attributable to lower revenues. Revenues plummeted 77.6% to $1.4 million in the second quarter of 2012. Though we are concerned regarding the challenges faced by Theravance relating to Vibativ’s supplies following the termination of the deal with Astellas, we are impressed by Theravance’s pipeline. We are positive on Theravance’s collaborations with Glaxo for respiratory candidates and Alfa Wassermann for the GI motility dysfunction candidate. We see limited upside from current levels and remain Neutral on the stock.”

Other equities research analysts have also recently issued reports about the stock. Analysts at Piper Jaffray reiterated an “overweight” rating on shares of Theravance in a research note to investors on Friday, September 7th. They now have a $35.00 price target on the stock. Separately, analysts at Sterne Agee downgraded shares of Theravance from an “outperform” rating to a “market perform” rating in a research note to investors on Thursday, July 19th. They now have a $70.00 price target on the stock, up previously from $28.00. They noted that the move was a valuation call. Finally, analysts at Sanford C. Bernstein downgraded shares of Theravance from an “outperform” rating to a “market perform” rating in a research note to investors on Thursday, July 19th.

Shares of Theravance traded up 0.57% during mid-day trading on Friday, hitting $26.40. Theravance has a one year low of $12.91 and a one year high of $31.87. The company’s market cap is $2.558 billion.

Theravance last issued its quarterly earnings data on Tuesday, July 31st. The company reported ($0.42) earnings per share for the quarter, meeting the analysts’ consensus estimate of ($0.42). The company’s quarterly revenue was down 78.1% on a year-over-year basis. Analysts expect that Theravance will post $-0.27 EPS for the current fiscal year.

Theravance, Inc. (Theravance) is a biopharmaceutical company with a pipeline of internally discovered product candidates.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Fossil’s second quarter 2012 earnings of $0.93 per share exceeded the year-ago earnings by 16.3% and the Zacks Consensus Estimate by 19.2%. The results also outperformed management’s expectations. Earnings growth was driven by double-digit sales increases in all the geographic regions. We are also encouraged by the acquisition of Skagen, which added to sales growth. Fossil also experienced increase in comparable store sales. We are impressed by the improvement in Asia Pacific wholesale business and continued strength across North American watch business. However, gross margin was flat due to higher labor costs and currency fluctuations. Uncertainties in Europe also continued to remain a headwind. We thus maintain a Neutral recommendation on the stock and a target price of $92.00.”

Several other analysts have also recently commented on the stock. Analysts at Citigroup reiterated a “neutral” rating on shares of Fossil in a research note to investors on Friday, September 14th. They now have a $100.00 price target on the stock. Separately, analysts at ISI Group downgraded shares of Fossil from an “overweight” rating to a “hold” rating in a research note to investors on Tuesday, August 21st. Finally, analysts at Jefferies Group cut their price target on shares of Fossil to $115.00 in a research note to investors on Wednesday, August 8th.

Shares of Fossil traded down 0.05% during mid-day trading on Friday, hitting $87.94. Fossil has a one year low of $62.77 and a one year high of $139.20. The company has a market cap of $5.350 billion and a P/E ratio of 18.21.

Fossil last issued its quarterly earnings data on Tuesday, August 7th. The company reported $0.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.79 by $0.13. The company’s revenue for the quarter was up 14.3% on a year-over-year basis. On average, analysts predict that Fossil will post $5.30 earnings per share for the current fiscal year.

Fossil, Inc. a global designer, marketer and distributer company that specializes in consumer fashion accessories.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Lexmark posted disappointing second quarter 2012 results with both the top and bottom lines missing the Zacks Consensus Estimates. The company also provided an unimpressive revenue and earnings outlook for the third quarter of 2012. New products launched during the quarter and strength in the Managed Print Services area could win back lost market share. But stiff competition from key players such as Hewlett-Packard Company, Canon Inc., Epson and Samsung, advent of digital technology and e-commerce and board-based weakness in the printing market are major concerns. But due to a favorable position in MPS market and expected synergies from back-to-back software acquisitions, we maintain our Neutral recommendation on the stock.”

A number of other analysts have also recently weighed in on LXK. Analysts at Sanford C. Bernstein reiterated a “market perform” rating on shares of Lexmark International in a research note to investors on Friday, September 14th. Finally, analysts at Brean Murray reiterated a “hold” rating on shares of Lexmark International in a research note to investors on Wednesday, August 29th.

Shares of Lexmark International traded up 3.34% during mid-day trading on Friday, hitting $21.9401. Lexmark International has a 52 week low of $16.10 and a 52 week high of $38.34. The company has a market cap of $1.543 billion and a P/E ratio of 6.64.

Lexmark International last announced its earnings results on Tuesday, July 24th. The company reported $0.89 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.88 by $0.01. The company’s quarterly revenue was down 12.1% on a year-over-year basis. On average, analysts predict that Lexmark International will post $3.73 earnings per share for the current fiscal year.

Lexmark International, Inc. (Lexmark) is engaged in developing, manufacturing and supplying printing, imaging, document workflow, and content management solutions for the office.

To view Zacks’ full report, visit www.zacks.com

Several other analysts have also recently commented on the stock. Analysts at Piper Jaffray raised their price target on shares of Healthways from $7.00 to $9.00 in a research note to investors on Wednesday, July 25th. Analysts at Noble Financial upgraded shares of Healthways from a “hold” rating to a “buy” rating in a research note to investors on Wednesday, July 25th. They now have a $12.00 price target on the stock.

Healthways traded up 0.86% on Friday, hitting $11.68. Healthways has a 1-year low of $5.59 and a 1-year high of $11.96. The company’s market cap is $391.6 million.

Healthways last issued its quarterly earnings data on Tuesday, July 24th. The company reported $0.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.06 by $0.09. The company’s revenue for the quarter was up .4% on a year-over-year basis. On average, analysts predict that Healthways will post $0.46 earnings per share for the current fiscal year.

Healthways, Inc. provides solutions to help people to maintain or improve their health. The Company’s health, prevention and well-being services are made available to consumers via phone, direct mail, the Internet, face-to-face consultations and venue-based interactions.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “The shares of Edwards have been trading up over the recent past and reached its 52-week high on October 4, 2012. The company had reported strong Sapien sales in the US in the second quarter and also raised its 2012 outlook for the valve in the US. We expect the momentum of Sapien to continue with reimbursement uncertainties getting over. Moreover, final FDA approval for Sapien in high-risk patients is expected shortly. Meanwhile, we are impressed by the company’s attempt to expand its pipeline, despite which margins improved during the last reported quarter. However, headwinds remain in the form of dismal performance in southern Europe and unfavorable foreign currency translations. We maintain our Neutral’ recommendation on the stock.”

Edwards Lifesciences traded down 0.71% on Friday, hitting $108.97. Edwards Lifesciences has a 1-year low of $61.59 and a 1-year high of $110.79. The company has a market cap of $12.609 billion and a price-to-earnings ratio of 52.54.

Edwards Lifesciences last released its earnings data on Tuesday, July 24th. The company reported $0.67 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.66 by $0.01. The company’s quarterly revenue was up 11.8% on a year-over-year basis. Analysts expect that Edwards Lifesciences will post $2.65 EPS for the current fiscal year.

Several other analysts have also recently commented on the stock. Analysts at Jefferies Group raised their price target on shares of Edwards Lifesciences from $115.00 to $125.00 in a research note to investors on Friday, September 28th. They now have a “buy” rating on the stock. Separately, analysts at Northland Securities upgraded shares of Edwards Lifesciences to an “underperform” rating in a research note to investors on Friday, September 7th. Finally, analysts at Northland Securities initiated coverage on shares of Edwards Lifesciences in a research note to investors on Friday, September 7th. They set an “under perform” rating and a $72.00 price target on the stock.

Edwards Lifesciences Corporation (Edwards Lifesciences) is engaged in the science of heart valves and hemodynamic monitoring.

To view Zacks’ full report, visit www.zacks.com

Shares of Family Dollar Stores traded up 0.36% during mid-day trading on Friday, hitting $68.90. Family Dollar Stores has a 52 week low of $51.52 and a 52 week high of $74.73. The company has a market cap of $8.052 billion and a P/E ratio of 19.33.

Family Dollar Stores last released its earnings data on Wednesday, October 3rd. The company reported $0.75 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.75. The company had revenue of $2.36 billion for the quarter, compared to the consensus estimate of $2.36 billion. The company’s quarterly revenue was up 10.8% on a year-over-year basis. Analysts expect that Family Dollar Stores will post $4.23 EPS for the current fiscal year.

A number of other firms have also recently commented on FDO. Analysts at Credit Suisse initiated coverage on shares of Family Dollar Stores in a research note to investors on Thursday. They set an “outperform” rating and a $81.00 price target on the stock. Separately, analysts at Canaccord Genuity raised their price target on shares of Family Dollar Stores to $70.00 in a research note to investors on Wednesday. Finally, analysts at Goldman Sachs reiterated a “buy” rating on shares of Family Dollar Stores in a research note to investors on Monday.

Family Dollar Stores, Inc. (Family Dollar) operates a chain of more than 7,000 general merchandise retail discount stores in 44 states, providing primarily consumers with a selection of merchandise in neighborhood stores.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We have downgraded our recommendation on TECO Energy Inc. to Underperform from Neutral, primarily due to stringent federal regulations related to underground mining operations and waste management, over-reliance on weather patterns, volatile commodity prices and unsold tons of coal at TECO Coal. In addition, chances of elimination of the provision for depletion tax deduction of coal mines and other hard minerals are expected to negatively affect the company’s forthcoming financial performance in the future. These negatives may be to some extent mitigated by gradual revival of Florida’s economy, strong customer growth in the company’s operating territory as well as strong thermal coal contracts pipeline.”

Several other analysts have also recently commented on the stock. Analysts at Citigroup downgraded shares of TECO Energy from a “neutral” rating to a “sell” rating in a research note to investors on Friday, September 7th. They now have a $51.00 price target on the stock. Separately, analysts at UBS AG downgraded shares of TECO Energy from a “neutral” rating to a “sell” rating in a research note to investors on Friday, September 7th. They now have a $15.00 price target on the stock, down previously from $17.50. Finally, analysts at Robert W. Baird reiterated a “neutral” rating on shares of TECO Energy in a research note to investors on Tuesday, September 4th. They now have a $22.00 price target on the stock.

Shares of TECO Energy traded up 0.06% during mid-day trading on Friday, hitting $17.62. TECO Energy has a one year low of $16.90 and a one year high of $19.41. The company has a market cap of $3.816 billion and a P/E ratio of 14.20.

TECO Energy last issued its quarterly earnings data on Thursday, August 2nd. The company reported $0.34 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.36 by $0.02. TECO Energy’s revenue was down 11.1% compared to the same quarter last year. On average, analysts predict that TECO Energy will post $1.22 earnings per share for the current fiscal year.

TECO Energy, Inc. (TECO Energy) is a holding company for regulated utilities and other businesses. TECO Energy owns no operating assets but holds all of the common stock of Tampa Electric Company, and through its subsidiary TECO Diversified, Inc.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “The shares of Quest Diagnostics are on its recovery path on the back of rebounded physician’s office visits since the month of July (according to IMS data). This should also have a positive impact on the company’s third quarter performance, slated to be released on October 17. Earlier the company had disappointed us with its second quarter 2012 performance due to sluggish volume growth. This also led the company to lower its fiscal 2012 revenue guidance. However, we appreciate the company’s current focus on gene-based, esoteric testing, which has immense potentials. We are also encouraged with the company’s $500 million cost-reduction initiative which is expected to improve its bottom line further. Currently, we remain Neutral’ on Quest Diagnostics. “

Shares of Quest Diagnostics traded up 0.50% during mid-day trading on Friday, hitting $64.39. Quest Diagnostics has a 52 week low of $46.34 and a 52 week high of $64.16. The company has a market cap of $10.222 billion and a P/E ratio of 14.70.

Quest Diagnostics last announced its earnings results on Thursday, July 19th. The company reported $1.17 earnings per share for the quarter, meeting the analysts’ consensus estimate of $1.17. The company’s revenue for the quarter was up .2% on a year-over-year basis. Analysts expect that Quest Diagnostics will post $4.56 EPS for the current fiscal year.

A number of other firms have also recently commented on DGX. Analysts at Credit Suisse downgraded shares of Quest Diagnostics from an “outperform” rating to a “neutral” rating in a research note to investors on Friday, September 14th. They now have a $67.00 price target on the stock. Separately, analysts at WallachBeth initiated coverage on shares of Quest Diagnostics in a research note to investors on Monday, August 27th. They set a “hold” rating on the stock.

Quest Diagnostics Incorporated is a provider of diagnostic testing, information and services. It offers diagnostic testing services and products to patients, physicians, payers, and others.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Leading network security provider Check Point delivered decent year-over-year growth in the second quarter 2012, but missed the Zacks Consensus Estimate on both the top and bottom lines. We think that investor sentiment will be in Check Point’s favor, since it picked up market share from Cisco and Juniper. Check Point continues to benefit from its strength at the high end of the market, and growing demand for its blade solutions. We are also encouraged by its new product lineup that should improve its competitive positioning and generate higher margins. However, scope for margin expansion is limited in the near term given its over-dependence on the indirect sales model), an uncertain economic environment and European exposure. We maintain our Neutral recommendation on Check Point.”

A number of other analysts have also recently weighed in on CHKP. Analysts at RBC Capital downgraded shares of Check Point Software from an “outperform” rating to a “sector perform” rating in a research note to investors on Monday. They now have a $53.00 price target on the stock, down previously from $65.00. Separately, analysts at Oppenheimer reiterated an “outperform” rating on shares of Check Point Software in a research note to investors on Monday, September 24th. They now have a $70.00 price target on the stock. Finally, analysts at Oppenheimer reiterated an “outperform” rating on shares of Check Point Software in a research note to investors on Wednesday, August 15th. They now have a $70.00 price target on the stock.

Shares of Check Point Software traded up 0.15% during mid-day trading on Friday, hitting $46.70. Check Point Software has a one year low of $43.18 and a one year high of $65.00. The company has a market cap of $9.596 billion and a P/E ratio of 16.83.

Check Point Software last issued its quarterly earnings data on Wednesday, July 18th. The company reported $0.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.75 by $0.02. The company’s revenue for the quarter was up 9.3% on a year-over-year basis. On average, analysts predict that Check Point Software will post $3.18 earnings per share for the current fiscal year.

Check Point Software Technologies Ltd. (Check Point) develops technologies to communications and transactions over the Internet by enterprises and consumers.

To view Zacks’ full report, visit www.zacks.com

Other equities research analysts have also recently issued reports about the stock. Analysts at Needham & Company cut their price target on shares of CONMED from $35.00 to $30.00 in a research note to investors on Friday, July 27th. They now have a “buy” rating on the stock. Analysts at Ladenburg Thalmann initiated coverage on shares of CONMED in a research note to investors on Wednesday, July 25th. They set a “buy” rating and a $38.70 price target on the stock.

CONMED traded up 0.07% on Friday, hitting $29.35. CONMED has a 1-year low of $23.45 and a 1-year high of $31.94. The company has a market cap of $834.1 million and a price-to-earnings ratio of 246.47.

CONMED last released its earnings data on Thursday, July 26th. The company reported $0.43 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.45 by $0.02. CONMED’s revenue was up 3.5% compared to the same quarter last year. Analysts expect that CONMED will post $1.76 EPS for the current fiscal year.

CONMED Corporation (CONMED) is a medical technology company with an emphasis on surgical devices and equipment for minimally invasive procedures and monitoring.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are maintaining our Neutral recommendation on Shaw Communications mainly based on improving EBITDA margin and free cash flow. Moreover, complete elimination of its promotional activities will further lend support to its improving margin growth. Furthermore, the stock price has decreased nearly 17% in the last year and it is fairly valued at current level. However, continuous loss of its video subscribers coupled with dampness in the Canadian advertisement market has forced the company to reduce its previous outlook for fiscal 2012. “

Separately, analysts at CIBC cut their price target on shares of Shaw Communications from $23.00 to $22.00 in a research note to investors on Monday, September 10th. They now have an “outperform” rating on the stock.

Shares of Shaw Communications traded up 0.68% during mid-day trading on Friday, hitting $20.88. Shaw Communications has a one year low of $18.25 and a one year high of $21.63. The company has a market cap of $9.231 billion and a P/E ratio of 13.42.

Shaw Communications Inc. (Shaw) is a diversified Canadian communications company. Shaw is engaged in the business of providing broadband cable television, Internet, Digital Phone, telecommunications services (through Shaw Business Solutions), satellite direct-to-home services (through Shaw Direct) and engaging programming content (through Shaw Media).

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “The nightmare of Radioshack persists as the company continues with its disappointing performance. Second-quarter 2012 financial results were well below the Zacks Consensus Estimates. Management has suspended its dividend in order to reduce its debt burden. Adverse product-mix toward low-margin devices and a volatile macro-economic scenario in the U.S. are taking a toll on the company’s financials. The company’s core consumer electronics retail business is on a secular downtrend and is unlikely to be revived in the near future. Consumers increasingly prefer online purchasing to visiting retail stores. Loss of foot traffic has severe negative impact on RadioShack’s business. Most of the consumers prefer tablets and smartphones, which are less profitable for the retail industry. We do not find any immediate growth catalyst and therefore downgrade our recommendation on RadioShack to Underperform.”

RadioShack traded down 0.24% on Friday, hitting $2.075. RadioShack has a 1-year low of $2.01 and a 1-year high of $13.94. The company’s market cap is $206.3 million.

RadioShack last announced its earnings results on Wednesday, July 25th. The company reported ($0.21) EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.04 by $0.25. The company’s quarterly revenue was up 1.2% on a year-over-year basis. On average, analysts predict that RadioShack will post $-0.32 earnings per share for the current fiscal year.

A number of other analysts have also recently weighed in on RSH. Analysts at Bank of America reiterated an “underperform” rating on shares of RadioShack in a research note to investors on Wednesday, September 26th. Separately, analysts at Wedbush downgraded shares of RadioShack from a “neutral” rating to an “underperform” rating in a research note to investors on Thursday, July 26th. Finally, analysts at Griffin Securities cut their price target on shares of RadioShack from $8.00 to $4.00 in a research note to investors on Wednesday, July 25th. They now have a “hold” rating on the stock.

RadioShack Corporation (RadioShack) is engaged in the retail sale of consumer electronics goods and services through its RadioShack store chain.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are upgrading our recommendation on Regions based on repayment of the bailout money and improving credit quality. Regions’ second quarter 2012 earnings from continuing operations surpassed the Zacks Consensus Estimate. Quarterly results benefited from improved net interest margin and better credit quality, backed by lower loan loss provisions and reduced non-performing assets. Moreover, improved funding mix and decline in non-interest expenses were the positives for the quarter. Yet, lower top-line was a dampener. We believe Regions’ favorable funding mix, improved core business performance and better expense management will yield profitability in the upcoming quarters. Although the de-risking measures at the company are encouraging, regulatory issues remain a major area of concern.”

Other equities research analysts have also recently issued reports about the stock. Analysts at Jefferies Group reiterated a “hold” rating on shares of Regions Financial Corp in a research note to investors on Tuesday. They now have a $8.00 price target on the stock. Separately, analysts at JPMorgan Chase raised their price target on shares of Regions Financial Corp from $8.00 to $8.50 in a research note to investors on Friday, September 28th. They now have a “neutral” rating on the stock. Finally, analysts at Raymond James reiterated a “strong-buy” rating on shares of Regions Financial Corp in a research note to investors on Thursday, September 27th. They now have a $9.00 price target on the stock.

Shares of Regions Financial Corp traded up 1.00% during mid-day trading on Friday, hitting $7.58. Regions Financial Corp has a 52 week low of $3.35 and a 52 week high of $7.73. The company’s market cap is $10.713 billion.

Regions Financial Corp last announced its earnings results on Tuesday, July 24th. The company reported $0.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.15 by $0.05. On average, analysts predict that Regions Financial Corp will post $0.72 earnings per share for the current fiscal year.

Regions Financial Corporation (Regions) is a financial holding company. Regions operate throughout the South, Midwest and Texas.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are maintaining our Neutral recommendation on McDermott International. Given its geographic footprint in high-growth regions, technology leadership and efficient execution skills, the company is poised to benefit from the strong industry fundamentals for offshore construction activities through 2012 and beyond. We believe order flow and backlog for McDermott’s products and services will continue to be healthy and trend higher in the near-to-medium term. Additional positives in the McDermott story include continued success on big awards, growing international operations and a solid balance sheet. However, steep operating costs, a slower award environment in 2011 and the clouded post-split outlook will continue to weigh on McDermott’s results. As such, we expect its growth potential to be restrained.”

McDermott International traded down 0.68% on Friday, hitting $11.77. McDermott International has a 52-week low of $9.04 and a 52-week high of $15.35. The company has a market cap of $2.775 billion and a price-to-earnings ratio of 24.23.

McDermott International last released its earnings data on Monday, August 6th. The company reported $0.22 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.22. The company’s quarterly revenue was up 4.6% on a year-over-year basis. Analysts expect that McDermott International will post $0.97 EPS for the current fiscal year.

MDR has been the subject of a number of other recent research reports. Analysts at Tudor Pickering initiated coverage on shares of McDermott International in a research note to investors on Thursday, September 20th. They set an “accumulate” rating on the stock. Separately, analysts at Global Hunter Securities initiated coverage on shares of McDermott International in a research note to investors on Wednesday, September 12th. They set a “buy” rating and a $16.00 price target on the stock. Finally, analysts at Stephens initiated coverage on shares of McDermott International in a research note to investors on Friday, August 24th. They set an “overweight” rating and a $15.00 price target on the stock.

McDermott International, Inc. (MII) is an engineering, procurement, construction and installation (EPCI) company.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are upgrading our recommendation on KeyCorp to Outperform based on its recent announcement of cost cutting initiatives. Moreover, the company’s second quarter 2012 earnings surpassed the Zacks Consensus Estimate by a nickel. Better-than-expected results were aided by stable non-interest income, continued improvement in credit quality and robust capital ratios. However, these positives were partly offset by lower net interest income and rising operating expenses. We expect the company’s business restructuring actions to continue to fuel its credit quality and liquidity. Though the approval for the company’s capital plan highlights its sound capital position, we remain wary of the persisting slow economic recovery, stringent regulatory restrictions and the low interest rate scenario. Nevertheless, we are optimistic on the company’s strong balance sheet and improved market share. “

KeyBanc traded up 1.77% on Thursday, hitting $8.905. KeyBanc has a 52-week low of $6.04 and a 52-week high of $9.12. The company has a market cap of $8.402 billion and a price-to-earnings ratio of 9.98.

KeyBanc last posted its quarterly earnings results on Thursday, July 19th. The company reported $0.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.05. KeyBanc’s revenue was up .5% compared to the same quarter last year. On average, analysts predict that KeyBanc will post $0.85 earnings per share for the current fiscal year.

Other equities research analysts have also recently issued reports about the stock. Analysts at Sandler O’Neill downgraded shares of KeyBanc from a “buy” rating to a “hold” rating in a research note to investors on Wednesday. Separately, analysts at Jefferies Group reiterated a “hold” rating on shares of KeyBanc in a research note to investors on Tuesday. They now have a $9.00 price target on the stock. Finally, analysts at Wells Fargo & Co. reiterated a “market perform” rating on shares of KeyBanc in a research note to investors on Tuesday, September 25th.

KeyCorp is a bank holding company for KeyBank National Association (KeyBank). Through KeyBank and certain other subsidiaries, the Company provides a range of retail and commercial banking, commercial leasing, investment management, consumer finance and investment banking products and services to individual, corporate and institutional clients through two business segments: Key Community Bank and Key Corporate Bank.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Waddell & Reed’s second quarter earnings marginally lagged the Zacks Consensus Estimate. Results were negatively affected by fall in operating revenues and higher expenses. Also, gross sales across all the revenue channels, except Advisory channel declined. Nevertheless, stable assets under management (AUM) and solid balance sheet were among the positives. The company s sustained growth and history of boosting shareholder value through meaningful capital deployment activities are impressive. However, volatile equity markets and significant intangibles on the company s balance sheet are expected to mar profitability in the near term. Though we remain optimistic considering the competitive ranking of Waddell & Reed’s funds and its efforts to control cost in the upcoming year, irregular investment performance and rising competition remain causes of concern.”

Waddell & Reed Financial traded up 0.85% on Thursday, hitting $32.01. Waddell & Reed Financial has a 1-year low of $23.41 and a 1-year high of $34.04. The company has a market cap of $2.747 billion and a price-to-earnings ratio of 16.10.

Waddell & Reed Financial last released its earnings data on Thursday, July 26th. The company reported $0.52 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.53 by $0.01. The company’s quarterly revenue was down .5% on a year-over-year basis. On average, analysts predict that Waddell & Reed Financial will post $2.14 earnings per share for the current fiscal year.

Other equities research analysts have also recently issued reports about the stock. Analysts at Stifel Nicolaus downgraded shares of Waddell & Reed Financial from a “buy” rating to a “hold” rating in a research note to investors on Wednesday. Separately, analysts at Bank of America cut their price target on shares of Waddell & Reed Financial from $37.00 to $36.00 in a research note to investors on Wednesday, August 1st. They now have a “buy” rating on the stock. Finally, analysts at RBC Capital initiated coverage on shares of Waddell & Reed Financial in a research note to investors on Tuesday, July 24th. They set a “sector perform” rating and a $30.00 price target on the stock.

Waddell & Reed Financial, Inc. is engaged in providing investment management, investment product underwriting and distribution, and shareholder services administration to mutual funds and institutional and separately managed accounts.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “State Street’s second-quarter 2012 earnings marginally beat the Zacks Consensus Estimate. The better-than-expected results came on the back of enhanced net interest revenue and reduced operating expenses. The capital ratios of the company also remained strong in the quarter. We anticipate the company’s restructuring programs along with well-off core servicing and investment management franchises to help offset the weakness caused by the sluggish economic recovery. Further, the recent acquisitions will benefit revenue growth. However, the low interest rate environment and deteriorating net interest margin (NIM) are expected to dent its top line in the upcoming quarters. Despite these concerns, sound capital deployment activities will boost investors’ confidence in the stock.”

A number of other firms have also recently commented on STT. Analysts at Macquarie reiterated an “outperform” rating on shares of State Street in a research note to investors on Monday. They now have a $52.00 price target on the stock. Separately, analysts at Citigroup initiated coverage on shares of State Street in a research note to investors on Monday, September 24th. They set a “buy” rating and a $54.00 price target on the stock. They noted that the move was a valuation call. Finally, analysts at RBC Capital reiterated an “outperform” rating on shares of State Street in a research note to investors on Wednesday, September 12th. They now have a $50.00 price target on the stock.

Shares of State Street traded up 0.83% during mid-day trading on Thursday, hitting $42.29. State Street has a one year low of $31.55 and a one year high of $47.20. The company has a market cap of $20.261 billion and a P/E ratio of 11.37.

State Street last issued its quarterly earnings data on Tuesday, July 17th. The company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.98 by $0.03. State Street’s revenue was down 2.6% compared to the same quarter last year. Analysts expect that State Street will post $3.86 EPS for the current fiscal year.

State Street Corporation (State Street) is a financial holding company. Through its subsidiaries, including its principal banking subsidiary, State Street Bank and Trust Company (State Street Bank), the Company provides a range of financial products and services to institutional investors worldwide.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “CIGNA Corp. reported second-quarter core earnings of $1.52 per share outpacing the Zacks Consensus Estimate by $0.09. Moreover, the results were up 3.4% year over year. We believe that Cigna is strongly poised to record earnings growth given a number of strategic investments undertaken. It is well positioned with a differentiated portfolio of businesses, expected to deliver competitively attractive growth prospects. This includes its U.S. commercial business, which is likely to deliver strong organic growth, its International business, with strong top line and earnings growth in excess of 20%, and the expansion in Seniors and Medicare business, where the acquisition of HealthSpring is likely to drive growth in 2012 and be highly accretive on a cash basis. However, the volatility associated with its discontinued guaranteed minimum income benefit (GMIB) business and pension burden keeps us on the sidelines.”

Shares of CIGNA traded up 0.65% during mid-day trading on Thursday, hitting $49.18. CIGNA has a 52 week low of $39.01 and a 52 week high of $49.89. The company has a market cap of $14.182 billion and a P/E ratio of 10.83.

CIGNA last announced its earnings results on Thursday, August 2nd. The company reported $1.52 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.41 by $0.11. The company’s quarterly revenue was up 35.4% on a year-over-year basis. Analysts expect that CIGNA will post $5.53 EPS for the current fiscal year.

A number of other analysts have also recently weighed in on CI. Analysts at Wells Fargo & Co. reiterated a “market perform” rating on shares of CIGNA in a research note to investors on Thursday, September 20th. Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of CIGNA in a research note to investors on Tuesday, September 18th. They now have a $56.00 price target on the stock. Finally, analysts at Credit Suisse upgraded shares of CIGNA from a “neutral” rating to an “outperform” rating in a research note to investors on Thursday, August 30th. They now have a $56.00 price target on the stock, up previously from $54.00.

CIGNA Corporation (CIGNA) is a holding company. CIGNA is a global health service organization with subsidiaries that are providers of medical, dental, disability, life and accident insurance and related products and services.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Embraer S.A. reported diluted EPADS of $0.30 in 2Q12, down drastically from earnings per ADS of $0.53 in the year-ago quarter. The results reflected heavier tax burden, rising wages in Brazil, overt dependence on a few customers and a drop in demand for business jets. Moreover, rising expenses on the back of a competitive aircraft manufacturing industry and increasing cost of sales and services had an adverse impact on margins in the quarter. However, Embraer’s firm order backlog, rising delivery of commercial and executive aircraft as well as continued investment in the global support network offset the above risks for the coming quarters. The company’s margin consistency and strict cost controls as well as management’s upwardly revised EBIT and EBITDA guidance hold optimism for future earnings. All the above factors thus balance our view and we maintain our Neutral recommendation on the stock.”

ERJ has been the subject of a number of other recent research reports. Analysts at Cowen downgraded shares of Embraer from an “outperform” rating to a “neutral” rating in a research note to investors on Wednesday. Separately, analysts at BB&T initiated coverage on shares of Embraer in a research note to investors on Friday, September 28th. They set a “hold” rating on the stock. Finally, analysts at BB&T initiated coverage on shares of Embraer in a research note to investors on Friday, September 28th. They set a “hold” rating on the stock.

Shares of Embraer traded up 1.91% during mid-day trading on Thursday, hitting $25.65. Embraer has a 52 week low of $22.57 and a 52 week high of $35.55. The company has a market cap of $4.652 billion and a P/E ratio of 171.22.

Embraer-Empresa Brasileira de Aeronautica SA (Embraer) is engaged in the manufacturing of commercial aircraft.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “LabCorp reported a disappointing second quarter 2012 with both revenues and adjusted EPS lagging the Zacks Consensus Estimates. The low-volume-growth environment is reflected in flat testing volume while revenue per requisition increased 1.5%. The company is also exposed to the reduction in clinical and physician lab fee schedule, effective January 2013. Given the challenging scenario, the company narrowed its growth outlook for 2012. Meanwhile, the company believes that it can generate 45% of revenues from esoteric testing over the next 3-5 years from the current level of 40%. The company is quite well capitalized and rewards shareholders through share buybacks. We reiterate our Neutral recommendation on the company.”

Laboratory Corp. of America traded up 0.86% on Thursday, hitting $93.39. Laboratory Corp. of America has a 1-year low of $76.21 and a 1-year high of $95.30. The company has a market cap of $8.956 billion and a price-to-earnings ratio of 15.81.

Laboratory Corp. of America last released its earnings data on Thursday, July 19th. The company reported $1.77 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.76 by $0.01. The company’s revenue for the quarter was up 1.5% on a year-over-year basis. Analysts expect that Laboratory Corp. of America will post $6.96 EPS for the current fiscal year.

LH has been the subject of a number of other recent research reports. Analysts at Credit Suisse initiated coverage on shares of Laboratory Corp. of America in a research note to investors on Friday, September 14th. They set a “neutral” rating and a $95.00 price target on the stock. Separately, analysts at Piper Jaffray raised their price target on shares of Laboratory Corp. of America to $91.00 in a research note to investors on Tuesday, September 4th. They now have a “neutral” rating on the stock. Finally, analysts at WallachBeth initiated coverage on shares of Laboratory Corp. of America in a research note to investors on Monday, August 27th. They set a “hold” rating and a $91.00 price target on the stock.

Laboratory Corporation of America Holdings is a clinical laboratory company in the United States. As of December 31, 2011, the Company had a national network of 54 primary laboratories and over 1,700 patient service centers (PSCs) along with a network of branches and STAT laboratories (which are laboratories that have the ability to perform certain routine tests quickly and report the results to the physician immediately).

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are upgrading our recommendation on Helmerich & Payne shares to Neutral from Underperform, reflecting a balanced risk/reward profile. Helmerich & Payne is a leading drilling contractor with activities in the U.S. and overseas. Supported by a superior and diversified drilling fleet, together with a healthy financial profile, we expect the company to sustain its profitability over the foreseeable future. We believe Helmerich’s technologically-advanced FlexRigs will continue to benefit from an upswing in U.S. land drilling activity and the shift to complex onshore plays that require highly intensive solutions. However, weak natural gas fundamentals and the challenging international operational scenario remain areas of concern. Additionally, Helmerich’s below par dividend yield and miniscule payout keep us worried. “

Shares of Helmerich & Payne traded up 2.23% during mid-day trading on Thursday, hitting $46.23. Helmerich & Payne has a one year low of $38.71 and a one year high of $68.60. The company has a market cap of $4.886 billion and a P/E ratio of 9.05.

Helmerich & Payne last issued its quarterly earnings data on Friday, July 27th. The company reported $1.38 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.16 by $0.22. The company’s revenue for the quarter was up 27.3% on a year-over-year basis. Analysts expect that Helmerich & Payne will post $5.05 EPS for the current fiscal year.

A number of other firms have also recently commented on HP. Analysts at Jefferies Group cut their EPS estimates on shares of Helmerich & Payne in a research note on Wednesday. They now have a “buy” rating and a $55.00 price target on the stock. Separately, analysts at Canaccord Genuity reiterated a “buy” rating on shares of Helmerich & Payne in a research note to investors on Monday. They now have a $62.00 price target on the stock.

Helmerich & Payne, Inc. is engaged in contract drilling of oil and gas wells for others. The Company’s contract drilling business consists of three business segments: U.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are maintaining our Neutral recommendation on BCE Inc. The company’s second quarter earnings outpaced the Zacks Consensus Estimate and the year-ago earnings on the back of higher EBITDA and a lower tax rate. We are encouraged by management’s confidence about delivering strong results going forward, based on its substantial investments to expand broadband wireless and wireline footprint. In addition, the expected robust free cash flow trajectory and financial flexibility would underpin the company’s dividend growth further. Nevertheless, continued investments in broadband network expansion could restrict the company’s profitability going forward. Further, stiff competition from national carriers and continued decline in network access services keep us cautious on the stock.”

A number of other firms have also recently commented on BCE. Analysts at TD Securities raised their price target on shares of BCE from $39.00 to $40.00 in a research note to investors on Monday, August 20th. They now have a “reduce” rating on the stock. Separately, analysts at National Bank raised their price target on shares of BCE from $43.00 to $44.00 in a research note to investors on Thursday, August 9th. They now have a “sector perform” rating on the stock. Finally, analysts at Macquarie raised their price target on shares of BCE from $40.00 to $46.00 in a research note to investors on Thursday, August 9th. They now have a “neutral” rating on the stock.

BCE traded up 1.77% on Thursday, hitting $44.74. BCE has a 52-week low of $36.48 and a 52-week high of $45.68. The company has a market cap of $34.623 billion and a price-to-earnings ratio of 13.57.

BCE last posted its quarterly earnings results on Wednesday, August 8th. The company reported $1.02 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.82 by $0.20. The company’s quarterly revenue was down .6% on a year-over-year basis. Analysts expect that BCE will post $3.22 EPS for the current fiscal year.

BCE Inc. is a communications company, providing residential, business and wholesale customers with a range of solutions to all their communications needs.

To view Zacks’ full report, visit www.zacks.com

A number of other firms have also recently commented on BIG. Analysts at JPMorgan Chase reiterated an “underweight” rating on shares of Big Lots in a research note to investors on Tuesday. They now have a $28.00 price target on the stock, down previously from $34.00. Separately, analysts at Barclays Capital reiterated an “overweight” rating on shares of Big Lots in a research note to investors on Friday, August 24th. Finally, analysts at Wedbush cut their price target on shares of Big Lots from $49.00 to $42.00 in a research note to investors on Friday, August 24th. They now have an “outperform” rating on the stock.

Shares of Big Lots traded up 1.66% during mid-day trading on Thursday, hitting $30.295. Big Lots has a one year low of $29.08 and a one year high of $47.22. The company has a market cap of $1.804 billion and a P/E ratio of 10.54.

Big Lots last issued its quarterly earnings data on Thursday, August 23rd. The company reported $0.36 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.41 by $0.05. The company had revenue of $1.22 billion for the quarter, compared to the consensus estimate of $1.24 billion. The company’s quarterly revenue was up 4.4% on a year-over-year basis. Analysts expect that Big Lots will post $2.86 EPS for the current fiscal year.

Big Lots, Inc., through its wholly owned subsidiaries, is a North America’s closeout retailer. At January 28, 2012, the Company operated a total of 1,533 stores in two countries: the United States and Canada.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “BioMarin’s second quarter 2012 loss of $0.27 per share was wider than the Zacks Consensus loss estimate of $0.20 and the year-ago loss of $0.05 per share. The higher loss was due to an increase in operating expenses which offset an increase in revenues. Total revenues climbed 12.1% driven by strong sales of key products. We are pleased to see the company working on developing its pipeline – top-line phase III data on GALNS will be available by year end. The successful development of GALNS would allow the company to achieve profitability in the second half of 2014. However, while encouraged by the company’s pipeline development efforts, we prefer remaining on the sidelines until we see late-stage data.”

Biomarin Pharm traded down 0.02% on Thursday, hitting $40.74. Biomarin Pharm has a 52-week low of $30.06 and a 52-week high of $44.18. The company’s market cap is $5.034 billion.

Biomarin Pharm last posted its quarterly earnings results on Wednesday, August 1st. The company reported ($0.27) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.19) by $0.08. The company’s revenue for the quarter was up 12.1% on a year-over-year basis. Analysts expect that Biomarin Pharm will post $-0.87 EPS for the current fiscal year.

A number of other firms have also recently commented on BMRN. Analysts at Jefferies Group raised their price target on shares of Biomarin Pharm from $44.00 to $46.00 in a research note to investors on Wednesday. They now have a “buy” rating on the stock. Separately, analysts at Summer Street raised their price target on shares of Biomarin Pharm from $45.00 to $52.00 in a research note to investors on Friday, September 28th. They now have a “buy” rating on the stock. Finally, analysts at William Blair raised their price target on shares of Biomarin Pharm from $46.00 to $49.00 in a research note to investors on Thursday, September 27th. They now have an “outperform” rating on the stock.

BioMarin Pharmaceutical Inc. (BioMarin) develops and commercializes pharmaceuticals for serious diseases and medical conditions.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “The beleaguered BlackBerry handset manufacturer Research In Motion posted better than expected second quarter of fiscal 2013 financial results. Both the top and bottom line outpaced the Zacks Consensus Estimates. In the previous quarter, Research In Motion added net subscribers and its cash position improves sequentially. Management maintains its previous guideline that the BlackBerry 10 software-based smartphones will hit the market in the first calendar quarter of 2013. Although we believe a real turnaround of Research In Motion will take more time than previously expected as we remain uncertain when the company will achieve profitability, the just concluded second-quarter of fiscal 2013 ushered some rays of hope as the market is eagerly waiting for the company’s next-generation Blackberry devices. We, thus, reaffirm our long-term Neutral recommendation on Research In Motion. “

A number of other analysts have also recently weighed in on RIMM. Analysts at FBR Capital raised their price target on shares of Research In Motion from $6.00 to $6.50 in a research note to investors on Tuesday. They now have an “underperform” rating on the stock. Separately, analysts at BGC Financial reiterated a “sell” rating on shares of Research In Motion in a research note to investors on Friday, September 28th. They now have a $7.00 price target on the stock. Finally, analysts at Cormark upgraded shares of Research In Motion to a “buy” rating in a research note to investors on Friday, September 28th.

Shares of Research In Motion traded up 2.36% during mid-day trading on Thursday, hitting $8.25. Research In Motion has a 52 week low of $6.22 and a 52 week high of $24.74. The company’s market cap is $4.260 billion.

Research In Motion last announced its earnings results on Thursday, September 27th. The company reported ($0.27) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.46) by $0.19. The company had revenue of $2.90 billion for the quarter, compared to the consensus estimate of $2.50 billion. The company’s revenue for the quarter was down 31.1% on a year-over-year basis. On average, analysts predict that Research In Motion will post $-1.26 earnings per share for the current fiscal year.

Research In Motion Limited (RIM) is a designer, manufacturer and marketer of wireless solutions for the worldwide mobile communications market.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “P&G’s fourth quarter earnings of $0.82 were better than the Zacks Consensus Estimate. Nonetheless, earnings were flat with the prior-year levels, as benefits from pricing and cost savings were offset by top-line shortfall and rising commodity costs. Revenues declined 1% largely due to foreign exchange headwinds. Slowdown in developed nations and commodity cost increases has resulted in a series of disappointing earnings results and guidance cuts for P&G. However, the fourth quarter was much better than past quarters. Overall, we are encouraged by P&G s strong brand recognition, diversified portfolio, rapid growth in developing nations, impressive product development capabilities and marketing prowess. While fiscal 2012 was a tough year for P&G, the company has laid out plans to improve results in developed markets while maintaining momentum in the developing nations. Moreover, the company will increase focus on the most profitable business, its biggest innovations and further accelerate cost savings. We are encouraged by the company’s strategic plans and thus revert back to a Neutral rating from Underperform.”

A number of other firms have also recently commented on PG. Analysts at Credit Agricole reiterated an “underperform” rating on shares of Procter & Gamble in a research note to investors on Tuesday. They now have a $68.00 price target on the stock. Separately, analysts at Deutsche Bank raised their price target on shares of Procter & Gamble from $67.00 to $70.00 in a research note to investors on Monday, August 6th. Finally, analysts at Bank of America raised their price target on shares of Procter & Gamble from $67.00 to $71.00 in a research note to investors on Monday, August 6th. They now have a “buy” rating on the stock.

Procter & Gamble traded up 0.49% on Thursday, hitting $69.51. Procter & Gamble has a 52-week low of $59.07 and a 52-week high of $69.97. The company has a market cap of $191.4 billion and a price-to-earnings ratio of 18.91.

Procter & Gamble last posted its quarterly earnings results on Friday, August 3rd. The company reported $0.82 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.77 by $0.05. The company’s quarterly revenue was down 1.2% on a year-over-year basis. Analysts expect that Procter & Gamble will post $3.90 EPS for the current fiscal year.

The Procter & Gamble Company (P&G) is focused on providing consumer packaged goods. The Company’s products are sold in more than 180 countries primarily through mass merchandisers, grocery stores, membership club stores, drug stores and high-frequency stores, the neighborhood stores, which serve many consumers in developing markets.

To view Zacks’ full report, visit www.zacks.com

A number of other analysts have also recently weighed in on WIN. Analysts at DA Davidson reiterated a “buy” rating on shares of Windstream in a research note to investors on Tuesday. They now have a $14.25 price target on the stock. Analysts at Nomura downgraded shares of Windstream from a “neutral” rating to a “reduce” rating in a research note to investors on Wednesday, August 8th. They now have a $8.50 price target on the stock.

Windstream traded up 0.21% on Thursday, hitting $10.0515. Windstream has a 52-week low of $9.00 and a 52-week high of $12.60. The company has a market cap of $5.910 billion and a price-to-earnings ratio of 34.35.

Windstream last posted its quarterly earnings results on Thursday, August 9th. The company reported $0.12 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.12. The company’s quarterly revenue was up 49.3% on a year-over-year basis. Analysts expect that Windstream will post $0.51 EPS for the current fiscal year.

Windstream Corporation (Windstream) is a telecommunications company that provides phone, high-speed Internet and digital television services.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We reiterate our Neutral recommendation on Manitowoc Company, Inc. with a target price of $14. The company’s second-quarter 2012 adjusted earnings were $0.32 per share, beating the Zacks Consensus Estimate of $0.25. Total sales increased 5.9% year over year to $1.006 billion, but missed the Zacks Consensus Estimate of $1.045 billion. Margins in the Foodservice business are expected to improve in fiscal 2013, driven by the launch of new products, reduction of costs and soaring demand. Crane demand is expected to soar, benefited by the new highway bill which leads to increased spending in construction activities. However, high debt levels and increased competition in the Chinese market will be headwinds moving ahead.”

Separately, analysts at Goldman Sachs reiterated a “buy” rating on shares of Manitowoc Company in a research note to investors on Thursday, September 6th. They now have a $13.00 price target on the stock.

Manitowoc Company traded up 3.00% on Thursday, hitting $13.75. Manitowoc Company has a 52-week low of $7.07 and a 52-week high of $16.97. The company has a market cap of $1.819 billion and a price-to-earnings ratio of 22.14.

Manitowoc Company last posted its quarterly earnings results on Monday, August 6th. The company reported $0.32 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.26 by $0.06. The company’s revenue for the quarter was up 5.8% on a year-over-year basis. On average, analysts predict that Manitowoc Company will post $0.83 earnings per share for the current fiscal year.

The Manitowoc Company, Inc. (MTW) is a multi-industry, capital goods manufacturer. It operates in two markets: Cranes and Related Products (Crane) and Foodservice Equipment (Foodservice).

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We recently downgraded our recommendation on The Washington Post Company to Underperform following disappointing second-quarter 2012 results. The quarterly earnings came in at $5.38 per share, down 22% from $6.88 earned in the prior-year quarter. The decline reflected slump in the students’ enrollment and soft advertising demand. Revenue for the quarter fell 5% to $1,006.9 million, reflecting sluggish performance in the Newspaper Publishing and Education divisions. Newspaper Publishing revenue fell 7%, while print advertising revenue declined 15%. Education division’s revenue went down 9%, reflecting a 19% fall in Higher Education revenue, a 4% drop in Test Preparation revenue, and a 6% decline in Kaplan Ventures revenue. Total student enrollment dropped 14% during the quarter. To counter the sluggishness in student enrollment, Kaplan Education division has undertaken a restructuring plan to lower its costs structure in the near future.”

Shares of Washington Post traded up 1.23% during mid-day trading on Thursday, hitting $365.90. Washington Post has a 52 week low of $318.02 and a 52 week high of $405.00. The company has a market cap of $2.724 billion and a P/E ratio of 20.06.

Separately, analysts at EVA Dimensions downgraded shares of Washington Post to an “underweight” rating in a research note to investors on Wednesday, August 29th.

The Washington Post Company is a diversified education and media company. The Company’s Kaplan, Inc. (Kaplan) subsidiary provides a variety of educational services, both domestically and outside the United States.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Federated’s second-quarter 2012 earnings per share lagged the Zacks Consensus Estimate by $0.01. Earnings were also lower compared with the prior-year quarter. Results reflected higher operating expenses, partly offset by an enhanced top line, rise in fixed income and equity assets as well as a hike in assets under management (AUM). We expect the persistent regulatory pressures, slow global economic growth and a low-interest rate environment to keep the company’s earnings under pressure in the upcoming quarters. However, Federated has the potential for significant growth in the long run, given its fairly liquid balance sheet and a diversified asset as well as product mix. Moreover, investors’ increased demand for the company’s wide range of income-oriented products will help it to increase profitability.”

Shares of Fed Investors traded up 2.08% during mid-day trading on Thursday, hitting $21.08. Fed Investors has a 52 week low of $14.36 and a 52 week high of $23.89. The company has a market cap of $2.195 billion and a P/E ratio of 13.58.

Fed Investors last announced its earnings results on Thursday, July 26th. The company reported $0.39 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.41 by $0.02. The company’s quarterly revenue was up 2.8% on a year-over-year basis. On average, analysts predict that Fed Investors will post $1.63 earnings per share for the current fiscal year.

FII has been the subject of a number of other recent research reports. Analysts at JPMorgan Chase reiterated an “underweight” rating on shares of Fed Investors in a research note to investors on Thursday. They now have a $20.50 price target on the stock. Separately, analysts at RBC Capital reiterated an “underperform” rating on shares of Fed Investors in a research note to investors on Tuesday. They now have a $19.00 price target on the stock. Finally, analysts at Goldman Sachs upgraded shares of Fed Investors from a “sell” rating to a “neutral” rating in a research note to investors on Wednesday, September 12th. They now have a $20.00 price target on the stock.

Federated Investors, Inc. (Federated), together with its consolidated subsidiaries, is a provider of investment management products and related financial services.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Walgreen reported a disappointing fourth quarter 2012 with a 15% decline in adjusted EPS to $0.48 and a 5% drop in. revenues to $17.1 billion. The termination of the Express Scripts contract took its toll on Walgreen with a negative impact of $0.06 on the bottom line. We are encouraged by the renegotiation of the contract between the two players in July, thereby ending the seven long months of deadlock. However winning back its previous customers remains a matter of concern. Meanwhile, the company’s decision to form a partnership with Alliance Boots is expected to accelerate its revenue. Moreover the company launched a customer loyalty program to improve customer traffic. However, the problems of unemployment and low discretionary spending still remain as major headwinds. We remain Neutral on Walgreen. “

Other equities research analysts have also recently issued reports about the stock. Analysts at Susquehanna reiterated a “positive” rating on shares of Walgreen in a research note to investors on Tuesday. They now have a $50.00 price target on the stock. Separately, analysts at William Blair reiterated an “outperform” rating on shares of Walgreen in a research note to investors on Monday. Finally, analysts at SunTrust reiterated a “buy” rating on shares of Walgreen in a research note to investors on Thursday, September 27th. They now have a $45.00 price target on the stock.

Shares of Walgreen traded down 0.03% during mid-day trading on Thursday, hitting $36.35. Walgreen has a 52 week low of $28.53 and a 52 week high of $37.35. The company has a market cap of $32.344 billion and a P/E ratio of 15.02.

Walgreen last announced its earnings results on Friday, September 28th. The company reported $0.63 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.56 by $0.07. The company had revenue of $17.10 billion for the quarter, compared to the consensus estimate of $17.16 billion. The company’s quarterly revenue was down 5.0% on a year-over-year basis. On average, analysts predict that Walgreen will post $3.36 earnings per share for the current fiscal year.

Walgreen Co (Walgreen), together with its subsidiaries, provides its customers with multichannel access to consumer goods and services, and pharmacy, health and wellness services in communities across America.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are upgrading our recommendation on Invesco to Neutral based on the recent rise in assets under management (AUM) along with gradually stabilizing equity markets. However, the company’s second quarter 2012 earnings marginally missed the Zacks Consensus Estimate. Results were adversely impacted by lower net revenue, partially offset by slightly lower operating expenses. We expect operating leverage to improve significantly over the long term due to its cost-control initiatives. Also, meaningful capital deployment activities will enhance shareholders’ confidence in the stock. However, volatile U.S. dollar, higher level of debt and increasing competition remain matters of concern. Overall, we believe that the company is well-positioned to benefit from improved global investment flows, resulting from its broad diversification.”

Shares of Invesco traded up 1.20% during mid-day trading on Wednesday, hitting $25.37. Invesco has a 52 week low of $15.77 and a 52 week high of $26.94. The company has a market cap of $11.295 billion and a P/E ratio of 16.06.

Invesco last announced its earnings results on Thursday, July 26th. The company reported $0.41 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.43 by $0.02. Invesco’s revenue was down 5.7% compared to the same quarter last year. Analysts expect that Invesco will post $1.76 EPS for the current fiscal year.

IVZ has been the subject of a number of other recent research reports. Analysts at UBS AG reiterated a “buy” rating on shares of Invesco in a research note to investors on Thursday, September 13th. Separately, analysts at BMO Capital Markets raised their price target on shares of Invesco to $28.00 in a research note to investors on Thursday, September 13th. Finally, analysts at Jefferies Group reiterated a “buy” rating on shares of Invesco in a research note to investors on Thursday, September 13th. They now have a $31.00 price target on the stock.

Invesco Ltd. (Invesco) is an independent global investment management company. Invesco provides a range of investment strategies and vehicles to its retail, institutional and high-net-worth clients worldwide.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “BNY Mellon’s second-quarter earnings were substantially ahead of the Zacks Consensus Estimate. Despite the decreases in net interest revenue and fee income, BNY Mellon’s results benefited from lower operating expenses. Moreover, asset quality continued to show improvements and capital ratios remained healthy. We expect the top line to benefit from various restructuring initiatives and acquisitions. However, a low interest rate environment and changing regulatory landscape are expected to mar its revenue growth in the subsequent quarters. In addition, we remain wary of the rising operating expenses.”

Shares of Bank of New York Mellon traded down 0.65% during mid-day trading on Wednesday, hitting $22.81. Bank of New York Mellon has a one year low of $17.61 and a one year high of $24.72. The company has a market cap of $26.945 billion and a P/E ratio of 12.42.

Bank of New York Mellon last released its earnings data on Wednesday, July 18th. The company reported $0.57 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.53 by $0.04. Bank of New York Mellon’s revenue was down 6.1% compared to the same quarter last year. Analysts expect that Bank of New York Mellon will post $2.06 EPS for the current fiscal year.

Other equities research analysts have also recently issued reports about the stock. Analysts at Macquarie reiterated an “outperform” rating on shares of Bank of New York Mellon in a research note to investors on Monday. They now have a $28.00 price target on the stock. Separately, analysts at Citigroup initiated coverage on shares of Bank of New York Mellon in a research note to investors on Monday, September 24th. They set a “buy” rating and a $27.00 price target on the stock. They noted that the move was a valuation call. Finally, analysts at Rochdale Securities upgraded shares of Bank of New York Mellon from a “fairly valued” rating to an “under valued” rating in a research note to investors on Tuesday, September 18th. They now have a $31.00 price target on the stock, up previously from $23.00.

The Bank of New York Mellon Corporation (BNY Mellon) is a global financial services company. The Company divides its businesses into two principal segments: Investment Management and Investment Services.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Energy Transfer Partners remains a premier MLP with strategically-positioned assets that serve major North American natural gas-producing basins. We like the partnership’s robust organic growth profile, stable fee-based operating income and strong liquidity position. While the partnership kept its distribution unchanged, we expect growth to resume shortly, driven by the completion of a broad array of organic growth projects. Additionally, the proposed acquisition of Sunoco will help ETP to diversify and recalibrate its pipeline assets. However, we believe that the near- to medium-term outlook for the partnership’s natural gas gathering and processing business continues to be weak, which remains a major liability, in our view. As such, we rate Energy Transfer units as Neutral.”

Energy Transfer traded down 1.43% on Wednesday, hitting $41.795. Energy Transfer has a 1-year low of $40.55 and a 1-year high of $51.00. The company has a market cap of $10.256 billion and a price-to-earnings ratio of 9.01.

Energy Transfer last released its earnings data on Tuesday, August 7th. The company reported $0.00 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.38 by $0.38. Energy Transfer’s revenue was down 23.8% compared to the same quarter last year. On average, analysts predict that Energy Transfer will post $1.31 earnings per share for the current fiscal year.

Separately, analysts at Robert W. Baird initiated coverage on shares of Energy Transfer in a research note to investors on Wednesday, August 29th. They set a “neutral” rating and a $48.00 price target on the stock.

Energy Transfer Partners, L.P. (ETP) is a limited partnership based in the United States engaged in natural gas operations.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Buffalo Wild Wings posted lower-than-expected second quarter 2012 results due to higher wing costs. Thus, the hike in wing costs continues to remain a major headwind for 2012, hampering the profitability of the company. Due to this, the company also trimmed its net earnings growth outlook for 2012. Furthermore, an uncertain economic environment and stiff competition from other casual dining operators, along with budget-constrained customers, are the major concerns. However, the company’s long track-record of success, viable business strategy and debt-free balance sheet offer investors one of the strongest growth profiles in the industry. The company is also focusing on expanding in the international market and is combating cost inflation through menu price increases and expenses control. Hence, we remain Neutral on the stock. “

Shares of Buffalo Wild Wings traded down 0.05% during mid-day trading on Wednesday, hitting $85.25. Buffalo Wild Wings has a 52 week low of $56.47 and a 52 week high of $94.81. The company has a market cap of $1.585 billion and a P/E ratio of 29.00.

Buffalo Wild Wings last announced its earnings results on Tuesday, July 24th. The company reported $0.62 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.68 by $0.06. The company’s quarterly revenue was up 29.7% on a year-over-year basis. Analysts expect that Buffalo Wild Wings will post $3.18 EPS for the current fiscal year.

A number of other analysts have also recently weighed in on BWLD. Analysts at Deutsche Bank reiterated a “buy” rating on shares of Buffalo Wild Wings in a research note to investors on Monday. Finally, analysts at RBC Capital upgraded shares of Buffalo Wild Wings from a “sector perform” rating to an “outperform” rating in a research note to investors on Tuesday, September 25th. They now have a $95.00 price target on the stock.

Buffalo Wild Wings, Inc. is an owner, operator and franchisor of restaurants featuring a variety of menu items, including its Buffalo, New York-style chicken wings spun in any of its 14 signature sauces or four signature seasonings.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are upgrading our recommendation on Rogers Communications to Outperform based on its current valuation, which is trading at significantly low multiples compared to the industry average and the S&P 500, with respect to several valuation metrics. We believe massive expansion of LTE networks and an attractive dividend yield will also boost the stock price in the near future. As of now, Rogers expanded its superfast LTE network to 60% of Canada. Management has aimed to achieve 100% foothold by the end of 2013. Deployment of LTE network has resulted in a 80% year over year increase of Internet usage by its subscribers. Growing demand for mobile data and huge activation of latest smartphones will pave the way for Rogers’ future growth. The strategic decision taken by management to diversify in the mobile banking segment will also open up an additional revenue stream for the company. “

Several other analysts have also recently commented on the stock. Analysts at National Bank raised their price target on shares of Rogers Communications from $41.50 to $42.50 in a research note to investors on Monday. Separately, analysts at Bank of America upgraded shares of Rogers Communications from a “neutral” rating to a “buy” rating in a research note to investors on Wednesday, September 12th. They now have a $44.50 price target on the stock, up previously from $42.75. Finally, analysts at CIBC raised their price target on shares of Rogers Communications from $42.00 to $43.00 in a research note to investors on Monday, September 10th. They now have an “outperform” rating on the stock.

Shares of Rogers Communications traded up 0.81% during mid-day trading on Wednesday, hitting $40.85. Rogers Communications has a 52 week low of $32.83 and a 52 week high of $42.26. The company has a market cap of $21.048 billion and a P/E ratio of 14.04.

Rogers Communications last issued its quarterly earnings data on Tuesday, July 24th. The company reported $0.92 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.86 by $0.06. The company’s quarterly revenue was up .3% on a year-over-year basis. On average, analysts predict that Rogers Communications will post $3.14 earnings per share for the current fiscal year.

Rogers Communications Inc. (Rogers) is a diversified Canadian communications and media company with its operations in Canada.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Amazon.com is one of the largest online retailers in the world and despite its high market share, continues to grow strongly. However, the company’s decision to significantly increase the number of fulfillment centers to cater to demand across different markets and technology investments will likely have a negative impact on its earnings this year. Stiff competition and the corresponding pricing pressure are also expected to continue. We believe that current investments are supported by the strong balance sheet and expect them to drive the next growth phase, enabling international expansion. However, it is not clear how long the investment phase will continue, which makes us incrementally cautious. We therefore have a Neutral rating on Amazon shares. “

Other equities research analysts have also recently issued reports about the stock. Analysts at Jefferies Group reiterated a “buy” rating on shares of Amazon.com in a research note to investors on Wednesday. They now have a $300.00 price target on the stock. Separately, analysts at Piper Jaffray reiterated an “overweight” rating on shares of Amazon.com in a research note to investors on Monday. They now have a $297.00 price target on the stock. Finally, analysts at Cantor Fitzgerald initiated coverage on shares of Amazon.com in a research note to investors on Thursday, September 20th. They set a “buy” rating and a $300.00 price target on the stock.

Amazon.com traded up 1.33% on Wednesday, hitting $253.935. Amazon.com has a 52-week low of $166.97 and a 52-week high of $264.11. The company has a market cap of $114.8 billion and a price-to-earnings ratio of 305.24.

Amazon.com last posted its quarterly earnings results on Thursday, July 26th. The company reported $0.01 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.01. The company’s quarterly revenue was up 29.5% on a year-over-year basis. On average, analysts predict that Amazon.com will post $0.71 earnings per share for the current fiscal year.

Amazon.com, Inc. (Amazon.com) serves consumers through its retail Websites and focuses on selection, price, and convenience.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “Kimberly-Clark’s second quarter 2012 earnings of $1.30 per share surpassed the Zacks Consensus Estimate by 1.6% and the prior year quarter earnings by 10.2%. The upswing in earnings was driven by organic sales growth, cost savings and lower commodity cost. The company’s organic sales increased year on year on the back of volume growth and better pricing during the quarter. Moreover, we are encouraged by the company’s restructuring and cost saving program, which has improved profitability. Further, new innovations and the company’s international presence make the stock attractive. However, the company has been hit hard by an uncertain economy and increasing costs, which keep us on the sidelines with a Neutral rating and a target price of $91.00.”

KMB has been the subject of a number of other recent research reports. Analysts at UBS AG reiterated a “neutral” rating on shares of Kimberly Clark Corp in a research note to investors on Friday, July 27th. Separately, analysts at Deutsche Bank raised their price target on shares of Kimberly Clark Corp from $80.00 to $86.00 in a research note to investors on Friday, July 27th. Finally, analysts at Credit Agricole upgraded shares of Kimberly Clark Corp from an “underperform” rating to an “outperform” rating in a research note to investors on Friday, July 27th.

Shares of Kimberly Clark Corp traded up 0.15% during mid-day trading on Wednesday, hitting $86.50. Kimberly Clark Corp has a 52 week low of $68.27 and a 52 week high of $88.25. The company has a market cap of $34.158 billion and a P/E ratio of 19.06.

Kimberly Clark Corp last announced its earnings results on Thursday, July 26th. The company reported $1.30 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.28 by $0.02. The company’s quarterly revenue was up .2% on a year-over-year basis. On average, analysts predict that Kimberly Clark Corp will post $5.18 earnings per share for the current fiscal year.

Kimberly-Clark Corporation (Kimberly Clark), is engaged in the manufacturing and marketing of a range of products made from natural or synthetic fibers using advanced technologies in fibers, nonwovens and absorbency.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We are maintaining our Neutral recommendation on Dril-Quip over the long term. The company reported impressive second quarter results fueled by higher demand for offshore equipments. The increased deepwater activity over the near term, recent capacity additions in Brazil and Singapore, as well as ongoing capacity expansions could prove beneficial over time. However, Dril-Quip remains exposed to the highly volatile oil and gas sector fundamentals. We remain concerned about company-specific risks, which include new product growth challenges and potential backlog losses. Additionally, any delay in execution of contracts may also hinder the growth prospect of Dril-Quip. “

Other equities research analysts have also recently issued reports about the stock. Analysts at ISI Group upgraded shares of Dril-Quip from a “hold” rating to a “buy” rating in a research note to investors on Monday, September 24th. Separately, analysts at Global Hunter Securities downgraded shares of Dril-Quip from an “accumulate” rating to a “neutral” rating in a research note to investors on Monday, September 17th. They now have a $79.00 price target on the stock. Finally, analysts at Bank of America downgraded shares of Dril-Quip from a “buy” rating to an “underperform” rating in a research note to investors on Wednesday, August 8th. They now have a $79.00 price target on the stock, up previously from $72.00.

Shares of Dril-Quip traded up 1.13% during mid-day trading on Tuesday, hitting $72.18. Dril-Quip has a 52 week low of $47.49 and a 52 week high of $77.12. The company has a market cap of $2.918 billion and a P/E ratio of 26.24.

Dril-Quip last announced its earnings results on Monday, August 6th. The company reported $0.74 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.70 by $0.04. The company’s revenue for the quarter was up 28.9% on a year-over-year basis. Analysts expect that Dril-Quip will post $2.96 EPS for the current fiscal year.

Dril-Quip, Inc. (Dril-Quip) designs, manufactures, sells and services engineered offshore drilling and production equipment that is suited for use in deepwater, harsh environment and severe service applications.

To view Zacks’ full report, visit www.zacks.com

Zacks‘ analyst wrote, “We have reiterated our Neutral recommendation on Deere & Co. with a target price of $87. The company’s third quarter fiscal 2012 earnings of $1.98 per share missed the Zacks Consensus Estimate of $2.32. However, worldwide total sales increased 15% year over year to $9.59 billion, beating the Zacks Consensus Estimate of $9.49 billion. The ramp up in the construction industry is expected to increase demand for Deere’s construction equipment in the coming quarters. Moreover, worldwide crop production has been witnessing a bullish trend, which is expected to encourage farmers to invest more in machinery. However, severe drought conditions in the U.S. and a rising inventory level during the reported quarter remain headwinds for the company.”

A number of other analysts have also recently weighed in on DE. Analysts at Piper Jaffray reiterated an “overweight” rating on shares of Deere & Company in a research note to investors on Monday, September 24th. They now have a $91.00 price target on the stock. Separately, analysts at William Blair reiterated a “market perform” rating on shares of Deere & Company in a research note to investors on Wednesday, August 29th. They now have a $80.00 price target on the stock. Finally, analysts at UBS AG cut their EPS estimates on shares of Deere & Company in a research note on Thursday. They now have a “buy” rating and a $100.00 price target on the stock.

Deere & Company traded down 0.46% on Tuesday, hitting $82.22. Deere & Company has a 1-year low of $59.92 and a 1-year high of $89.70. The company has a market cap of $32.203 billion and a price-to-earnings ratio of 11.02.

Deere & Company last released its earnings data on Wednesday, August 15th. The company reported $1.98 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.32 by $0.34. Deere & Company’s revenue was up 15.6% compared to the same quarter last year. On average, analysts predict that Deere & Company will post $7.77 earnings per share for the current fiscal year.

Deere & Company (John Deere), along with its subsidiaries, operates in three segments: agriculture and turf segment, construction and forestry segment and financial services segment.

To view Zacks’ full report, visit www.zacks.com

Shares of U.S. Steel traded down 1.66% during mid-day trading on Tuesday, hitting $18.99. U.S. Steel has a one year low of $17.67 and a one year high of $32.52. The company’s market cap is $2.740 billion.

U.S. Steel last issued its quarterly earnings data on Tuesday, July 31st. The company reported $0.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.21. U.S. Steel’s revenue was down 2.0% compared to the same quarter last year. Analysts expect that U.S. Steel will post $1.45 EPS for the current fiscal year.

A number of other firms have also recently commented on X. Analysts at Deutsche Bank reiterated a “buy” rating on shares of U.S. Steel in a research note to investors on Monday, September 24th. They now have a $34.00 price target on the stock. Separately, analysts at Citigroup downgraded shares of U.S. Steel from a “buy” rating to a “neutral” rating in a research note to investors on Monday, September 24th. They now have a $23.00 price target on the stock, down previously from $30.00. Finally, analysts at Nomura downgraded shares of U.S. Steel from a “buy” rating to a “neutral” rating in a research note to investors on Thursday, September 20th. They now have a $20.00 price target on the stock.

United States Steel Corporation (U. S. Steel) produces and sells steel mill products, including flat-rolled and tubular products, in North America and Europe.

To view Zacks’ full report, visit www.zacks.com

Shares of Lowe’s traded down 0.07% during mid-day trading on Tuesday, hitting $30.29. Lowe’s has a 52 week low of $18.55 and a 52 week high of $32.29. The company has a market cap of $34.548 billion and a P/E ratio of 20.32.

Lowe’s last posted its quarterly earnings results on Monday, August 20th. The company reported $0.68 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.71 by $0.03. The company’s revenue for the quarter was down 2.0% on a year-over-year basis. Analysts expect that Lowe’s will post $1.65 EPS for the current fiscal year.

A number of other analysts have also recently weighed in on LOW. Analysts at RBC Capital reiterated an “outperform” rating on shares of Lowe’s in a research note to investors on Monday. They now have a $33.00 price target on the stock. Separately, analysts at Morgan Stanley raised their price target on shares of Lowe’s to $33.00 in a research note to investors on Monday. They now have an “overweight” rating on the stock. Finally, analysts at Nomura reiterated a “buy” rating on shares of Lowe’s in a research note to investors on Friday, September 7th. They now have a $32.00 price target on the stock.

Lowe’s Companies, Inc. (Lowe’s) is a home improvement retailer. As of February 3, 2012, Lowe’s operated 1,745 stores, consisted of 1,712 stores across 50 United States, 31 stores in Canada and two stores in Mexico.

To view Zacks’ full report, visit www.zacks.com

A number of other analysts have also recently weighed in on TSS. Analysts at Goldman Sachs reiterated a “neutral/neutral” rating on shares of Total System Services in a research note to investors on Tuesday, September 4th. They now have a $24.00 price target on the stock. Separately, analysts at Nomura reiterated a “neutral” rating on shares of Total System Services in a research note to investors on Wednesday, July 25th. Finally, analysts at JMP Securities downgraded shares of Total System Services from an “outperform” rating to a “market perform” rating in a research note to investors on Wednesday, July 25th.

Total System Services traded up 0.76% on Tuesday, hitting $23.79. Total System Services has a 1-year low of $16.59 and a 1-year high of $25.06. The company has a market cap of $4.474 billion and a price-to-earnings ratio of 18.69.

Total System Services last released its earnings data on Tuesday, July 24th. The company reported $0.35 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.32 by $0.03. The company’s revenue for the quarter was up 3.4% on a year-over-year basis. On average, analysts predict that Total System Services will post $1.29 earnings per share for the current fiscal year.

Total System Services, Inc. (TSYS) is a global payment solutions provider. During the year ended December 31, 2011, the Company operated in three segments: North America Services, which accounted for 51.

To view Zacks’ full report, visit www.zacks.com